Structural studies on dihydrolipoyl transacetylase : the core component of the pyruvate dehydrogenase complex of Azotobacter vinelandii by Hanemaaijer, J.R.O.
STRUCTURAL STUDIES ON 
DIHYDROLIPOYL TRANSACETYLASE 
the core component of the pyruvate dehydrogenase complex 
of Azotobacter vinelandii 
0000 0307 6235 
Promotor: dr. C. Veeger, hoogleraar in de Biochemie 
Co-promotor: dr. A. de Kok 
tö^oßzöf, /237-
J. R. O. Hanemaaijer 
STRUCTURAL STUDIES ON 
DIHYDROLIPOYL TRANSACETYLASE 
the core component of the pyruvate dehydrogenase complex 
of Azotobacter vinelandii 
PROEFSCHRIFT 
TER VERKRIJGING VAN DE GRAAD VAN 
DOCTOR IN DE LANDBOUWWETENSCHAPPEN 
OP GEZAG VAN DE RECTOR MAGNIFICUS, 
DR. H. C. VAN DER PLAS, 
IN HET OPENBAAR TE VERDEDIGEN 
OP WOENSDAG 5 OKTOBER 1988 
DES NAMIDDAGS TE VIER UUR IN DE AULA 
VAN DE LANDBOUWUNIVERSITEIT TE WAGENINGEN 
Yj\i ^Y9\VU 
]i lßLlÜ'i iU:,h;rv 
LANDBOUW UNilVEUSITEIT 
S WAGENJNGKNT 
Aan M ar ja 
en mijn ouders 
tjMo?zoty 123Ï-
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1 . 
De konklusie dat de Ei - en de E3 komponenten van het pyruvaat 
dehydrogenase complex uit E.coli op verschillende plaatsen op 
de E2-keten binden, is niet af te leiden uit de beschreven 
experimenten. 
L.C. Packman & R.N. Perham (1986), FEBS Lett. 206, 193-198 
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resultaten uit fluorescentiemetingen. 
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3. 
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aminozuursamenstelling niet van bekend is, kan noch met de 
methode van Lowry, noch met de Coomassie brilliant blue 
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De konklusie van Makinen & Makinen, dat modifikatie van een 
tyrosyl residue ten grondslag ligt aan de inaktivatie van 
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beschreven resultaten af te leiden. 
P-L Makinen & K.K. Makinen (1988) 
Biochem.Biophys.Res.Commun. 153, 74-80 
6. 
De konstatering van Yang et al. dat STEM-metingen een uit 24 
subunits bestaande PDC-core ondersteunen, is onjuist. 
H. Yang, J.F. Hainfeld, J.S. Wall & P.A. Frey (1985) 
J.Biol.Chem. 260, 16049-16052 
7. 
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Publishers, New York 
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INTRODUCTION 
Basic structure and mechanism 
The pyruvate dehydrogenase complex is a multi-enzyme complex 
which catalyzes the oxidative decarboxylation of pyruvate to 
acetylCoA. It is built from multiple copies of three enzymes: 
pyruvate dehydrogenase (Ei), dihydrolipoyl transacetylase (E2) 
and lipoamide dehydrogenase (E3) [1]. The mechanism of reaction 
is shown schematically in Fig. 1. Ej, which requires TPP as an 
essential cofactor, catalyzes the decarboxylation of pyruvate 
with formation of an hydroxyethyl intermediate. Ej then catalyzes 
the reductive acetylation of the lipoic acid cofactor of E2. This 
lipoyl group is covalently bound to the E2 core through an amide 
linkage with a lysine e-aminogroup [2]. The acetylgroup is 
transferred by E2 to CoA. The reduced lipoic acid cofactor is 
reoxidized by E3, which via FAD and a redox-active S-S bridge 
transfers the reduction equivalents to NAD+. 
PDC is closely related to two other 2-oxoacid dehydrogenase 
multi-enzyme complexes: the 2-oxoglutarate dehydrogenase complex 
(OGDC) of the tricarboxylic acid cycle, and the branched-chain 
2-oxoacid dehydrogenase complex (BCOADC) of the common pathway 
for the catabolism of the essential branched-chain amino acids 
0 
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Figure 1. Reaction nechanisn of the pyruvate dehydrogenase conplex. 
[3](Fig. 2). These complexes are built fron similar components, 
2-oxoacid dehydrogenase (El), acyltransferase (E2) and lipoamide 
dehydrogenase (E3). E3 is apparently common to all three complexes 
[4], whereas Ej and Eg are unique to each complex. The basis of 
overall structure of the three complexes is similar, with E2 
forming a structural, symmetrical core to which the E^ and E3 
components are tightly but non-covalently bound [5]. OGDC is iso-
lated from Gram-negative bacteria [6,7] and mammals [8]. It is 
composed of a core of 24 Eg subunits, arranged in a cubic struc-
ture with 432 symmetry. The same structure is found for BCOADC 
from mammals [9]. The quaternary structure is most variable in 
carbohydrate 
amino acids 
fatty acids -
pyruvate 
I ŒU 
— — a c e t y l C o A —•-
a ketoglutacate 
Figure 2. Outl ine of the » e t a b o l i e r o l e of the 2-oxoacid dehydrogenase complexes. PDC - pyru-
vate dehydrogenase complex; OGDC - 2-oxoglutarate dehydrogenase complex; BCOADC « branched-
chaln 2-oxoacid dehydrogenase complex; TCA cyc le - t r i c a r b o x y l i c acid c y c l e . The broken l i n e s 
indicate that several s t e p s are involved. 
PDC. The E2 core of PDC from the Gram-negative bacterium E.co l i i s 
a l so composed of 24 subuni ts [ 6 , 10 ] , but the E2 core of PDC from 
mammalian sources [ 5 ] , yeas t [11] or Gram-positive b a c t e r i a [12] 
c o n s i s t s of 60 subun i t s , showing icosahedral symmetry. In the gram 
negat ive A.v ine landi i PDC i s based on a t e t r amer i c E2 core [13] . 
This core , upon removal of the per iphal components, a s s o c i a t e s to 
an E . c o l i - l i k e s t r u c t u r e , as observed on electronmicrographs and 
in the a n a l y t i c a l u l t r a c e n t r i f u g e [14] . 
In a l l organisms s tudied Ej and E3 are bound as dimers to the 
E2 core [5 ,11 ,12 ] . In Gram-negative b a c t e r i a Ej i s i d e n t i f i e d as a 
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homodimer [5], in Gram-positive bacteria and mammals as a dimer of 
non-identical chains [9,12]. E3 is always identified as a dimer, 
the same is shown for Ej from OGDC [15]. Transmission electron 
microscopy of partly assembled PDC and OGDC from E.coll reveals E3 
as binding on the faces of the cube with Ej bound along the edges 
[16]. This has been confirmed by computer modelling [17] and by 
scanning transmission electron microscopy [18,19]. 
Regulation 
Bacterial PDC's are regulated by feed-back inhibition (NADH, 
acetylCoA) and by cooperative binding of pyruvate and CoA [20-
22]. The sites of allosteric action are located on the Ej-
component. It was shown for PDC from Pseudomonas aerigunosa that 
also NAD+, which will act on the E3 component, shows cooperativity 
towards the enzyme complex [23]. Mammalian PDC has a more 
sophisticated regulation mechanism. To the E2 component a kinase 
is tightly bound and a phosphatase is loosely bound [24,25]. 
Inactivation of the complex occurs after phosphorylation by kinase 
of the a-subunit of Ej [26]. Multiple sites are phosphorylated, 
although inactivation occurs with phosphorylation of one specific 
site [27,28]. The role of the additional sites are unclear yet. 
The inactivation is reversible. After action of the phosphatase, 
activity is restored for 100%. The kinase and phosphatase activi-
ties are regulated by the present amount of substrates and pro-
ducts, cations (Mg2+, Ca2+) and hormones [29-31]. Recently an 
additional component of mammalian PDC, protein X, has been iden-
tified. It possesses a lipoic acid cofactor which can be acety-
lated [32]. The role of protein X is unclear yet, but a possible 
involvement in anchoring the kinase to the PDC core has been 
suggested [33]. 
Stoichiometry and size 
The best studied PDC is that of E.coli. However, subunit 
structure and molecular weight have been subject to considerable 
controversy. Reconstitution experiments by the group of Reed [10] 
showed a catalytic optimum stoichiometry of 24:24:12 (Ej:E2:E3). 
By the group of Perham [34] in reconstitution experiments a 
15 
stoichiometry of 38:24:19 is reported, which agrees well with 
direct chain stoichiometry determinations of 28-36:24:14-20 
[35,36]. These ratios have been recalculated [37] from the 
original values using the amino acid compositions and molecular 
masses obtained from the DNA-sequences of the structural genes 
for Ej, E2 and E3 [38-40]. Recent reconstitution experiments by 
De Kok et al. [41] confirmed the catalytic optimum stoichiometry 
of 24:24:12. In reconstitution experiments using analytical 
ultracentrifugation saturation at an E1/E2 ratio of 2.0 and an 
E3/E2 ratio of 2.5 was observed [41]. Obviously, more Ej and E3 
can bind without effecting the activity. Therefore it is 
concluded that the complex is not an exact, homogeneous 
structure. This is in agreement with the determination of the 
molecular mass of the whole complex, ranging from 3.8-6.1 MDa 
[42-45]. PDC from A.vinelandii shows a catalytic optimum at a 
stoichiometry of 6:4:2 [13]. It is the smallest complex isolated, 
Mr ± 860 kDa [14]. Because of their large structural cores 
complexes from other sources are large enzymes with M r 5-10xl06. 
On electron micrographs they can easily be seen as particles 
having a diameter of 20-45 nm [12,16]. This means that they are 
larger than ribosomes. There are reports [46-48] that the isolated 
E.coli PDC is not homogeneous, but that in addition to the main 
component with S2o,w = 60S it contains a smaller subcomplex, S2o,w 
= 17S, which is enzymatically active. Also in pigeon breast muscle 
in the presence of Triton a 1000 kDa active PDC has been deter-
mined [49], and in mammalian PDC in the presence of Triton an 
equilibrium between a small enzymatically active particle of 
1000-3000 kDa and the regular PDC of 8000 kDa [50] has been 
observed [51]. After immunolabelling of innermembrane vesicles no 
large PDC was found. The same result was obtained after immunola-
belling of permeabilized mitochondria. These studies suggest that 
in situ and probably ^n vivo, PDC is not present as the large 
molecule which is found after isolation of the complex. 
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The E 2 component of PDC 
Primary structure and the lipoic acid cofactor 
In A.vinelandii 2-2.5 lipoyl groups per E2 chain were determined 
by 14C-acetyl incorporation [52], NEM-labelling [53] and by 
modification with TNBS [14]. E.coli E 2 possesses two lipoyl groups 
per chain after labelling of the complex with substrates [54-56] 
and by direct measurements by means of mass spectrometry [57], 
although the possibility of three lipoyl groups per E 2 chain, 
found after growing E.coli on (35s)-sulphate, could not be 
excluded [57]. Since only one lipoyl-lysine residue containing 
sequence could be identified, the presence of repeating sequences 
in the primary structure of E 2 was suggested [58]. Such an orga-
nization of the E 2 chain became evident from the primary struc-
ture, inferred from the determination of the DNA-sequence of the 
structural gene encoding E 2 [39]; three highly homologous regions 
of sequence, comprising about 100 amino acid residues each, are 
repeated in the N-terminal half of the protein (Fig. 3). A poten-
tial lipoylatlon site is present in each repeat. All three sites 
in E 2 are at least partly lipoylated [37] and each lipoyl group 
can be reductively acetylated by pyruvate. 
Three lipoyl groups per E 2 chain of PDC is specific for Gram-
negative bacteria. E 2 chains from PDC from mitochondria or Gram-
positive bacteria contain only one lipoyl group [51,59-61]. Also 
OGDC's possess only one lipoyl group per E 2 chain [57,62]. The 
three repeats in E 2 of PDC from E.coli can be obtained by limited 
proteolysis (see below) as functional entities [37], indicating an 
independent folding. Why the E 2 chains from E.coli and 
A.vinelandii possess a three-fold repeat of lipoyl domains is 
obscure. It is shown that not all lipoyl domains in E.coli are 
required for activity. A part of them can be chemically modified 
or excised enzymatically without a corresponding loss of complex 
activity [63-66]. With genetic engineering experiments, in which 
deletions were made of one or two of the repeating units in the 
gene encoding E.coli E 2 [67,68], a fully active complex was 
obtained, suggesting that the extra two lipoyl domains can be 
regarded as surplus. 
17 
Domain structure 
The tertiary structure of E2 contains specific features to locate 
the lipoyl groups, the transacetylase active site, the binding 
sites for the Ej and E3 components and the E2 intersubunit 
binding sites. The E2 components of all 2-oxoacid dehydrogenase 
complexes are exceptionally sensitive to proteolytic cleavage 
under non-denaturing conditions [59,62,63,69-71]. After limited 
proteolysis usually a domain bearing the lipoyl group(s) is 
readily cleaved off, suggesting that this domain distinguishes 
itself physically from a structural core. In E.coli the lipoyl 
domain can be proteolysed into three stable domains, resembling 
the single stable domain obtained after proteolysis of E2 from 
Gram-positive bacteria or mitochondria [37]. In the structural 
core domain the quaternary structure of intact E2 and the tran-
sacetylase active site are retained [62,63]. The binding sites for 
the Ej and E3 components are retained [63,72] or lost [70,73-75] 
during proteolysis, depending on the source of the E2 and on the 
conditions of proteolysis. After limited proteolysis of E.coli E2 
a core domain is found which is still able to bind Ej and E3 
[63,76]. Under harsher conditions a + 6 kDa smaller domain is 
found (called catalytic domain), which no longer contains the E3 
binding site [74]. The E^ binding site has been claimed to be 
retained on the catalytic domain, although limited proteolysis 
experiments with PDC and OGDC from other organisms suggest that 
the Ei and E3 binding sites are located in the same regions 
[70,73] . 
The region between the lipoyl domain and the catalytic domain is 
easily proteolysed. It contains many charged residues and is 
therefore indicated as a hinge region. From limited proteolysis 
experiments and the primary structure a model for the structure 
of the E2 chain can be derived as shown in Fig. 3. On electron 
micrographs the structural core shows a similar, but somewhat 
clearer cubic appearance as intact E2 [63]. Obviously, in 
electron micrographs of E2 the lipoyl domain, accounting for about 
half of the E2 chain, is only visible as a diffuse appearance 
around the cubic structure. 
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Figure 3. A model for the structure of the E2 chain fro» PDC. E2(G-)- Eg chain fron Gram-
negative bacteria; E2(G+.M)-= E2 chain fro« Gram-positive bacteria and mitochondria. It also . 
represents the E2-chain fro» OGDC. The site of lipoylation is indicated by o. represents a part 
of the E2 chain rich in alanine, proline and charged amino acids. The residue numbering is 
based on data from E.coli. 
Mobility and active-site coupling 
The extent of reductive acetylation of the reconstructed complex 
with one lipoyl domain is 40-50% below the expected value, 
indicating that only 50* of the sites are lipoylated [64-66], 
while still full activity was present. In Bacillus 
staerothermophilus PDC, containing only one lipoyl domain, about 
half of the lipoyl domains could be removed from E2 by chymotryp-
tic digestion, without loss of activity [60]. These results can 
be explained in the light of active site coupling: the lipoyl 
groups of different E2 chains can interact with each other via an 
extensive network of intramolecular coupling reactions that per-
mits the transfer of acetyl groups between E2 subunits within the 
enzyme core [55,56,77]. In addition, the active site of an E^ 
subunit can be visited by more than one lipoyl group [65,66,78]. 
The lipoyl group, shuttling the substrates between the different 
active sites in the complex, is thought to rotate as a 'swinging 
arm' between the active sites [79]. After labelling the lipoyl 
group with spinlabels indeed mobility was found [80,81]. However, 
in fluorescence experiments no energy transfer between the 
labelled active sites of the different components was found, from 
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which it was concluded that the active sites of the different com-
ponents are at least 4 nm apart in the complex [82-84] , too far 
away for a single lipoyl-lysine group. Both the large distance and 
the active site coupling involve movement of the region of the 
Eg chain around the lipoyl group. Strong evidence in favor of the 
existence of conformational mobility in the Eg chain has been 
obtained from 'H-NMR spectroscopy [85,86]. The 'H-NMR-spectrum of 
the intact complex features some sharp signals characteristic of 
mobile polypeptide chain [85]. A major source of the unusually 
sharp signal is thought to be the three long alanine+proline-rich 
regions which link the lipoyl domains to each other and to the E3 
binding domain [37,87-89]. In addition a second sharp signal is 
found, probably arising from a smaller alanine+proline-rich 
region, located at the N-terminus of the catalytic domain [87,89]. 
Because the E3 binding site is located in the region between the 
lipoyl domain and the catalytic (core) domain [74,75], it is 
suggested [89,90] that, if this alanine-proline segment is confor-
mationally mobile, this could explain the unexpected mobility of 
E3, bound to the Eg core [91]. Because of the limited solubility 
of E.coli Eg no 'H-NMR spectrum of isolated Eg is known. 
A.vinelandii PDC 
The A.vinelandii PDC is the smallest PDC which is isolated. Its 
sedimentation coefficient is 17-19S [14,92], and its molecular 
mass is about 850 kDa. Previously it was isolated as a four-
component complex [92,93]. The function of the fourth component 
(63 kDa on SDS-gel) was obscure. It has been shown that it could 
act as an additional transacetylase [94], may be analogous to the 
protein X, which is found as a fourth component in mammals 
[32,33]. The fourth component of A.vinelandii PDC can be resolved 
from the complex without loss in activity (6U/mg)[93], and via a 
modification in the isolation procedure a three component complex 
is isolated with a high specific activity (15-19U/mg)[52]. 
The complex can be resolved into its components by thiol-
Sepharose chromatography [95]. After reconstitution the overall-
activity is restored for 100* [96]. After resolution the 
tetrameric E2 core associates to a multimeric structure, 
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analogous to the E.coli structure [14]. Based on the molecular 
mass of the large structure (1.9-2.1 MDa), the cubic appearance 
on electronmicrographs, and the E.coli model of a cube composed 
of eight morphological subunlts, a 32-meric structure was 
concluded [14], built from eight tetramers. Within the tetrameric 
E2 core active-site coupling is observed, but, in contrast to 
E.coli, no coupling is observed within the large aggregated core 
[52]. Upon addition of the peripheral components the 32-mer 
dissociates again into tetramers. Besides aggregation of the 
isolated E2 core also aggregation of the whole complex is found. 
In the presence of polyethylene glycol and MgCl2 the A.vinelandii 
complex associates to a well defined, E.coli-like, polymer with a 
sedimentation coefficient of 56-60S [97]. From pressure-dependent 
light-scattering studies [42] an association from tetramer into 
32-mer is proposed, although from the results an association into 
24-mer cannot be excluded. In reconstitution experiments [96] 
active hybrid complexes can be obtained from either an 
E1E2 subcomplex from A.vinelandii and the E3 component from E.coli 
or from an E2E3 subcomplex from E.coli and the Ej component from 
A.vinelandii, showing that the binding sites on E2 for the 
peripheral components are largely conserved. 
Obviously, many similarities exist between the A.vinelandii and 
the E.coli complexes, although differences are present like mole-
cular mass, stoichiometry and active site coupling. Since the 
similarities and differences are mainly concerned within the E2 
component, we focussed our attention to this component of the 
pyruvate dehydrogenase complex from A.vinelandii. 
In this thesis the domain structure of A.vinelandii E2 is 
analysed by limited proteolysis, the primary strucure is 
determined by cloning and sequencing the gene encoding E2. A 
production clone is obtained of E2 and of the two main domains, 
yielding a 15-fold higher expression of E2 with a two-fold higher 
specific activity as found in A.vinelandii itself. The mobility 
of the lipoyl domain is analysed by time-resolved fluorescence 
anisotropy decay. Because of the high solubility of E2 and the 
catalytic domain we were able to obtain 600 MHz 'H-NMR spectra of 
OGDC, PDC, E2 and the catalytic domain. From hydrodynamic studies 
on E2 and the catalytic domain it is shown that isolated 
A,vlnelandii E2 consists of 24 subunits. A model is presented in 
which the A.vinelandii complex can be regarded as a morphological 
subunit of the cubic pyruvate dehydrogenase complex from E.coli. 
This model may be universal for all the related 24-meric 2-oxoacid 
dehydrogenase complexes. 
References 
1. Reed, L.J. & Cox, D.J. (1966) Annual Reviews Biochem. 35, 57. 
2. Nawa, H., Brady, W.T., Koike, M. & Reed, L.J. (1960) 
J.Am.Chem.Soc. 82, 896. 
3. Martin, R.R., Marshall, V.P., Sokatch, J.R. & Unger, L. (1973) 
J.Bacteriol. 115, 198. 
4. Reed, L.J., Pettit, F.H., Yeaman, S.J. & Teague. W.M. (1980) 
in "Enzyme Regulation and Mechanism of Action" (Mildner, P. & 
Ries, B. eds.) pp. 47-56, Pergamon Press Ltd., Oxford. 
5. Reed, L.J. (1974) Ace.Chem.Res. 7, 40. 
6. Reed, L.J. & Oliver, R.M. (1968) Brookhaven Symp.Biol. 21, 
397. 
7. Pettit, F.H., Hamilton, L., Munk, P., Namihira, G., Eley, 
M.H., Wilms, CR. & Reed, L.J. (1973) J.Biol.Chem. 248, 5282. 
8. Koike, M., Hamada, M., Koike, K., Hiraoka, T. & Nakaula, Y. 
(1976) In "Thiamine" (Gubler, C.J., Fujiwara, M & Dreyfus, 
P.M., eds.) pp. 5-18. John Wiley, New York. 
9. Reed, L.J., Damuni, Z. & Merryfield, M.L. (1985) 
Curr.Top.Cell.Regul. 27, 41. 
10. Eley, M.H., Namihira, G., Hamilton, L., Munk, P. & Reed, L.J. 
(1972) Arch.Biochem.Biophys. 152, 655. 
11. Reha, E.E., Ronft, H. & Kresze, G.-B. (1982) FEBS Lett. 145, 
289. 
12. Henderson, CE., Perham, R.N. & Finch, J.T. (1979) Cell 17, 
85. 
13. Bosma, H.J. , Westphal, A.H., de Kok, A. & Veeger, C. (1984) 
Eur.J.Biochem. 142, 541. 
14. Bosma, H.J., de Kok, A., van Markwijk, B.W. & Veeger, C 
(1984) Eur.J.Biochem. 140, 273. 
15. Stepp, L.R., Pettit, F.H., Yeaman, S.J. & Reed, L.J. (1983) 
J.Biol.Chem. 258, 9454. 
22 
16. Oliver, R.M. & Reed, L.J. (1982) irT'Electron Microscopy of 
Proteins" (Harris, R., ed.), vol. 1, pp. 1-48, Academic Press, 
London. 
17. Hackert, M.L., Oliver, R.M. & Reed, L.J. (1983) 
Proc.Natl.Acad.Sei.USA 80, 2907. 
18. Yang, H., Hainfield, J.F., Wall, J.S. & Frey, P.A. (1985) 
J.Biol.Chem. 260, 16049. 
19. Wagenknecht, T., Francis, N., DeRosier, D.J., Hainfield, J.F. 
& Wall, J.S. (1987) J.Chem.Biol. 262, 877. 
20. Schwartz, E.R. & Reed, L.J. (1970) Biochemistry 9, 1434. 
21. Bisswanger, H. & Henning, U. (1971) Eur.J.Biochem. 24, 376. 
22. Bisswanger. H. (1974) Eur.J.Biochem. 48, 377. 
23. Ghosh, R., Guest, J.R. & Jeyaseelan, K. (1981) 
Biochim.Biophys.Acta 658, 232. 
24. Linn, T.C., Pelley, J.W., Hucho, F. & Reed, L.J. (1972) 
Arch.Biochem.Biophys. 148, 327. 
25. Barrera, CR., Namihira, G., Hamilton, R., Munk, P., Eley, 
M.H., Linn, T.C. & Reed, L.J. (1972) Arch.Biochem.Biophys. 
148, 343. 
26. Roche, T.E. & Reed, L.J. (1972) Biochem.Biophys.Res.Commun. 
48, 840. 
27. Cook, K.G., Lawson, R. & Yeaman, S.J. (1983) FEBS Lett. 157, 
59. 
28. Denton, R.M. & McCormack, J.G. (1985) Am.J.Physiol. 249, E543. 
29. Denton, R.M., Rändle, P.J. & Martin, B.R. (1972) Biochem.J. 
128, 161. 
30. Rändle, P.J. (1978) Trends Biochem.Sei. 3, 217. 
31. Block, K.P., Heywood, B.W., Buse, M.G. & Harper, A.E. (1985) 
Biochem.J. 232, 593. 
32. Hodgson, J.A., De Marcucci, O.G. & Lindsay, J.G. (1986) 
Eur.J.Biochem. 158, 595. 
33. Rahmatullah, M., Jilka, J.M., Radke, G.A. & Roche, T.E. (1986) 
J.Biol.Chem. 261, 6515. 
34. Bates, D.L., Danson, M.J., Hale, G., Hooper, E.A. & Perham, 
R.N. (1977) Nature 268, 313. 
35. Bates, D.L., Harrison, R.A. & Perham, R.N. (1975) FEBS Lett. 
60, 427. 
36. Hale, G. & Perham, R.N. (1979) Biochem.J. 177, 129. 
23 
37. Packman, L.C., Hale, G. & Perham, R.N. (1984) EMBO J. 3, 1315. 
38. Stephens, P.E., Darlison, M.G., Lewis, H.M. & Guest, J.R. 
(1983) Eur.J.Biochem. 1J33, 35. 
39. Stephens, P.E., Darlison, M.G., Lewis, H.M. & Guest, J.R. 
(1983) Eur.J.Biochem. 133, 481. 
40. Stephens, P.E., Lewis, H.M., Darlison, M.G. & Guest, J.R. 
(1983) Eur.J.Biochem. 135, 519. 
41. De Kok, A., Bosma, H.J., Westphal, A.H. & Veeger, C. (1988) In 
"Thiamine Pyrophate Biochemistry", Vol. 2, (Schowen, R. & 
Schellenberger, A., eds.), pp. 19-36, CRC Press, Boca Raton. 
42. Danson, M.J., Hale, G., Johnson, P., Perham, R.N., Smith, J. & 
Spragg, P. (1979) J.Mol.Biol. 129, 603. 
43. Anglides, K.J., Akiyama, S.K. & Hammes, G.G. (1979) 
Proc.Natl.Acad.Sei.USA 75, 4877. 
44. Durchschlagg, H. (1975) Mechanism 1, 153. 
45. Vogel, 0., Hoehn, B. & Henning, U. (1972) Eur.J.Biochem. 30, 
354. 
46. Schmitt, B. (1975) Biochimie 58, 1405. 
47. Schmitt, B. & Cohen, R. (1980) Biochera.Biophys.Res.Commun. 
135, 802. 
48. Gilbert,G.A. & Gilbert, L.M. (1980) J.Mol.Biol. 144. 405. 
49. Forster, M., Schumacher, J., Brouwer, M. & Staib, W. (1985) 
Hoppe-Seylers Z.Physiol.Chem. 366, 787. 
50. Hayakawa, T., Kanazaki, T., Kitamura, T., Fukoyoshi, Y., 
Sakurai, Y., Koike, K., Suematsu, T. & Koike, M.(1969) 
J.Biol.Chem. 244, 3660. 
51. Sumegi, B., Liposits, Z., Inman, L., Pauli, W.K. & Srere, P.A. 
(1987) Eur.J.Biochem. 169, 223. 
52. Bosma, H.J., de Graaf-Hess, A.C., de Kok, A., Veeger, C , 
Visser, A.J.W.G. & Voordouw, G. (1982) Ann.N.Y.Acad.Sci. 378, 
265. 
53. De Kok, A., Visser, A.J.W.G. & de Graaf-Hess, A.C. (1982) In 
"Flavins and Flavoproteins" (Massey, V. & Williams, C.H., 
eds.) pp. 61-67, Elsevier, Amsterdam. 
54. Danson, M.J. & Perham, R.N. (1976) Biochem.J. 159, 677. 
55. Bates, D.L., Danson, M.J., Haie, G., Hooper, E.A. & Perham, 
R.N. (1977) Nature, Lond. 268, 313. 
56. Collins, J.H. & Reed, L.J. (1977) Proc.Natl.Acad.Sci.USA 76, 
2k 
4385. 
57. White, R.H. , Bleue, D.M. & Reed, L.J. (1980) 
Biochem.Biophys.Res.Commun. 94, 78. 
58. Hale, G. & Perham, R.N. (1980) Biochem.J. 187, 905. 
59. Bielle, D.M., Hackert, M.L., Pettlt, F.H. & Reed, L.J. (1981) 
J.Biol.Chem. 256, 514. 
60. Duckworth, H.W., Jaenicke, R., Perham, R.N., Wilkle, A.G., 
Finch, J.T. & Roberts. G.C.K. (1982) J.Biol.Chem. 260, 13779. 
61. Hamada, M., Hiraoka, T., Koike, K., Ogasahara, K., Kanzaki, T. 
& Koike, M. (1979) J.Biochem. 79, 1273. 
62. Perham, R.N. & Roberts, G.C.K. (1981) Biochem.J. 199, 733. 
63. Bleile, D.M., Munk, P., Oliver, R.M. & Reed, L.J. (1979) 
Proc-Natl.Acad.Sci.USA 76, 4385. 
64. Ambrose-Griffin, M.C., Danson, M.J., Griffin, W.G., Haie, G. & 
Perham, R.N. (1980) Biochem.J. 187, 393. 
65. Stepp, L.R., Bleile, D.M., McRorie, D.K., Pettit, F.H. & Reed, 
L.J. (1981) Biochemistry 20, 4555. 
66. Berman, J.N., Chen, G.-X., Haie, G. & Perham, R.N. (1981) 
Biochem.J. ^ 99, 513. 
67. Guest, J.R., Lewis, H.M., Graham, L.D., Packman, L.C. & 
Perham, R.N. (1985) J.Mol.Biol. 185, 743. 
68. Graham, L.D., Guest, J.R., Miles, J.S., Packman, L.C., Perham, 
R.N. & Radford, S.E. (1986) Phi 1.Trans.R.Soc.Lond.A317, 391. 
69. Packman, L.C. & Perham, R.N. (1984) Biochem.J. 242, 531. 
70. Perham, R.N. & Wilkie, A.O.M. (1980) Biochem.Int. 1, 470. 
71. Chuang, D.T., Hu, C.-W.C, Ku, L.S., Markovitz, P.J. & Cox, 
R.P. (1985) J.Biol.Chem. 260, 13779. 
72. Packman, L.C., Perham, R.N. & Roberts, G.C.K. (1984) 
Biochem.J. 217, 219. 
73. Kresze, G.B., Ronft, H. & Dietl, B. (1980) Eur.J.Biochem. 105, 
371. 
74. Packman, L.C. & Perham, R.N. (1986) FEBS Lett. 306, 193. 
75. Packman, L.C. & Perham, R.N. (1987) Biochem.J. 242, 531. 
76. Haie, G. & Perham, R.N. (1979) FEBS Lett. 105, 263. 
77. Packman, L.C., Stanley, C.J. & Perham, R.N. (1983) Biochem.J. 
213, 331. 
78. Hackert, M.L., Oliver, R.M. & Reed, L.J. (1983) 
Proc-Natl.Acad.Sci.USA 80, 2907. 
25 
79. Koike, M., Reed, L.J. & Caroll, W.R. (1963) J.Biol.Chem. 235, 
1924. 
80. Grande, H.J., Bresters, T.W., de Abreu, R.A., de Kok, A. & 
Veeger, C. (1975) Eur.J.Biochem. 59, 355. 
81. Ambrose, M.C. & Perham, R.N. (1976) Biochem.J. 155, 429. 
82. Moe, O.A.Jr., Lerner, D.A. & Hammes, G.G. (1974) Biochemistry 
13, 2552. 
83. Shepherd, G.B. & Hammes, G.G. (1977) Biochemisty 16, 5234. 
84. Scouten, W.H., de Graaf-Hess, A.C., de Kok, A., Visser, 
A.J.W.G. & Veeger, C. (1978) Eur.J.Biochem. 84, 17. 
85. Perham, R.N., Duckworth, H.W. & Roberts, G.CK. (1981) Nature, 
Lond. 292, 474. 
86. Roberts, G.C.K., Duckworth, H.W., Packman, L.C. & Perham, R.N. 
(1983) Ciba Found.Symp. 93, 47. 
87. Spencer, M.E., Darlison, M.G., Stephens, P.E., Duckenfield, 
I.K. & Guest, J.R. (1984) Eur.J.Biochem. 141, 361. 
88. Radford, S.E., Laue, E.D. & Perham, R.N. (1986) 
Biochem.Soc.Trans. 14, 1231. 
89. Radford, S.E., Laue, E.D., Perham, R.N., Miles, J.S. & Guest, 
J.R. (1987) Biochem.J. 247, 641. 
90. Perham, R.N., Packman, L.C. & Radford, S.E. (1988) 
Biochem.Soc.Symp. 54, 67. 
91. Grande, H.J., Visser, A.J.W.G. & Veeger, C. (1980) 
Eur.J.Biochem. 106, 361. 
92. Bresters, T.W., De Abreu, R.A., de Kok, A., Visser, J. & 
Veeger, C. (1975) Eur.J.Biochem. 59, 335. 
93. De Abreu, R.A., de Kok, A. & Veeger, C. (1977) FEBS Lett. 82, 
99. 
94. De Abreu, R.A., de Kok, A., de Graaf-Hess, A.C. & Veeger, C. 
(1977) Eur.J.Biochem. 81, 357. 
95. De Graaf-Hess, A.C. & de Kok, A. (1982) FEBS Lett. 143, 261. 
96. De Kok, A. & Westphal, A.H. (1985) Eur.J.Biochem. 152, 35. 
97. Bosma, H.J., Voordouw, G., de Kok, A. & Veeger, C. (1980) FEBS 
Lett. 120, 179. 
26 
CHAPTER 2 
THE DOMAIN STRUCTURE OF THE DIHYDROLIPOYL TRANSACETYLASE 
COMPONENT OF THE PYRUVATE DEHYDROGENASE COMPLEX FROM 
AZOTOBACTER VINELANDII 
Roeland Hanemaaijer, Arie de Kok, Jacqueline Jolles and 
Cees Veeger 
27 
Eur. J. Biochem. 169. 245-252 (1987) 
© FEBS 1987 
The domain structure of the dihydrolipoyl transacetylase component 
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Limited proteolysis with trypsin has been used to study the domain structure of the dihydrolipoyltransacetylase 
(E2) component of the pyruvate dehydrogenase complex of Azotobacter vinelandii. Two stable end products were 
obtained and identified as the N-terminal lipoyl domain and the C-terminal catalytic domain. By performing 
proteolysis of E2 , which was covalently attached via its lipoyl groups to an activated thiol-Sepharose matrix, a 
separation was obtained between the catalytic domain and the covalently attached lipoyl domain. The latter was 
removed from the column after reduction of the S-S bond and purified by ultrafiltration. The lipoyl domain is 
monomeric with a mass of 32.6 kDa. It is an elongated structure with f/f0 = 1.62. Circulair dichroic studies 
indicates little secondary structure. The catalytic domain is polymeric with s2o.w = 17 S and mass = 530 kDa. It 
is a compact structure with //ƒ„ = 1.24 and shows 40% of the secondary structure of E2 . The cubic structure of 
the native E2 is retained by this fragment as observed by electron microscopy. Ultracentrifugation in 6 M guanidine 
hydrochloride in the presence of 2 mM dithiothreitol yields a mass of 15.8 kDa. An N-terminal sequence of 36 
amino acids is homologous with residues 370 — 406 of Escherichia colt E2 . The catalytic domain possesses the 
catalytic site, but in contrast to the E. coli subunit binding domain the pyruvate dehydrogenase ( E ^ and lipoamide 
dehydrogenase (E3) binding sites are lost during proteolysis. From comparison with the E. coli E2 sequence a 
model is presented in which the several functions, such as lipoyl domain, the E3 binding site, the catalytic site, 
the E 2 /E 2 interaction sites, and the E, binding site, are indicated. 
The pyruvate dehydrogenase complex (PDC) catalyzes 
the oxidative decarboxylation of pyruvate resulting in the 
production of acetyl-coenzyme A and N A D H . In gram-nega-
tive bacteria three enzymes take part in this reaction : pyruvate 
dehydrogenase (Ei), lipoylacetyltransferase (E2) and 
lipoamide dehydrogenase (E3). E t and E3 are non-covalently 
bound as dimers to a core of E2 [1], The structure of PDC 
from Azotobacter vinelandii is based on a tetrameric core of 
E2 , to which three E] dimers and one E3 dimer are bound [2]. 
This quaternary structure differs considerably from that of 
the Escherichia coli PDC which is based on a core of 24 E2 
chains arranged in a cubic structure with 432 symmetry [3]. 
To this core twelve E] dimers and six E 3 dimers are bound in 
the catalytically optimum stoichiometry [4], Upon removal of 
the peripheral components, the A. vinelandii E2 associates to 
multimer. Although its appearance in the electron 
microscope is similar to that of E. coli E 2 , hydrodynamic 
studies indicate differences in quaternary structure [5, 6]. Ex-
periments with hybrid E. colijA. vinelandii PDC complexes 
Correspondence to A. de Kok, Laboratorium voor Biochemie, 
Landbouwuniversiteit, De Dreijen 11. NL-6703 BC Wageningen, The 
Netherlands 
Abbreviations. Pyruvate dehydrogenase complex, PDC; phen-
ylmethylsulfonyl fluoride, PhMcS02F. 
Enzymes. Pyruvate dehydrogenase (E,), pyruvate.iipoate oxido-
reductase (EC 1.2.4.1); lipoate acctyltransferase (E2), acetylCoA:di-
hydrolipoamide S-acetyltransferase (EC 2.3.1.21); lipoamide dehy-
drogenase (E3) NADH:lipoamide oxidoreductase (EC 1.8.1.4); 
trypsin (EC 3.4.21.4). 
showed that the differences in quaternary structure reside in 
the E2 component [7]. 
Limited proteolysis has proved to be useful tool in study-
ing the domain structure of proteins. In the case of 
multifunctional proteins such as the fatty acid synthetase 
complex [8] and the enzyme complex for the synthesis of 
aromatic amino acids [9] structural domains are obtained 
which catalyze partial reactions. The E2 chain of PDC 
comprises many functions: the Ei , E2 and E3 intersubunit 
binding sites, the covalently bound lipoyl groups which are 
involved in the transport of activated substrates between the 
three different active site of the complex, and the site for 
acetyltransferase activity. Bleile et al. [10] and Packman et al. 
[11] have studied the domain structure of the E. coli E2 . Bleile 
et al. [10] obtained two stable fragments by limited proteolysis 
with trypsin: an N-terminal lipoyl domain containing the 
potential lipoyl binding sites, and a C-terminal domain which 
contains the active site, the E2 intersubunit binding sites and 
the binding site for E, and E3 . Sequence determination [12] 
showed that the lipoyl domain consists of three homologous 
sequences which contain alanyl prolyl-rich regions at their C-
termini. Packman et al. [11] showed by digestion with Staphy-
lococcus aureus V8 proteinase that these homologous 
sequences can be considered as separate domains, each con-
taining a potential lipoyl binding site. We will use here the 
term lipoyl domain to indicate the intact N-terminal fragment. 
The C-terminal domain (residues 317 — 629) is usually 
called the subunit binding domain [10, 12—14], although 
other names such as inner core fragment [11], binding and 
catalytic domain [12] or cat [13, 14] have been used as well. 
29 
In this paper we will refer to this fragment as the subunit 
binding domain. 
In order to analyse the structural basis for the differences 
between the E2 components of A. vinelandii and E. coli we 
performed limited proteolysis with trypsin of the A. vinelandii 
E2 component. Again two stable fragments were isolated, a 
lipoyl domain and a domain which contained the catalytic 
activity and the E2 intersubunit binding sites, which we call 
the catalytic domain. In contrast to limited proteolysis of E. 
coli E2, both the E! and E3 binding sites are lost. A 
comparison with the sequence data of the E. coli E2 was made 
which resulted in the assignment of the function in the primary 
structure. 
E i . 
E 2 -
Ê3-
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MATERIALS AND METHODS 
Materials 
Trypsin (treated with tosylphenylalanylchloromethane) 
was obtained from Worthington Biochemical Corp. Activated 
thiol-Sepharose 4B was from Pharmacia. 
Dihydrolipoamide was synthesized by the method of Reed 
[15]. Eosin 5-maleimide was obtained from Molecular Probes 
Inc. (Oregon). All other chemicals used were of analytical 
grade. 
Isolation of the complex and resolution into its components 
The pyruvate dehydrogenase complex was isolated from 
Azotobacter vinelandii as described by Bosma et al. [16]. After 
ethanolamine —Sepharose chromatography the enzyme was 
concentrated by precipitation with 10% poly(ethyleneglycol) 
6000 instead of ultracentrifugation. The complex was resolved 
into its components by covalent chromatography on thiol-
Sepharose 4B as described before [17] with the following 
modifications. Dissociation of E, was performed at pH 9.4 
instead of pH 8.8. The E3 waseluted overnight with 3 M KBr 
in ethanolamine buffer pH 9.0 to remove small amounts of 
E, still present. The E2 and E3 components were dialysed 
against standard buffer (50 mM potassium phosphate pH 7.0 
containing 0.5 mM EDTA and 0.05 mM PhMeS02F) and 
used immediately or stored under liquid nitrogen. The Et 
component was dialysed against standard buffer containing 
0.1 mM thiamin diphosphate and 1 mM MgCl2, and stored 
in 20% (v/v) glycerol at - 20 C. 
Limited proteolysis 
The isolated E2 component (0.8 — 1.0 mg/ml) was in-
cubated with trypsin (10 ug/ml) in standard buffer without 
PhMeS02F at 0 C. Samples were withdrawn at timed in-
tervals and added to an equal volume of sample buffer (80 °C) 
for SDS/polyacrylamide gel electrophoresis. 
Isolation of the main fragments 
obtained by limited proteolysis of E2 
Isolation of the main proteolytic fragments was performed 
by proteolysis of E2 which was covalently bound on thiol-
Sepharose 4B through covalent linkage of the activated thiol 
groups with the lipoyl SH groups, which were generated by 
incubation of the complex with pyruvate, thiamin 
diphosphate and MgCl2. The E, and E3 components were 
eluted as described before [17]. After washing with standard 
buffer without PhMeS02F the E2 component, still bound on 
0 ! 3 ; 8 | 20 ; 60 ; 
1 5 10 30 16h 
time (mini 
Fig. 1. Limited proteolysis of pyruvate dehydrogenase complex. PDC 
(2 mg/ml) was incubated with trypsin (10 ug/ml) in standard buffer 
without PhMeS02F at 0C. Aliquots of 5 nl were taken al the in-
dicated timed intervals, added to an equal volume of sample buffer 
(80 C) and analysed by SDS gel electrophoresis 
the matrix, was digested by incubating with standard buffer 
containing 10 ug/ml trypsin at 4 C for 1 h. After washing with 
standard buffer containing 0.2 mM PhMeS02F the catalytic 
domain fragment was eluted with standard buffer containing 
3 M KBr. The lipoyl domain fragment, still covalently 
attached to the column matrix was eluted like undigested 
E2 by standard buffer containing 0.5 M hydroxylaminc or 
50 mM Tris/HCl pH 8.5 containing 20 mM dithiothreitol. 
This fraction was separated from large proteins such as the 
E3 dimer and undigested E2 by ultrafiltration using an 
Amicon YM-100 membrane. The lipoyl domain, which passed 
the membrane, was concentrated on an Amicon YM-10 mem-
brane. Both fragments were dialysed immediately against 
standard buffer and stored under liquid nitrogen. 
Other techniques 
Sedimentation velocity and equilibrium experiments were 
performed in standard buffer or standard buffer containing 
6 M guanidine hydrochloride in an MSE Centriscan 75, 
equipped with an ultraviolet/visible monochromator. Cor-
rections for the solvent density and viscosity were made ac-
cording to standard procedures [18]. For the E2 component, 
the catalytic and the lipoyl domain, partial specific volumes 
of 0.740, 0.747 and 0.736 ml/g respectively were calculated 
from the amino acid composition, according to the method of 
Cohn and Edsall [19]. For the determination of the molecular 
mass of the catalytic domain monomer, gel chromatography 
in 6 M guanidine hydrochloride was carried out, using FPLC 
equipped with a Superose 12 HR 10/30 column (Pharmacia). 
The peak fraction was directly used for sedimentation 
equilibrium experiments. 
For amino acid analysis, samples were hydrolysed under 
nitrogen in sealed tubes in 3 M mercaptoethanesulfonic acid 
for 72 hat HOC [20]. Analyses were performed on a Kontron 
Liquimat III analyser. Corrections were made for threonine, 
serine and tyrosine. For protein sequencing the samples were 
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Fig. 2. Limited proteolysis of dihydrolipoyllransacetylase (E2). (A) SDS gel electrophoresis of E2 and its tryptic digest at timed intervals. Lane 
1. markers (mass is indicated in kDa); lanes 2 — 6, E2 (1 mg/ml) incubated with trypsin for 0 min (lane 2), 0.5 min (lane 3). 10 min (lane 4). 
60 min (lane 5) and 150 min (lane 6). (B) Western blotting of L2 and its tryptic digest after incubation for 0 min (lanes 1). 10 min (lanes 2) 
and 90 min (lanes 3). The blots were incubated with antibodies raised against the 51-kDa fragment (I), the 27-kDa fragment (II) and intact 
E, (III) 
purified as follows. Gel chromatography was carried out in 
6 M guanidine hydrochloride, after which the protein fraction 
was S-carboxymethylated. After dialysis against ammonium 
carbonate the samples were concentrated by freeze-drying, 
and gel filtration in 50% acetic acid was carried out. 
Protein sequencing was carried out by automated Edman 
degradation in an Applied Biosystems 470 A gas-phase pro-
tein sequencer. The phenylthiohydantoin derivatives were 
automatically identified with an Applied Biosystems 120 A 
PTH analyser used on-line with the sequencer. 
CD spectra were measured with a Jobin Yvon mark V 
dichrograph using quartz cells with a 0.1 — 0.5-mmpathlength 
in the wavelength region 195 — 255 nm. The cell holder was 
thermostatted at 20 C and the cell compartment purged with 
nitrogen. 
Electron microscopy of E2 was carried out after cross-
linking of the protein by reaction with 2% (w/v) glutaralde-
hyde in standard buffer, at room temperature for 10 min. 
The sample was stained with 1% (w/v) uranyl acetate and 
examined in a Jeol electron microscope operated at 80 kV. 
The catalytic domain was examined without cross-linking 
beforehand. Enzyme activities were assayed at 25 C as de-
scribed previously [21]. Protein concentrations were cal-
culated from measurements of absorbance at 280 nm. The 
absorption coefficients A 2S'Ö/" for E2 and the catalytic domain 
were 0.45 and 0.93, respectively, as determined by amino acid 
analysis. Because of the low coefficient for the lipoyl domain 
(/42Y0!" < 0.05) this protein concentration was measured ac-
cording to the method of Lowry [22]. Gel electrophoresis 
in the presence of sodium dodecyl sulfate was carried out 
essentially as described by Laemmli [23]. 
For the production of antisera, digested and undigested 
E2 were subjected to preparative SDS gel electrophoresis. 
After lightly staining, the protein bands were cut out and 
protein was extracted from the gel. The protein was dissolved 
in phosphate-buffered saline pH 7.2 and mixed with Freund's 
incomplete adjuvants. For immunisation male New Zealand 
White rabbits were used. After five weeks a booster injection 
was given and ten days later the antisera were collected. For 
the immunological detection of proteins the western blotting 
method was used as described by Voordouw et al. [24], 
whereby visualization of the bands was performed with 
alkaline-phosphatase-linked immunodetection (Protoblot 
Immunoblotting System, Promega Biotec). 
RESULTS 
Limited proteolysis ofPDC and the E2 core 
Incubation of the pyruvate dehdrogenase complex with 
trypsin at pH 7 and 4' C resulted in digestion of the E, and 
E2 components (Fig. 1). The overall activity was lost as well 
as the E, activity, but no loss was observed of 
dihydrolipoyltransacetylase (E2) activity, i.e. the acetylation 
of exogenous dihydrolipoamide, or of lipoamidehydrogenase 
(E3) activity. 
It is well known that E2 and its fragments behave 
anomalously on SDS gels [6, 10]. Therefore the chain masses 
given below are an indication of relative position rather than 
presenting true molecular mass data. When trypsin-digested 
E2 (mass 83 kDa on SDS gels) was subjected to SDS gel 
electrophoresis two main products were found: a 51-kDa 
fragment and a 27-kDa fragment (Fig. 2A). With antibodies 
raised against the 51-kDa fragment, a 40-kDa minor fragment 
was identified as a proteolytic degradation product of the 51-
kDa fragment. A 34 —37-kDa minor fragment (mass varying 
between isolations) showed cross-reactivity with antibodies 
raised against the 27-kDa fragment (Fig. 2B). Some cross-
reactivity is observed with the 51-kDa fragment. This could 
be due to contamination of the 27-kDa fragment with degra-
31 
MriKDa) 
• 9 4 
»67 
• 43 
• 30 
• 20 
• 14 
. 1 * 2 3 4 1 2 
Fig. 3. Isolation of the proteolytic fragments of E2. (A) After incuba-
tion of E2, covalently bound to thiol-Sepharose, with trypsin, 
fractions were eluted with standard buffer containing 0.2 mM 
PhMeS02F (lane 1), standard buffer containing 3 M KBr (lane 3) 
or standard buffer containing 0.5 M hydroxylamine (lane 2). (B) 
Purification of the 51-kDa fragment by ultrafiltration. The fraction 
containing the 51-kDa fragment (lane I) was eluted over an YM 100 
membrane (lane 2) 
dation products originating from the 51-kDa fragment. 
Alternatively the presence of homologous epitopes (e.g. the 
Ala —Pro-rich sequence in the N-terminal sequence of the 27-
kDa fragment, see Fig. 4B) may be the cause of this weak 
cross-reactivity. The cross-reactivity of antibodies raised 
against SDS-denatured E2 was larger with the 51-kDa frag-
ment than with the 27-kDa fragment. This was confirmed 
with the ELISA technique. With antibodies raised against 
native E2 this difference was even larger. No fragments below 
27 kDa could be detected on SDS gels up to 20% acrylamide 
or by using antibodies raised against intact E2, the 51-kDa or 
the 27-kDa fragment. 
Proteolysis of E2 with trypsin after amidination of the 
lysyl residues (cf. [25]) yielded essentially the same results, 
which indicates that proteolysis takes place on arginyl resi-
dues, or on closely spaced lysyl and arginyl residues. These 
experiments indicate that the presence of E3 or Ej does not 
protect potential cleavage sites on E2. 
Purification of the proteolytic fragments 
The purification of the tryptic fragments was carried out 
as described in Methods. After elution with buffer containing 
3 M KBr, pure 27-kDa fragment was obtained (Fig. 3 A, lane 
3). After elution with buffer containing hydroxylamine or 
dithiothreitol a fraction containing the 51-kDa fragment was 
obtained (Fig. 3 A, lane 2, and Fig. 3 B, lane a). This fragment 
was purified by removing undigested E2 and the 27-kDa frag-
ment, which are polymeric (>0.5MDa), by ultrafiltration 
which resulted in a fraction containing the 51-kDa fragment 
and a trace of its 40-kDa degradation product (Fig. 3B, 
lane 2). 
Characterization of the fragments 
The 51-kDa fragment was eluted in the same way as 
undigested E2 and should for this reason contain the lipoyl 
moieties by which E2 is covalently bound to the matrix. This 
was confirmed by labelling E2 with an SH-binding fluorescent 
probe, eosin 5-maleimide. After trypsinolysis of the labelled 
E2 a fluorescent 51-kDa band was observed on the SDS gel. 
This fragment, which we will call the lipoyl domain in analogy 
with E. coli E2 [10], has a molecular mass of 32.6 kDa as 
determined by sedimentation equilibrium analysis. Its sedi-
mentation coefficient .«2o.w = 2.2 S, from which a frictional 
ratio can be calculated of 1.62. By using analytical ultracentrif-
ugation no binding of E3 with the lipoyl domain was observed. 
The transacetylase activity, which is retained after E2 
digestion, is located on the 27-kDa fragment. When this frag-
ment is titrated with either the E, or the E3 component no 
significant change in sedimentation coefficient was found. 
During E3 titration, when scanned at 456 nm where E3 is 
detected, a sedimentation coefficient of 5.9 S was found, 
belonging to the E3 dimer. These results show that the 27-
kDa fragment possesses no detectable Ei or E3 binding sites. 
In this respect it differs from the subunit-binding domain 
obtained by limited proteolysis with trypsin of E. coli E2 
[10], which has a larger peptide chain (29.6 kDa instead of 
15.8 kDa, see below) and still possesses the E
 ( and E3 binding 
sites. To distinguish the A. vinelandii 27-kDa fragment from 
the E. coli subunit-binding domain it will be called the catalytic 
domain. Also in contrast to the E. coli domain, the catalytic 
domain remains soluble in 50 mM potassium phosphate buf-
fer and is suitable for further characterization such as sedi-
mentation analysis, circular dichroism and electron microsco-
py. It has a sedimentation coefficient of 16.8 S; for intact E2 
a sedimentation coefficient of 21.8 S was found. By sedimen-
tation equilibrium analysis of the catalytic domain a molec-
ular mass of 530 + 17 kDa (n = 3) was determined (intact E2 
mass =1.9MDa); apparently it still possesses the E2 in-
tersubunit binding sites, resulting in the same quaternary 
structure as E2 (see electron microscopy below). From the 
molecular mass and sedimentation coefficient a frictional 
ratio of 1.24 was calculated, indicating a compact, globular 
structure. The mass of the catalytic domain as determined by 
sedimentation equilibrium analysis in the presence of 6 M 
guanidine hydrochloride and 2 mM dithiothreitol was found 
to be 15.8+ 0.5 kDa (n = 6), which agrees with a 32-mer 
structure as proposed by Bosma el al. [2, 6]. 
Because the E, and E3 binding sites are present neither on 
the lipoyl domain nor on the catalytic domain they are lost 
during proteolysis. This loss is also observed in an experiment 
where an E2-E3 subcomplex, covalently bound on a thiol-
Sepharose matrix, is digested with trypsin. After washing with 
standard buffer more than 75% of the bound E3 was lost. 
Apparently bound E3 does not protect its binding site. In the 
eluted E3 fraction no protein fragments could be observed by 
using SDS gel electrophoresis, probably because they are too 
small for detection. The results indicate that upon proteolysis 
of E2 (mass 63 kDa by sedimentation equilibrium analysis) 
two large fragments, the lipoyl domain (32.6 kDa) and the 
catalytic domain (15.8 kDa) are formed, but that in addition 
Table 1. Amino acid compositions of the A. vinelandii E2 component 
and its proteolytic fragments 
For comparison the amino acid composition of K. coli H2 and its 
lipoyl domain are given. The E. coli amino acid compositions are 
from Stephens et al. [12]. The tryptophan content of the A. vinelandii 
polypeptides was determined by direct amino acid analysis and by the 
method of Pajot [27] 
Amino acid 
Asx 
Thr 
Ser 
Gix 
Pro 
Glv 
Ala 
Cys 
Val 
M cl 
Ile 
Leu 
Tyr 
Phe 
Lys 
His 
Arg 
Trp 
R2 
A. vin 
residues 
39 
20 
35 
68 
53 
55 
132 
4 
48 
10 
28 
53 
6 
11 
34 
7 
23 
3 
E. coli 
1-629 
/molecule 
50 
27 
29 
73 
37 
51 
96 
1 
68 
16 
45 
33 
3 
19 
53 
5 
20 
3 
Lipoyl c 
A. vin 
19 
17 
24 
46 
26 
26 
68 
0 
35 
4 
17 
24 
1 
2 
10 
1 
9 
0 
omain 
K.coïi 
1-316 
23 
II 
13 
44 
22 
25 
67 
0 
42 
7 
19 
9 
0 
5 
29 
0 
0 
0 
Catalytic 
domain 
A. vin 
10 
6 
8 
14 
9 
11 
23 
1 
10 
3 
8 
18 
3 
5 
9 
3 
6 
2 
Total 
Mass 
629 
kDa 
63 
629 
66 
328 
32.6 
316 
31.6 
149 
15.8 
small fragments which constitute the E, and L\, binding sites, 
are lost (total molecular mass 14 kDa). 
Amino acid composition of E2 and its domains 
The amino acid compositions of E2 , the lipoyl domain and 
the catalytic domain are listed in Table 1. The compositions 
of the E. coli E2 and lipoyl domain as determined from the 
DNA sequence by Stephens et al. [12] are shown for 
comparison. Much similarity exists in the compositions of 
the lipoyl domains of both organisms. Both contain large 
amounts of prolyl and alanyl residues which indicates a 
common domain structure. One striking difference is the pres-
ence of a single histidyl, a tyrosyl and nine argininyl residues 
in the A. vinelandii lipoyl domain. In the E. coli sequence a 
tyrosyl and a histidyl residue are found 9 - 1 1 amino acids C-
terminal of the trypsin cleavage site at residue 316 [11]. This 
result, together with a slight difference in molecular mass of 
the A. vinelandii lipoyl domain (32.6 kDa) and the E. coli 
lipoyl domain (31.6 kDa [10]) indicates that the A. vinelandii 
lipoyl domain extends about 10 — 25 residues beyond the E. 
coli cleavage site. The small fragmented material of pro-
teolysed A. vinelandii E2, compared to the corresponding E. 
coli sequences (residues 329 — 369 and 519 — 629) contains 
many prolyl, alanyl and lysyl residues. In E. coli E2 a hinge 
region is indicated between the lipoyl domain and the subunit 
binding domain [10, 12]. This region is rich in prolyl, alanyl 
Table 2. Cross-reactivity between A. vinelandii E2. lipoyl domain and 
catalytic domain and E. coli E2 of antibodies raised against A. 
vinelandii E2. its lipoyl domain and its catalytic domain 
Antibodies to A. vinelandii A. vinelandii E. coli 
lipoyl 
domain 
catalytic E2 
domain 
Ant i •H2 
Anti-(l ipoyl domain) 
Ant i -(catalytic domain) 
+ + 
+ + 
— 
+ + 
-
+ + 
+ + 
+ + 
+ 
+ + 
+ 
+ 
' 0»p]l"p]lp| = p. F 
< ?bi'--.y»iiU';.i. 
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Fig. 4. Alignment for amino acid sequences oj the N-terminal sequence 
of E2, the catalytic domain and F.. coli E2- The sequences, shown in 
single-letter amino acid code, were aligned for maximum homology. 
Identical residues arc enclosed by solid boxes. L'or E. coli F.2 only the 
related amino acid sequence is shown. The E. coli amino acid sequence 
is from Stephenset al. [12] 
and lysyl residues. The difference in arginyl residue content 
explains why the E. coli lipoyl domain, lacking arginyl resi-
dues, can hardly be visualized on SDS gels by the Coomassie 
staining [ 10, 25], whereas the A. vinelandii domain gives a well-
coloured band [26]. 
The largest differences in amino acid composition between 
the three PDC components of A. vinelandii and E. coli art-
found in E2 [6]. The differences in number of prolyl and 
small-chain residues were considered to produce differences in 
secondary structure. Nevertheless, antibodies raised against 
A. vinelandii E2 , its lipoyl domain and its catalytic domain 
show extensive cross-reactivity between the E. coli and A. 
vinelandii E2 (Table 2), whereas with antibodies raised against 
A. vinelandii E 3 no cross-reactivity between the E3 
components of the two organisms as found. 
N-terminal amino acid sequences of intact E2 
and the catalytic domain 
The N-terminal amino acid sequences of the intact E2 
chain and the catalytic domain were determined by automated 
Edman degradation. In both cases 1 nmol of the 
carboxymethylated sample was used. The N-terminal se-
quence of the intact E2 chain is shown in Fig. 4 A. The homol-
ogy with the E. coli E2 sequence is obvious. It shows that the 
lipoyl domain is. like that of E. coli E2 , located at the N-
terminal part of the E2 chain. 
The catalytic domain fragment shows two N-termini in 
the ratio 3:2. They show considerable homology with residues 
371 —406 and 373 — 406 of the E. coli E2 amino acid sequence 
as reported by Stephens et al. [12]. The 36-amino-acid-long 
N-terminal sequence is shown in Fig. 4B. Apparently the two 
N-termini are the result of random cleavage at two basic 
residues separated by one amino acid. If the residue at position 
33 
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Fig. 5. Electron micrographs of the isolated E2 (A) and the catalytic domain ( B, Cj. (A) L'2 (0.01 mg/ml) was cross-linked by reaction with 2% 
glutaraldehyde at room temperature for 10 min and applied on a grid. Uranyl aeelate was used as a negative stain. (B) Isolated catalytic 
domain (0.01 mg/ml). negatively stained with uranyl acetate. (C) Isolated catalytic domain (0.01 mg7ml) applied on a negatively loaded grid. 
Uranyl aeelate was used as a negative stain 
l-'ig. 6. Circular dichroic spectra of isolated E2, lipoyl domain and 
catalytic domain. The peptides were dissolved in standard buffer. The 
cell holder was thermostalled at 20 C. The response time was 10 s 
Table 3. Percentages of x-helix, fi-sheet and random coil in E2, the 
lipoyl domain and the catalytic domain of A. vinelandii PDC 
Protein a-Helix /i-Shect Random coil 
Hi 
Lipoyl domain 
Catalytic domain 
11 
6 
13 
37 
24 
50 
52 
70 
37 
information for the quaternary structure is retained in the 
catalytic domain (Fig. 5 B). The lipoyl domain and the K, and 
E, binding sites arc not observed although they constitute 
three quarters of the intact E, chain. They may be the cause 
of the vagueness of the cubes, probably because they form 
open, extended structures, which are not well stained. When 
a negative loaded grid was used the catalytic domain shows 
the tendency to form semi-crystalline aggregates (Fig. 5C). 
which may be used for three-dimensional reconstruction 
(work in progress). 
370 is an arginine it may explain why amidination does not 
effect the proteolysis pattern. 
Electron microscopy of intact E2 unci the catalytic domain 
We have shown previously [f6] that intact E2 . when freed 
of E! and E3, aggregates from a tetramer to a large particle 
of similar sedimentation coefficient but larger mass than that 
of E. coli F.2. For the A. vinelitiiilii E2 rather blurred cubic 
structures with edges of 13— 15 nm are observed by electron 
microscopy (Fig. 5A). The catalytic domain gives much 
sharper structures with the same dimensions. Apparently the 
Circular dichroism 
In order to determine the secondary structure of E2 and 
its proteolytic fragments CD studies in the peptide region 
were carried out. The spectra are shown in Fig. 6. From the 
spectra the percentages of secondary structure were calculated 
according to the method of Saxena and Wetlaufer [281 
(Table 3). The lipoyl domain has relatively little secondary 
structure. The catalytic domain and the part of the E2 chain 
which is proteolysed into small fragments contribute the same 
amount to the E2 secondary structure, as calculated from 
the difference in molar ellipticity between intact F 2 and the 
isolated fragments. 
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DISCUSSION 
The data presented in this paper show that the A. vinelandii 
transacetylase consists of at least two distinct folding 
domains: the lipoyl domain and the catalytic domain. To-
gether these domains represent about 80% of the native E2 
chain. The E! and E , binding sites are lost during proteolysis. 
The N-terminal lipoyl domain contains two to three lipoyl 
moieties [2] and makes up half of the E2 chain. It has many 
properties in common with the lipoyl domain of E. coli. The 
high Ala + Pro content is indicative of an analogous structure 
with three distinct domains [11]. The lipoyl domain constitutes 
the flexible protuberant structures [30] which gives E2 its 
swollen and extended character. This can be concluded from 
a comparison of the frictional ratios of 2.41 for the polymeric 
E2 , 1.62 for the monomeric lipoyl domain and 1.24 for the 
polymeric catalytic domain. The experiments with antibodies 
against native E 2 are in agreement with this model. Westhof 
et al. [29] have shown that a good correlation exists between 
chain flexibility and antigenicity. This may explain the higher 
cross-reactivity with the lipoyl domain compared to the cata-
lytic domain. It is more difficult to understand why this 
difference in response, though less pronounced, is also found 
with antibodies against SDS-denatured E2 . The lipoyl domain 
contributes little to the secondary structure of E2 . Neverthe-
less it is well protected against limited proteolysis, despite its 
many lysyl and arginyl residues. Probably these residues are 
confined to regions which do possess secondary structure, 
whereas other parts devoid of these residues, but rich in alanyl 
and prolyl residues, form coiled regions. Only at longer reac-
tion times or higher trypsin concentration does further degra-
dation takes place. 
The catalytic domain, which also possesses the E 2 /E 2 in-
teraction sites, forms a compact, globular core with apparent 
cubic symmetry. In contrast with the E. coli subunit binding 
domain [10] no E, and E3 binding sites are located on this 
fragment. In this respect it is more comparable to the inner 
core domain obtained by limited digestion of the Bacillus 
stearothermophilus pyruvate dehydrogenase complex [31] and 
the branched-chain 2-oxo-acid dehydrogenase complex from 
bovine liver [32]. It is readily soluble in standard buffer, 
whereas the E. coli subunit binding domain is not. This makes 
the A. vinelandii catalytic domain suitable for accurate 
characterization. 
Size determinations of E2 and its domains give large 
deviations depending on the method used. By SDS gel electro-
phoresis E2 has an apparent mass of 83 kDa (E. coli 82 kDa). 
By sedimentation equilibrium analysis in 6 M guanidine hy-
drochloride a value of 63 kDa (E. coli 63 kDa [6]) is found. 
The lipoyl domain has on gel an apparent mass of 51 kDa (in 
our gel system E. coli 56 kDa) and by sedimentation 
equilibrium analysis 32.6 kDa (E. coli 31.6 kDa [10]). It is 
thought that the large deviations are caused by the acidic 
nature of the lipoyl domain [10], or by the alanine + proline-
rich regions [13], which are thought to be responsible for 
anomalous electrophoretic mobility in other proteins, such as 
the bovine /?-crystallin Bj chains [33]. But also the catalytic 
domain gives a substantial difference in mass determinations: 
an apparent mass of 27 kDa on gel and of 15.8 kDa by sedi-
mentation equilibrium analysis. For the E. coli subunit-bind-
ing domain values of 36 —39 kDa and 29.6 kDa respectively, 
have been reported [10]. 
Although the amino acid sequence of A. vinelandii E2 is 
not yet known, we can compare our data with the known 
sequence of E. coli E2 [12] (Fig. 7). From the size of the lipoyl 
100 
I 
residue 
200 
number 
300 
H 
for E col 
too 
H 
'E; 
500 
l 
H 
600 
1 
lipoyl domain f i IE,7) catalytic and E, I?} 
binding E; binding binding 
domain domain domain 
Fig. 7. A model for the structure of E. coli E2 and A. vinelandii E2. 
The E. coli structure is according to Packman and Perham [34] 
domain and the presence of an extra tyrosyl and histidyl 
residue, which are not present in the E. coli lipoyl domain but 
are present at position 325 and 327, we locate the C-terminus 
of the A. vinelandii lipoyl domain between residues 325 — 340. 
The N-terminus of the catalytic domain is homologous with 
the sequence 370 — 406 of E. coli E2 and therefore this domain 
will have its C-terminal residue near position 520. Recently 
Packman and Perham [34, 35] have shown that the E3 binding 
domain in the E. coli transacetylase and transsuccinylase is 
located between the lipoyl domain and the catalytic domain. 
This binding domain is probably located between two 'hinge' 
regions which allow a high mobility of E 3 when bound to the 
complex. Fluorescence anisotropy measurements of the F A D 
in the free or bound E 3 indicate almost no change on 
rotational correlation coefficient, both in the A. vinelandii 
PDC [16] and in the much larger E. coli PDC [36]. Because a 
large fragment at the C-terminus of E2 is lost during pro-
teolysis it may be argued that this fragment may represent the 
E, binding site. On the other hand E, and E3 may share the 
same binding site. Binding experiments have shown competi-
tion between E, and E 3 and an equivalent binding site was 
proposed [7]. However, such a binding site could be composed 
from sequences quite far apart in the primary structure but 
closely related in the tertiary structure. Further studies will be 
devoted to elucidating the primary structure of E2 and the 
exact location of the E, and E3 binding sites. 
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The dihydrolipoyltransacetylase component of the pyruvate dehydrogenase complex 
from Azotobacter vinelandii 
Molecular cloning and sequence analysis 
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The gene encoding the dihydrolipoyltransacetylase component (E2) of the pyruvate dehydrogenase complex 
from Azotobacter vinelandii has been cloned in Escherichia coli. A plasmid containing a 2.8-kbp insert of A. 
vinelandii chromosomal DNA was obtained and its nucleotide sequence determined. 
The gene comprises 1911 base pairs, 637 codons excluding the initiation codon G U G and stop codon UGA. 
It is preceded by the gene encoding the pyruvate dehydrogenase component (E,) of pyruvate dehydrogenase 
complex and by an intercistronic region of 11 base pairs containing a good ribosomc binding site. The gene is 
followed downstream by a strong terminating sequence. The relative molecular mass (64913). amino acid compo-
sition and N-terminal sequence are in good agreement with information obtained from studies on the purified 
enzyme. Approximately the first half of the gene codes for the lipoyl domain. Three very homologous sequences 
arc present, which are translated in three almost identical units, alternated with non-homologous regions which 
are very rich in alanyl and prolyl residues. The N-terminus of the catalytic domain is sited at residue 381. Between 
the lipoyl domain and the catalytic domain, a region of about 50 residues is found containing many charged 
amino acid residues. This region is characterized as a hinge region and is involved in the binding of the pyruvate 
dehydrogenase and lipoamide dehydrogenase components. The homology with the dihydrolipoyltransacetylase 
from E. coli is high: 50% amino acid residues are identical. 
Dihydrolipoyltransacetylase (E2) is the core component 
of the pyruvate dehydrogenase complex. This complex 
catalyzes the oxidative decarboxylation of pyruvate to acetyl-
C o A a n d NADH [1]: 
Pyruvate + NAD ' + CoA 
+ NADH + H ! . 
• AcctylCoA + C O , 
The E2 component comprises many functions. In the 
Azotobacter vinelandii enzyme three pyruvate dehydrogenase 
(E,) dimers and one lipoamide dehydrogenase (E3) dimer are 
bound to a core of four E2 chains [2]. The E2 chain contains 
covalcntly bound lipoyl moieties which transport the sub-
strates between the different active sites of the complex. 
Limited proteolysis studies with trypsin have shown that 
E2 consists of at least two domains: an N-terminal lipoyl 
domain which contains the lipoyl moieties and the C-terminal 
catalytic domain which possesses the catalytic site and the E2-
E2 intersubunit binding sites [3]. The binding sites for the E, 
and E3 components were not found on these domains. 
Corrcspoiuleiice to A. de Kok, Laboratorium voor Biochemie. 
Landbouw-Hogcschool, De Dreijen 11. NL-6703 BC Wageningen. 
The Netherlands 
Abbreviations, kbp. 103 base pairs; LGT-agarose. low-gclling-
temperature agarose. 
bnzyitws. Pyruvate dehydrogenase (E,), pyruvate: lipoate 
oxidoreductase (EC 1.2.4.1); dihydrolipoyltransacetylase (E2), 
acelylCoA:dihydrolipoamidc .S'-acetyllransferasc (EC 2.3.1.21); 
lipoamide dehydrogenase (F..0. NADH : lipoamide oxidoreductase 
(EC 1.8.1.4); DNA polymerase I (Klenow fragment) (EC 2.7.7.7); calf 
intestinal alkaline phosphatase (EC 3.1.3.1); restriction cndonuclcascs 
BamWl, /-.(»Rl. IlindlU. SaißA and Snw\ (EC 3.1.24.4). 
The F.2 component of the pyruvate dehydrogenase com-
plex from Escherichia coli has a comparable domain structure: 
an N-terminal lipoyl domain and a C-terminal domain, which 
is called the catalytic and subunit-binding domain. In contrast 
to the A. vinelandii E2 . the C-terminal domain of E. coli 
possesses binding sites for the E, and E3 components [4. 5]. 
This domain contains an N-terminal extension of about 50 
residues and this region is indicated as a binding site for the 
E 3 component [6, 7]. The quaternary structure of the E. coli 
complex differs from that of A. vinelandii. being based on an 
E2 core of 24 subunits [8], whereas the A. vinelandii one is 
based on a tetrameric E2 core [2]. Upon removal of the periph-
eral components from the A. vinelandii complex, the E2 
tetramers associate to an E. co//-like multimer, as shown by 
sedimentation velocity experiments and electron microscopy 
[3, 9]. 
The gene for E. coli dihydrolipoyltransacetylase has been 
cloned and sequenced [10]. It is preceded by the gene encoding 
the pyruvate dehydrogenase component (Ei). Both genes are 
transcribed in one transcription unit, from a promoter up-
stream of the gene encoding E , to a terminating sequence 
downstream of the gene encoding E2. The gene encoding the 
E3 component lies downstream of this terminating sequence 
[11]. The gene organization in A. vinelandii is different: in this 
organism the gene encoding the E 3 component is located 
downstream of the gene encoding the E2 component of the 2-
oxoglutaratc dehydrogenase complex [12]. This paper reports 
on the cloning and nucleotide sequence analysis of the gene 
encoding the dihydrolipoyltransacetylase component of the 
pyruvate dehydrogenase complex from A. vinelandii. Infor-
39 
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94.0 — « 
67.0 "** 
43.0 
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Fig. 1. Expression o/'A. vinclandii dihydrolipoyltransacelylase (E2) in E. coli TG2 (pRA 282). (A) SDS gel electrophoresis of cell-free extracts. 
purified E2 and the pyruvate dehydrogenase complex stained with Coomassic brilliant blue R. (B) Western blot of cell-free extracts, purified 
E2 and pyruvate dehydrogenase complex. Lane A, marker proteins (molecular mass in kDa on left); lane B, pyruvate dehydrogenase complex 
from /;'. coli; lane C, cell-free extract of E. coli TCi2; lane D, cell-free extract of E. coli TG, (pRA 282); lane E. purified E, (with degradation 
products due to storage); lane E, pyruvate dehydrogenase complex from A. vinelondii 
mation is given about the size and the structural organization, 
and a comparison with the E. coli gene is made. 
MATERIALS A N D M E T H O D S 
Materials 
Restriction endonucleases were purchased from Bethesda 
Research Laboratories (BRL) and Boehringer. DNA 
polymerase (Klenow fragment) and T4-DNA ligase were 
obtained from BRL. Calf intestinal phosphatase, universal 
M l 3 sequencing primer and 7-deaza-dGTP were purchased 
from Boehringer. [a-32P]dATP (3000 Ci/mmol) was obtained 
fron New England Nuclear. All other chemicals used were of 
analytical grade. 
Bacterial strains and vectors 
A. vinelandii (ATCC478) was grown as described [13] and 
used for DNA isolation. E. coli strain TG 2 , a ree A ~ version of 
TG, [A (lac-pro), thi, sup£, hsdM ~ JisdR " ,F'( traD36 pro A" S + 
lacZ lad" AM\5)\ was used throughout [14]. Plasmid pUC9 
was used as a cloning vector [15] and phage Ml3mp18 and 
Ml3mp19 were used for sequencing [16]. 
DNA isolation and cloning 
Standard D N A operations were performed as described 
[17]. Chromosomal DNA was isolated from A. vinelandii cells 
[12] and partially digested with SaulA. Fragments of 9 — 
23 kb were isolated after LGT-agarose gel electrophoresis. 
These fragments were ligated into the BamH\ site of pUC9. 
E. coli TG 2 cells, transformed with recombinant plasmids, 
were grown on two-gridded nitrocellulose filters, placed on 
TY-agar plates, lysed according to [12], and screened for pro-
duction of A. v»ic/cOT(/»dihydrolipoyltransacetylase (H2) using 
antibodies raised against the catalytic domain of E2. A 
14-kbp plasmid of a positive clone [TG2(pRA177)] was iso-
lated as described in [18], with modifications according to 
[12]. After digestion with BamH\ the insert of the plasmid was 
isolated, partially digested with SauiA and fragments of 2 -
3 kbp and 3 —4kbp were isolated from electrophoresis in 
LGT-agarose. These fragments were ligated into the BamrW 
site of pUC9 and, after transformation in E. coli TG 2 cells, 
colonies were screened as described above. 
DNA sequence determinations and analysis 
The insert from a positive recombinant was isolated after 
digestion with BamHl. The double-stranded DNA was 
sonicated for three 30-s periods with 30-s intervals at 0 C. 
Fragments of 300 —600 bp were isolated, end-repaired as de-
scribed [19] and isolated after LGT-agarose gel electro-
phoresis. The fragments were cloned into the Smal site of the 
rcplicative form of Ml3mp19. The single-stranded form of 
the recombinant phage DNA was prepared by standard tech-
niques [20] and sequence data were obtained according the 
dideoxy-chain-termination method of Sanger [21], using the 
40 
TCGAAGTGGACCGCTACTGGGTTGTGCTGGCCGCGCTGGAAGCGCTGGCCGATCGTGGCG 
310 320 330 340 350 360 
<- - Structural gene for the pyrvvate dehydrogenase 
ACATCGAAGCCAAGGTGGTGGCCGAAGCCATCGCCAAGTTCGGCATCGATGrrGAGAAGC 
370 380 390 400 410 420 
N P L D C * S E I I R V I* I) I 
GCAACCCCCTGGACTGCTGJÄGGAGIAGGCATCGTGAGCGAAATGATCCGCGTACCCGATAT 
430 440 450 460 4 70 480 
G G D G F V Ï F L I , V K T G O I , I F . V E 
CGGCGGCGATGGGGAAGTCATCGAATTGCTGGTCAAGACCGGGGACCTCATCGAGGTCGA 
490 500 5!0 520 530 540 
Q G 1 , V V L K S A K A S M E V P S P K A 
GCAGGGGCTG6TGGTGCTGGAGTCXGCCAAGGCGAGCATGGAAGTT(XCAGTCXCAAGGC 
550 560 570 580 590 600 
G V V K S V S V K L G G K I , K F G D A I 
CGGAGTGGTCAAGAGCGTGAGCGTCAAGCTGGGCGACAAGCTGAAGGAAGGCGACGCGAT 
610 620 630 640 650 660 
I E I, E I' A A G A A A A P A K A A A V P 
CATCGAGCTGGAACGTGOCGCCGGTGCCGCGGCGGCACXTGCCGAAGCGGCGGCCGTGCC 
670 680 690 700 7 10 720 
A A P T q A V 11 E A F. A P S P G A S A T 
CGCXGCGCCGACCCAGGCCGTCGACGAGGCCGAGGCGCCCTCTCriXOCGCCTCCGCCAC 
730 740 750 760 770 780 
P A P A A A S Q E V R V P I ) I G S A G K 
GCCCGCGCCGGGCGCCGCCAGCGAGGAGGTCCGGGTTCCfT.AGATGGGCTrGGCCGGCAA 
790 800 810 820 830 840 
A R V [ F . V L V K A G D q V Q A E Q S L 
GGCACGGGT(:ATCX,AGGTGCTGGTCAAGGC(X.GCGA(:CAGGT(XAGGCCGAGCAGTCGCT 
850 860 870 880 890 900 
I V I, E S 0 K A S M E r P S P A S G V V 
GATCGTGCTGGAGTrCGACAAGGCCAGCATGGAGATCCIXTCXCCGGCTTGCGGAGTGGT 
910 920 930 940 950 960 
E S V A I Q L N A E V G T G 0 I. I I, T I, 
GGAAAGCGTCGCCATCCAGTTGAAGGCCGAGGTCGGGAGCGGGGAGGTGATCCTCACCCT 
970 980 990 1000 1010 1020 
R T T G A Q A Q P T A P A A A A A A S P 
GGGCACGACCGGCGCCCAGGCCCAGCCTACXCXGCCCXCXGCGGCCGCGGCCGCGAGCrx 
1030 1040 1050 1060 1070 1080 
A P A P L A P A A A G P Q E V K V P f ) I 
GGCAGCCGCTCCGCTGGCTCCGGCCGCGGCCGGTCrCCAGGAAGTCAAGGTGGCGGACAT 
1090 1100 1110 1120 1130 1140 
G S A G K A R V 1 E V I. V K A G 1) Q V Q 
CGGCTCGGCCGGCAAGCCACGGGTGATCGAGGTGCTGGTCAAGG(XGGCGACXAGGT(XA 
1150 1160 1170 1180 1190 1200 
A E Q S L I V I, E S O K A S M K I P S P 
GGCCGAACAGTCGCTGATCGTGCTGGAATCCGAGAAGGCCAGCATGGAGATaXCTCrxC 
1210 1220 1230 1240 1250 1260 
A A G V V E S V A V Q L N A E V G T G I ) 
GGCCGCCGGGGTGGTGGAAAGCGTCGGCGTCCAGTTGAACGCCGAGGTCGGCArXGGCGA 
1270 1280 1290 1300 1310 1320 
Q I L T I . R V A G A A P S G P R A R G S 
TCAGATCCTCAC(XTGCGCGTCGCCGGCtt(XGCGCCGAGCGG(X('CCGCGCCXGCGGCAG 
1330 1340 1350 1360 1370 1380 
P G Q A A A A P G A A P A P A P V G A P 
CCCCGGCCAAGCCGCCGCGGCTCGGGGCGCTGCCCCGGCTCCGGCCCCGGTCGGCGCACC 
1390 1400 1410 1420 1430 1440 
Fig. 2. Nucleotide sequence of the A. vinclandü dihydroiipoyltransacetylase gene and primary structure of its translation product. The nucleotide 
sequence of Ihe non-coding strand containing the gene encoding E2 is shown in the 5-3' direction. The amino acid sequence of the 637 residues 
comprising the dihydrolipoyltransaeetylase and of some residues comprising the C-terminus of pyruvate dehydrogenase are shown directly 
above the nucleotide sequence. The ribosome binding site is boxed, relevant stop codons are indicated by asterisks and possible transcriptional 
termination sites are uppcrlincd 
S R N G A K V H A G P A V R Q L A R E F 
GAGCCGCAACGGCGCCAAGGTGCATGCCGGCCCCGCCCTGCGCCAACTGGCCCGCGAGTT 
1450 1460 1470 1480 14 90 1500 
G V E I , A A I N S T G P R G R I I , K E D 
CGGCGTCGAACTGGCGGCGATCAACAGCACCGGTCCGCGCGGGCGCATCCTGAAGGAGGA 
1510 1520 1530 1540 1550 1560 
V Q A Y V K A M M Q K A K E A P A A G A 
CGTGCAGGCOTACGTCAAGGCGATGATGCAGAAGGCCAAGGAGGCGCCGGCCGC-CGGCGC 
15 70 1580 1590 1600 1610 1620 
A S G A G I P P I P P V D F A K Y f i E I 
GGCCAGCGGCGCCGGCATCCCGCCGATTCCGCCGGTCGACTTCGCCAAGTACGGCGAAAT 
1630 1640 1650 1660 1670 1680 
E E V P M T R L M Q I G A T N L H R S W 
CGAAGAAGTGflCGATGACTGGCrTGATGCAGATCGGGGC.GAIXAACCTGCACCGCAGTTG 
1690 1700 1710 1720 1730 1740 
L N V P H V T Q F E S A D I T F L E A F 
GCTGAAGGTGCCX.CACGTGACCCAGTTCGAGTCGGCCGATATCACCGAGCTGGAAGCCTT 
1750 1760 1770 1780 1790 1800 
R V A Q K A V A E K A G V K I, T V I, P I. 
CCüCGTCGCGCAGAAGGCCGTCGCCGAGAAGGCOGGGGTCAAGCTGACCGTGCTGCCGGT 
1810 1820 1830 1840 1850 1860 
I, I, K A C A Y I. Ï, K E I. P D F N S S I, A 
GCTGCTCAAGGCCTGCGCCTACCTGCTCAAGGAGCTGCCGGACTTCAAGAGGTIXCTGGC 
1870 1880 1890 1900 1910 1920 
P S G Q A L I R K K Y V H I G F A V O T 
ACGCAGCGGCCAGGGGCTGATGGGCAAGAAGTAGGTGCACATGGGrTTIXGGGTGGACAG 
1930 1940 1950 1960 1970 1980 
P II G [. [, V P V I R N V 0 Q K S I, [, Q I, 
(XCGGACGGOCTGCTGGTGCCGGTAATCCGCAACGTCGACCAGAAGAGCCTGCTGGAACT 
1990 2000 2010 2020 2030 2040 
A A E A A E L A E K A R S K K L G A D A 
GGCCGCGGAGGCCGCCGAACTGGCGGAGAAGGCGCGCAGCAAGAAGrTCGGfXGCGACGC 
205O 2060 2070 2080 2090 2100 
M Q G A C F T I S S I , G H I G G T A F T 
CATGCAGGGTGCCTGCTTCACCATCTCCAGCCTCGGCCACATCGGCGGCACGGGCTTCAC 
2110 2120 2130 2140 2150 2160 
P I V N A P E V A I L G V S K A S M Q P 
GCCGATCGTCAACGCCCCGGAAGTGGCGATCCTCGGCGTGTCCAAGGCCAGGATGCAGCC 
2170 2180 2190 2200 2210 2220 
V W 0 G K A F Q P R I, M L P I, S L S Y 1) 
GGTATGGGACGGCAAGGCGTTCCAGCCGCGCCTGATGCTGCCGCTGTGGCTGTCCTACGA 
2230 2240 2250 2260 2270 2280 
H R V I N G A A A A R F T K R L G D I . I, 
TCACCGGGTGATCAACGGCGCCGCCGCGGCGCGCTTCACCAAGCGTCTCGGCGACCTGCT 
2290 2300 2310 2320 2330 2340 
A D I R A I I, [. * ;i ,
 i a 
GGCGGATATCCGCGCCATCCTGCTGTGAGCTTCCCTTAAAGAGCGAGCCCGCCACGCTCT 
2350 2360 2370 2380 2390 2400 
b
 v , b 
TTAATrTTCGGCCCCGGrCTTCGTGGCGGGGCTTTTTTATGC 
2410 2420 2430 2440 
universal M13 primer or two synthetic oligonucleotides, re-
presenting two regions in the lipoyl domain. 
The sequencing reaction was carried out at 50 C. In some 
cases instead of dGTP, 7-deaza-dGTP was used [22]. Gels 
were run at 60"C to avoid secondary structure in the G + C-
rich regions [23]. 
The data were compiled in a VAX computer using the 
programs of Staden [24, 25]. 
Other techniques 
Enzyme activities were assayed at 25 C as described pre-
viously [12]. Antisera were collected as described in [3]. Be-
cause of cross-reactivity with E. coli E 2 , antisera were satu-
rated with E. coli TG 2 cell-free extract before use. Gel 
electrophoresis in the presence of sodium dodecyl sulphate 
was carried out essentially as described by Laemmli [26]. 
RESULTS A N D DISCUSSION 
Cloning strategy 
From partially 6V/w3A-digested A. vinelandiichromosomal 
DNA fragments of 9 —23 kbp were isolated and ligated into 
the BamW\ site of pUC9. E. coli TG 2 cells transformed with 
the recombinant plasmids were screened using antiserum 
aginst the catalytic domain of E2 . This antiserum shows less 
cross-reactivity with E. coli enzymes in cell-free extract than 
the antisera raised against intact E2 or against the lipoyl 
domain. Of 600 colonies screened two positives were found 
as shown by SDS gel electrophoresis of cell-free extracts fol-
lowed by Western blotting. From one of the positive colonies 
a I4-kbp recombinant plasmid was isolated. After partial 
digestion of the insert with Saul A, fragments of 2 —3 kbp and 
of 3 —4 kbp were isolated. After ligation in the BamH\ site of 
pUC9 and transformation to E. coli T G 2 cells, screening for 
kl 
Table 1. Codon usage in the gene encoding dihydrolipoyltransacelylase 
from A. vinclandii 
The GUG initiation codon is not included 
F UUU 0 
F UUC 10 
L UUA 0 
L UUG 3 
L CUU 0 
L CUC 10 
L CUA 0 
L CUG 44 
I AUU 1 
I AUC 34 
1 AUA 0 
M AUG 10 
V GUU 2 
V G U C 30 
V GUA 3 
V GUG 26 
S UCU 1 
S UUC 11 
S UCA 0 
S UCG 6 
P CCU 3 
P CCC 17 
P CCA 0 
P CCG 31 
T ACU 1 
T ACC 16 
T ACA 0 
T ACG 4 
A GCU 6 
A GCC 78 
A GCA 6 
A GCG 28 
Y UAU 0 
Y UAC 5 
* UAA 0 
* UAG 0 
H CAU 1 
H CAC 5 
Q CAA 3 
0 CAG 25 
N AAU 0 
N AAC 10 
K AAA 0 
K AAG 34 
D GAU 6 
D GAC 20 
E GAA 19 
E GAG 24 
C UGU 0 
C UGC 2 
* UGA 1 
W UGG 2 
R CGU 1 
R CGC 19 
R CGA 0 
R CGG 4 
S AGU 2 
S AGC 21 
R AGA 0 
R AAG 0 
G GGU 4 
G GGC 42 
G GGA 2 
G GGG 5 
E2 production was carried out. Of 400 colonies with a 3 — 
4 kbp insert screened, 19 were positive, 18 producing intact 
E2 as judged by SDS gel electrophoresis and Western blotting. 
Of 340 colonies with a 2 — 3 kbp insert screened 13 were posi-
tive, of which 12 produced intact enzyme as is shown for 
colony RA282 in Fig. 1. The plasmid of this colony contained 
an insert of 2.8 kbp and was used for sequencing analysis. 
The transacetylase activity in the cell-free extract of this 
colony was 15-fold higher than the activity of the E. coli 
enzyme measured in the cell-free extract of T G 2 cells contain-
ing pUC9 without insert. N o increased E2 activity was found 
when cells were grown without addition of isopropyl ß-o-
thiogalactoside to the growth medium, indicating that tran-
scription is dependent on the vector-encoded lacZ promoter. 
Sequencing strategy 
The 'shot-gun' cloning method was used to sequence the 
2.8-kbp fragment. The complete nucleotide sequence of the 
region containing the dihydrolipoyltransacetylase gene is 
shown in Fig. 2. The sequence was 9 1 % overlapping (100% 
in the coding region) and 79% (94% in the coding region) 
was derived from both strands of D N A (residues 1345 — 1355, 
2 0 0 9 - 2 0 1 9 and 2209-2310 are derived from one strand of 
DNA). Because it was difficult to sequence a very G + C-
rich part of D N A in the region encoding the lipoyl domain 
(residues 1030-1120) , 7-deaza-dGTP was used in the 
sequencing reaction and gels were run at 60 C. Also two 
synthetic oligonucleotides were used (identical to residues 
9 9 6 - 1 0 1 1 and 1146-1131) reading this sequence from both 
strands. 
Coding regions 
A 1911-bp open reading frame was found, which was 
identified as the gene encoding the dihydrolipoyltransace-
tylase, its initiation codon being G U G . This codon usually 
codes for the amino acid valine, but as a start codon it codes 
for formylmethionine [26]. In vitro binding experiments with 
fMet-tRNA do not show strong discrimination against G U G 
[26]. About 3 % of the known genes possesses the G U G start 
codon [27]. 
Table 2. Amino acid composition of dihydrolipoyltransacetylase from 
A. vinelandii 
The amino acid composition deduced from the nucleotide sequence 
is compared with the composition reported from the amino acid 
analysis on the purified enzyme [3]. The methionine initiation residue 
is not included 
Amino acid Number of 
residues from 
DNA sequence 
Composition from 
DNA 
sequence 
amino acid 
analysis 
Asp 
Asn 
Thr 
Scr 
Glu 
Gin 
Pro 
Gly 
Ala 
Cys 
Val 
Met 
He 
Leu 
Tyr 
Phe 
Lys 
His 
Arg 
Trp 
Total 
26 
10 
21 
41 
43 
28 
51 
53 
118 
2 
61 
10 
35 
57 
5 
10 
34 
6 
24 
2 
637 
64913 
mol/IOOmol 
4.1 \ 
1.6 I 
3.3 
6.4 
6.8 | 
4.4 I 
8.0 
8.3 
18.5 
0.3 
9.6 
1.6 
5.5 
8.9 
0.8 
1.6 
5.3 
0.9 
3.8 
0.3 
3.2 
5.5 
10.8 
8.4 
8.8 
21.0 
0.6 
7.7 
1.6 
4.5 
8.4 
1.0 
1.7 
5.4 
1.1 
3.7 
0.4 
The molecular mass of the protein deduced from the open 
reading frame corresponds to that determined by sedimen-
tation equilibrium analysis on the purified enzyme in 6 M 
guanidine hydrochloride [3]. One other open reading frame 
was identified preceding the gene encoding E2 . The deduced 
amino acid sequence (145 residues) showed a high degree of 
homology (49%) with the C-terminal part of the E. coli 
pyruvate dehydrogenase (E, , residues 774 — 886). 
The inlercistronic region 
Between the stop codon of the first open reading frame 
(E,) and the start codon of the second open reading frame 
(E2) an intercistronic region of 11 bp is found. It contains a 
good ribosome binding site (position 440 — 444, Fig. 2). N o 
independent promotor sequence could be identified, which 
indicates that, as in E. coli'[11], the genes encoding Et and E2 
are transcribed from the same promotor, suggesting that the 
difference in subunit ratio of the two components in the com-
plex (E! :E 2 = 1.5:1.0) is regulated at the translational level. 
The nucleotide sequence downstream of the gene encoding E2 
Downstream of the termination codon of the gene 
encoding E2 two regions of dyad symmetry are found, posi-
tions 2376 -2404 (a) and 2 4 1 1 - 2 4 3 2 (b). In these regions 
the m R N A transcripts can form very stable stem and loop 
structures with a free energy of —56.1 kJ (a) and —126.5 kJ 
(b), respectively. The presence of six thymidine residues fol-
A.vinelandii SEIIRVPDIG CDGEVIELI. VKTGDUEVK QGLWLESAK ASMEVPSPKA GWKSVSVKL 
E.coli AIEIKVPDIG ADEVEITEIL VKVGDKVEAE QSLITVEGDK ASMEVPSPQA GIVKEIKVSV 
1 11 21 31 41 51 
60 70 80 90 100 110 
GDKI.KEGDAl IFI.FPAAGAA AAPAEAAAVP AAPTQAVDF.A EAPSPGASAT PAPAAASQF.V 
GDKTQTGAU MIFDSAOGAA DAAPAQAEEK K EAAPAA APAAAAAKDV 
61 71 81 91 98 
120 130 140 150 160 170 
RVPDIGSAGK ARVIEVLVKA GnQVQAF.QSI, IVI.F.SOKASM EIPSPASGW FSVAIQLNAF 
NVPDIGS DE VFVTF.ILVKV GDKVEAEQSl. ITVEGDKASM F.VPAPFAGTV KEIKVNVGDK 
108 117 127 137 147 157 
180 190 200 210 220 230 
VGTGDI.ÏLTL RTTGAQAQPT APAAAAAASP APAPLAPAAA GPQEVKVPDI GSAGKARVIE 
VSTGS1.IMVF EV AGEAG AAAPAAKQEA APAAAPAPAA GVKFVNVP1H GG-DF.VEVTE 
167 177 184 194 204 214 
240 250 260 270 280 290 
Vt.VKAGOQVQ AEQSLTVI.ES DKASMEIPSP AAGVVFSVAV QLNAEVGTGD QII.TLRVAGA 
VMVKVGOKVA AEQSI.1TVEG OKASMEVPAP FAGVVKE[,KV NVGDKVKTGS UMIFEVEGA 
223 233 243 253 263 273 
300 310 320 330 333 343 
APSGPRARGS PGQAAAAPGA APAPAPVCAP S -RN GAKVHAGPAV RQl.ARFFGVF 
APAAAPAKQE AAAPAPAAKA EAPAAAPAAK AEGKSEFAF.N OAYVHATPI.T RRLAREFGVN 
283 293 303 313 323 333 
353 363 373 383 493 403 
l.AAINSTGPR GRI1.KEDVQA YVKAMMQKAK EAPAAGAASG AGIPPIPPV1) FAKYGFIFFV 
LAKVKGTGRK GRI1.RE0VQA YVKEAIKRAE AAPAATGGGI PGMl.PWPKVD FSKFGEIEEV 
343 353 363 373 383 393 
413 423 433 443 453 461 
PMTRI.MQIGA TNI.HRSWLNV PHVTQFESA1) ITFI.EAFRVA Q--KAVAEKA GVKLTVLPI.I. 
ELGRTQKISG ANLSRNWVMT PHVTHFDKTI) ITFLEAFRKQ QNFEAAKRKL DVKITPWFr 
403 413 423 433 443 453 
471 481 491 501 511 521 
LKACAYi.I.KE EPDFNSSLAP SGQAURKKY VHIGFAVDTP DGELVPVIRN VOQKSl.I.Ql.A 
MKAVAAAI.EQ MPRFNSSI.SE DGQRLTLKKY INIGVAVOTP NGLVVPVFKO VNKKG1TELS 
463 473 483 493 503 513 
531 541 551 561 571 581 
AEAAFEAEKA RSKKI.GADAM QGACFT1SSI, GIIIGGTAFTP IVNAPFVAII, GVSKASMQPV 
* ********* ****** * * * * * ********** **** * ** 
RET.MTISKKA RDGKLTAGFM QGGCFTISSI GG1.GTTHFAP IVNAPEVAH, GVSKSAMFPV 
523 533 54 3 553 563 573 
591 601 (ill 621 631 
WOGKAFQPRI. Ml.Pl.SI.SYDH RV1NGAAAAR FTKRI,GDI,LA DIRAUX* 
WNGKFFVPRI. M1.P1SI.SF0H RVIDGAI1GAR FITIINNTI.S OIRHLVM« 
r.83 5M 603 613 623 
Fig. 3. Comparison of the amino acid sequence of dihydrolipoyltransaeetyiase from A. vinclandii and E. coli [10}. Residues arc given in the 
single-letter amino acid code. Homologous residues are indicated by asterisks 
lowing the very G + C-rich dyad symmetry, characteristic for ' n i» 29 . 49 
„/, , . „ A ^ ^ A ^ t t ~ - ™ „ * n m „ 1 - . r i 1 * L * .i_ . Avl ip l SEIlRVPOIGGnGE-VIELLVKTGDUEVEQGLWI.ESAKASMEVPSPKAGVVKSVSVKL 
^ - i n d e p e n d e n t terminators [29], makes it likely that the tran-
 116 126 136 146 . ] 6 6 
scription termination takes place in this region. Av i i P 2 sQevRVPDiGSAGKARviEVLVKAGDQVQAEQsi.ivLESDKASMEtPSPASGWEsvAiQ 
In E. coil the Ipdgene encoding E 3 was found downstream Av] i p 3 22pQEVKVPn?GLGKARvrEvivKAGDQVQAÈQSLivi,EsDKASHEipsplAGvvEsvAVQ 
of the gene encoding E2 [11]. In the region downstream of the ***** * *** *** ** ** * **** ***** *** *** ** * 
gene encoding A. vinelandii E2 (500 bp) no reading frame 
could be found which codes for E3 . This is accordance with f>o 70 so 90 100 no 
the results of Westphal and de Kok [12] who showed that A 
the gene encoding E3 was located downstream of the gene A i^ij,2 NAEVGTGDLILTLRTTGAQAQPTAPAAAAAASPAPAPLAPAAAG 
GDKI.KEGnAIIELFPAAGAAAAPAFAAAVPAAPTQAVnEAEAPSPGASATPAPAAA 
177 187 197 207 
280 290 300 310 320 
Av1i p3 NAEVOTGDQ1LTLRVAGAAPSGPRARGSPGQAAAAPGAAPAPAPV encoding the dihydrolipoyltranssuccinylase component of the 
2-oxoglutarate dehydrogenase complex. The E 3 component 
is shared by both complexes [30]. Fig. 4. Repeating units in the lipoyl domain. The three homologous 
repeating units are aligned for maximum homology. Residues that 
Codon usage a r e 'dentical are indicated by asterisks. Residues are given in the 
single-letter amino acid code. Potential lipoyl-binding sites are postu-
The codon usage is shown in Table 1. It is non-random lated from homology with other organisms[10,30, 31]andareindicat-
with a typical high overall G + C content of 7 1 % , even higher ed by a closed circle ( • ) above the sequence 
than the G + C content of other A. vinelandii genes [12, 31]. 
The G + C content in the third position of the codons is 90%. 
formylmethionine residue is removed post-translationally, so 
D , , • • r.i r t n a t t n e serine residue corresponds to the first residue of the Primary structure and composition of the E2 component XT . - , - , r ., . , . , , 1
 ' N-terminal amino acid sequence that has been determined 
From the nucleotide sequence the primary structure was by automated Edman degradation of the purified protein as 
derived as shown in Fig. 2. It is assumed that the initiating isolated from A. vinelandii [3]. An internal sequence of 36 
U3 
residues, obtained by Edman degradation of the N-terminus 
of the catalytic domain [3], corresponds exactly with the se-
quence 381 —416. Only the last residue proved to be an arginyl 
residue instead of the reported methionyl residue. 
The gene encodes a polypeptide of 637 amino acid residues 
with a total mass of 64.9 kDa. This is in excellent agreement 
with the mass of 63 kDa as determined by sedimentation 
equilibrium analysis [3]. The chain mass is significant lower 
than that based on SDS/polyacrylamide gel electrophoresis 
(82 kDa). The predicted amino acid composition agrees well 
with that determined for the purified enzyme [3] (Table 2). 
The sequence indicates the presence of two cysteinyl residues, 
located in the catalytic domain. SH group determination with 
5,5'-dithiobis(2-nitrobenzoic acid) in the presence of 6 M 
guanidine • HCl without prior reduction indicated 1—2 SH 
groups, whereas no reaction was observed with the native 
enzyme, in agreement with previous labeling experiments of 
the whole complex with A'-ethyl[2,3-14C]maleimide [32]. This 
indicates that both SH groups are buried. 
Domain structure and comparison with the E. coli sequence 
The alignment of the amino acid sequences of E 2 from E. 
coli and A. vinelandii is shown in Fig. 3. The overall homology 
is very high: 50% of the residues are identical or 69% if closely 
related amino acids are included. In the N-terminal part of 
the E2 chain, concerning the lipoyl domain [10], the primary 
structure shows three repeating units, alternated by regions 
which are very rich in alanyl and prolyl residues (Fig. 4). In 
purified E2 2 — 3 lipoyl groups per subunit were estimated [33] 
so that potentially each unit will possess a lipoyl binding site. 
In E. coli the region around the lipoyl binding site was found 
to be very conserved in all three repeating structures [10, 34]. 
In A. vinelandii the same region is found in all three repeating 
units; therefore, we conclude that the lipoyl groups are at-
tached to Lys39, Lys l56and Lys261. Analogous regions have 
been found in the E2 chain of E. coli [35] and A. vinelandii 
(unpublished results) 2-oxoglutarate dehydrogenase com-
plexes and in the bovine heart pyruvate dehydrogenase com-
plex [36]. An homologous region is present in the biotin car-
boxyl carrier protein (EC 2.1.3.1) from Propionibacterium 
shermanii [37]. The biotinyl prosthetic group is bound to a 
lysyl residue in an equivalent position as the lipoyl carrying 
lysyl residue. 
The C-terminus of the lipoyl domain has not been deter-
mined. From the molecular mass of 32.8 kDa of the lipoyl 
domain, as determined by analytical ultracentrifugation, 
cleavage products with other proteases and homology with 
the E. coli sequence, the most probable location of the C-
terminus is in the region between residue 331 and 347. 
The N-terminal sequence of the A. vinelandii catalytic do-
main starts at residue 381, as concluded from a comparison 
with the N-terminal sequence of the catalytic domain, 
obtained by limited proteolysis [3]. Packman et al. [5] have 
reported that limited proteolysis of E. coli E2 by trypsin result-
ed in cleavage at position 316 of the E. coli sequence. A 
fragment called 'inner core domain ' was isolated which still 
contained the binding sites for E, and E3 . More recently [7] 
a smaller fragment was obtained after prolonged digestion 
with trypsin. This fragment, starting at position 370, 
equivalent with that of the A. vinelandii catalytic domain 
(Fig. 3), has lost the E3 binding site but seems to retain the 
E t binding site. In recent experiments (unpublished) we have 
determined the C-terminus of the catalytic domain using 
carboxypeptidase Y. It appeared to be identical to the C-
terminus of intact E2 . Therefore proteolytic removal of the 
C-terminus, a conclusion inferred from molecular mass deter-
mination of the catalytic domain, seems not to be justified. 
This will be more fully discussed in a subsequent paper. 
From the indicated domain structure it is concluded that 
the lipoyl domain and the catalytic domain are separated by 
about 50 amino acid residues. This region is very sensitive to 
proteolysis by trypsin [3], chymotrypsin and Staphylococcus 
aureus proteinase (unpublished results) and is therefore indi-
cated as a hinge region. 
In previous experiments we have shown that, after limited 
proteolysis of E2 with trypsin, the Ei and E 3 binding sites are 
lost [3]. This indicates that the hinge region is involved in the 
binding of both components, although from these exper-
iments we cannot exclude that other regions on E2 might 
contribute to the binding. 
We have shown previously that hybrid active complexes 
could be formed betweeen E3 from E. coli and the E]E 2 
subcomplex from A. vinelandii and between E, from A. 
vinelandii and the E 2 E 3 subcomplex from E. coli [30]. Further-
more the E 3 component of each organism binds to the E2 
components of both pyruvate and 2-oxoglutarate dehydro-
genase complexes. Therefore sequence homology between the 
E3 binding sites is expected. From an inspection of the se-
quences (Fig. 3) it is clear that it is mainly the charged amino 
acid residues in the hinge region which are conserved. This 
observation extends to the E2 chain of 2-oxoglutarate de-
hydrogenase complex from A. vinelandii (unpublished results). 
A further indication that charged residues are involved in the 
binding of the peripheral components is given by the methods 
used for resolution of the components from the complex: 
either high pH or high salt concentration. Further research is 
being directed to elucidating the E t and E 3 binding sites. 
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CHAPTER 4 
THE GENE ENCODING DIHYDROLIPOYL TRANSACETYLASE FROM AZOTOBACTER 
VINELANDII: EXPRESSION IN ESCHERICHIA COLI AND ACTIVATION AND 
ISOLATION OF THE PROTEIN 
Roeland Hanemaaijer, Adrie H. Westphal, Axel Berg, Arie de Kok 
and Cees Veeger 
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Summary 
The gene encoding the dihydrolipoyl transacetylase (E2) component 
from Azotobacter vinelandii has been cloned in Escherichia coli. 
High expression of the gene was found when the cells were grown 
for more than 14 hours. The produced E2 was partially inactive, 
varying between 10-90% in different experiments. By limited 
proteolysis of the protein it was shown that the catalytic domain 
was incorrectly folded, caused by formation of inter- or 
intramolecular S-S-bridges. The enzyme was fully activated after 
unfolding in 2.5 M guanidine hydrochloride containing 2 mM 
dithiothreitol, followed by refolding by dialysis. Active E2 was 
isolated in a simple three-step isolation procedure. It possessed 
a specific activity more than twice as high as found after 
isolation of E2 from purified pyruvate dehydrogenase complex from 
A.vinelandii. Active E2 comprises about 7% of the total soluble 
cellular protein in the E.coli clone. 
By genetic manipulation deletion mutants of E2 were created, one 
encoding the lipoyl domain and the N-terminal half of the Ej- and 
E3 binding domain, the other encoding the catalytic domain and 
the C-terminal half of the Ej-and E3 binding domain. In E.coli 
expression of both mutants was observed. 
Introduction 
Dihydrolipoyl transacetylase (E2) is the core component of the 
pyruvate dehydrogenase complex (PDC).It comprises many functions 
in which several sites are involved: binding sites for the 
pyruvate dehydrogenase (Ej) and lipoamide dehydrogenase (E3) 
components, the E2 intersubunit binding sites, the transacetylase 
active site and the covalently bound lipoyl moieties, which 
transport the substrates between the different active sites [1]. 
Limited proteolysis studies [2] have shown that E2 consists of at 
least two stable domains: an N-terminal lipoyl domain, containing 
the lipoyl moieties, and a C-terminal catalytic domain, 
possessing the transacetylase active site and the E2 intersubunit 
binding sites. The Ej and E3 binding sites are lost during 
proteolysis. 
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The gene encoding E2 of PDC from Azotobacter vinelandii has been 
cloned and sequenced [3], It consists of 637 codons. It is 
preceded by the gene encoding Ej and by an intercistronic region 
of 11 basepairs, containing a ribosome binding site, which has a 
high degree of homology with the E.coli consensus ribosome 
binding site. The lipoyl domain is located between residues 1 and 
331/347 [2,4]. The catalytic domain is located between residue 
381 and 637. The region between these two domains is thought to 
possess the Ej and E3 binding sites [2] . It possesses many 
charged residues and is easily digested by various proteases 
[2,4]. The homology of A.vinelandii E2 with E.coli E2 is high: 
50* of the amino acid residues is identical. 
E.coli cells, transformed with plasmid pRA282, that contain the 
gene encoding A.vinelandii E2 on a 2.8 kbp insert, show a high 
expression of this gene. A 15-fold higher activity was found 
compared to the background of E.coli E2 [2]. 
In this paper some characteristics of the A.vinelandii protein, 
synthesized in the E.coli host, are shown. A high E2 production 
is found when the cells are grown for more than 14 hours. E2 can 
be isolated in a simple three-step isolation procedure. A 
variable amount of the protein was inactive. An activation 
procedure is described by which fully active E2 is obtained. Two 
Plasmids are constructed encoding the lipoyl domain fused with 
six and the catalytic domain fused with ten vector-encoded 
residues. These separate domains are synthesized as stable 
proteins in the E.coli host. 
Materials and methods 
Bacterial strains and plasmids 
E.coli TG2 fA(lac-pro) thi recA' supE hsdR hsdM F'(traD36 proA+B+ 
laclq lacZAM15)1 [5] or E.coli MC1061 [araD139 A(ara 
leu7697)AlacY74 galU galK hsdM+ hsdR" strA] [6] were used as host 
for the expression of plasmid-encoded E2- E.coli Y1083 fthi 
A(lacIP0ZYA)U169 araD139 Alon phx rpsL hf!A150[chr::TnlO]], 
derived from Y1089 [7], was used as host for the expression of 
the plasmid-encoded lipoyl domain and catalytic domain. 
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Materials 
Standard restriction endonucleases, T4 DNA ligase, DNA polymerase 
I (Klenow fragment) were obtained from Bethesda Research 
Laboratories (BRL). Restriction endonuclease RsrII was obtained 
from Janssen Biochimica. Ampicillin, ethidium bromide and IPTG 
were from Sigma. Tosylphenylalanylchloromethane-treated trypsin 
was obtained from Worthington Biochemical Corp. DEAE-Sephacel and 
Sephacryl S300 were from Pharmacia Fine Chemicals. 
General methods 
Plasmid DNA was isolated from cleared lysates by equilibrium 
centrifugation in cesium chloride containing ethidium bromide 
[8]. Small-scale preparations were prepared according to [9]. 
Methods of digestion with restriction endonucleases, DNA 
ligation, plasmid transformation and agarose gel electrophoresis 
of DNA have been described before [2,10] or were carried out 
according to Maniatis et al. [11]. Western-blotting was carried 
out according to [12]; visualization of bound antibodies was with 
secondary antibodies (goat-anti-rabbit) conjugated to alkaline-
phosphatase (Protoblot, Promega Biotec). E2 transacetylase 
activity was assayed spectrophotometrically at 240 nm and 25°C as 
described previously [13]. The lipoyl content was determined 
using the 5,5'-dithio-bis(2-nitrobenzoic acid) cleavage reaction 
[14]. 
Construction of Plasmids 
Plasmid pRA282 (Fig.l), derived from the vector pUC9 [15] and 
encoding E2, has been described previously [2]. Plasmid pRCl was 
constructed from pRA282 by deleting the sequences encoding the 
lipoyl domain of E2 (Fig.l). Therefore, pRA282 was cut with 
restriction endonucleases RsrII and Hindlll; the ends were 
filled-up with Klenow polymerase and the blunt-ended plasmid was 
closed with T4 DNA ligase and introduced into E.coli. Plasmid pRLl 
was also derived from pRA282 by removing the sequences encoding 
the catalytic domain. (Fig.l). To this end pRA282 was cut with 
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r e s t r i c t i o n endonucleases RsrII and EcoRI. After end- repa i r with 
Klenow the plasmid was closed and introduced in to E . c o l i . For 
pRCl and pRLl E .co l i TG2 and E .co l i Y1083 were used as hos t . 
Figure 1. Physical »ap of plasmid pRA 282. Shown are the p o s i t i o n s of the gene encoding E 2 
(white box) , with the regions encoding the l ipoy l ( l i p ) and the c a t a l y t i c (cat) domain and part 
of the gene for Ej (hatched) and a non-coding region (a l so hatched) . The s i n g l e l i n e represents 
the v e c t o r , pl)C9, with the gene encoding /S-lacta«ase (amp) and the lacZ promoter/operator 
( lacZpo), whose d i r e c t i o n i s ind i ca ted by the arrow. R e s t r i c t i o n s i t e s are shown for BamHI (B), 
EcöRI (E), Hindl l l (H) and RsrII (R). 
Prepara t ion and ana ly s i s of c e l l - f r e e e x t r a c t s 
E . co l i TG2, E .co l i MC1061 or E .co l i Y1083, harbouring recombinant 
Plasmids, were grown a t 37°C in TY medium [16] . con ta in ing 
ampic i l l i n (75 ug/ml) and IPTG (20 )ig/ml ) , for a t l e a s t 17 h, 
unless described o therwise . A 10 ml c e l l suspension was 
concentra ted 20-fold and c e l l s were d is rupted by son ica t ion . 
After cen t r i fuga t ion for 10 min. a t 13,000xg the supernatant was 
assayed for E 2 -ac t i v i t y and subjected to SDS-PAGE. 
I s o l a t i o n of A.v ine landi i E2 expressed in E .co l i 
A s i n g l e colony of E .co l i TG2(pRA282) was picked from a TY-plate 
conta in ing 50 ug/ml ampic i l l i n and grown overnight a t 37°C in 10 
ml TY conta in ing 75 (ig/ml ampic i l l i n and 20 ug/ml IPTG. 0.5 ml of 
t h i s c u l t u r e was used to inocu la te 50 ml of the same medium and 
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this culture was grown at 37°C for 8 hours. The culture was 
stored overnight at 4°C and the next day used for inoculation of 
20 litres of cold (4°C) growth-medium. The large culture was 
grown for 40 hours at 37°C. Using these growth-conditions less 
than 10* of E2 was in the inactive form. Cells (80-100 grams) 
were harvested and used for isolation of E2. Cells were suspended 
in 50 mM potassium phosphate pH 7.0, containing 3 mM EDTA and 0.1 
mM PhMeSOaF (standard buffer), and disrupted using a Manton-
Gaulin laboratory homogenizer at 9000 psi. After centrifugation 
for 30 minutes at 14000xg a PEG-MgCl2-precipitation was carried 
out in two steps: after addition of 10% (w/v) PEG-6000 and 0.75 
mM MgC12 (final concentrations) a large amount of protein was 
precipitated, while E2 remained in solution. At 12 mM MgCl2 E2 
was precipitated and after centrifugation for 30 minutes at 
20000xg the pellet was suspended in standard buffer containing 12 
mM EDTA. The clear solution was applied to a DEAE-Sephacel column 
and eluted using a 0-500 mM KCl-gradient in standard buffer. The 
peak-fraction was concentrated by ultrafiltration (Amicon YM100) 
and applied to a Sephacryl S300 column. The fractions of this 
column were analysed for activity and on SDS-gel. 
Activation-procedure for E2 
Cell-free extract from E.coli MC1061(pRA282), which had grown for 
23 h, was diluted 6-fold in 50 mM potassium phosphate, pH 7.0, 
0.1 mM EDTA and 0.1 mM PhMeS02F. After addition of 0.5 volume of 
a 7.5 M GdnHCl stock solution (final concentration 2.5 M 
GdnHCl),the samples were incubated for at least 15 minutes at 
OOC. After incubation CoA and/or lipoic acid were added from a 
stock solution to a final concentration of 0.5 mg/ml CoA and/or 1 
mM lipoic acid. In the samples without CoA or lipoic acid a same 
volume of standard buffer was added. 
Renaturation and analysis of the activity was carried out in 
three ways: 1. dilution of the sample directly in the assay mix 
(the final concentration of GdnHCl is 25 mM; this concentration 
does not inhibit E2~activity); 2. a 5-fold dilution in standard 
buffer, and after incubation for at least 1 h measurement of the 
E2~activity and 3. dialysis (o/n) against standard buffer, after 
which E2~activity is measured. 
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Results and discussion 
Expression of A.vinelandii E2 in E.coli 
Plasmid pRA282 (Fig.l) was used for expression of A.vinelandii E2 
in E.coli TG2. The gene encoding E2 is preceded by a region of 
about 500 nucleotides, encoding the C-terminal part of the 
pyruvate dehydrogenase (EjJ component of the pyruvate 
dehydrogenase complex [2]. No terminator for transcription was 
found in the intercistronic region of 11 bp. The gene encoding E2 
is under regulation of the vector-encoded lacZ-promoter. 
The E2~activity of the E.coli clone that expresses A.vinelandii 
E2 is shown in Fig. 2 at different stages of growth. Expression 
of E2-activity is low in the exponential growth-phase (less than 
eight hours of growth), but steadily increases during the end-log 
and stationary phases of growth. 
After approximately 18-20 hours, when the cells are well within 
the stationary phase, a peculiar event takes place. In most 
experiments the E2-activity, expressed by the E.coli clone, 
remained fairly constant after this time (as represented by the 
E 
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Fieure 2 Expression of A.vinelandii E7-activity in E^QOJJ. TG2(pRA282) during cell-growth^ A 
colony was Picked up from a TY-plate and grown for 8 hours in TY containing 75 ug/ml ampicilli. 
and 20 ug/mï IPTG. 10 ml cultures were inoculated with 25 «1 of the pre-culture and grown for 
variable times. The 0D600 was determined U ) and after preparation of cell-free extract 
E,-activity was measured (.). The solid line (.—•) shows an experiment in which ^-activity 
d rease after !8-20 hours of growth, and is typical for most e * e e " " ^ s performed, 
the dashed line (.-.) represents an experiment, in which activity increased after this time. 
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Figure 3 Expression of A.vinelandii E2 protein in E.coli TG2(pRA282) during cell-growth. Cells 
were grown as described in the legends of Fig. 2; a culture was used that did not show an 
increase in E2-act lvi ty after 18-20 hours of growth. Cell-free extracts were subjected to 
SDS-PAGE. The cel l - f ree extracts were prepared from cel ls that had grown for 12 (lane a) , 16 
(lane b) ', 20 (lane c) . 24 (lane d) and 40.5 hours (lane e ) . In lane f molecular weight markers 
are shown. 
solid line in Fig. 2). In some experiments, however, the act ivi ty 
further increased more than twofold over the next 20 hours, as 
shown by the dashed line in Fig. 2. In earl ier experiments, this 
dramatic increase in the expression of E2-activity was never 
noticed, because E.coli s trains with pRA282 were grown less than 
16 hours. 
We also studied whether the amounts of Eg protein, produced by 
the E.coli clone, paralleled the changes in E2~activity expressed 
by the clone. Therefore, samples of the respective E.coli clone 
were collected after different growth-times, and cell-free 
extracts of these clones were analysed by SDS-PAGE. Fig. 3 shows 
the electrophoretic profiles of cell-free extracts of these 
samples drawn from a growth-experiment, in which no increase in 
E2-activity was found after 18-20 hours of growth (corresponding 
to the solid line in Fig. 2). Surprisingly, the amount of E2 
protein s t i l l increased after 18-20 hours of growth, as can be 
noticed from the increase in intensity of the E2 protein band on 
gel, although the act ivi ty remained fair ly constant. Apparently, 
after approximately 18 hours of growth, E2 was s t i l l produced, 
but was not enzymatically active in this experiment. After we 
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succeeded in activating this inactive E2 (see next section), 
fro» the ratio between the activities before and after activation 
we were able to estimate the relative amount of inactive E2 that 
was produced. This amount varied between 10* and 90% in different 
experiments. Usually, the longer the recombinant bacteria were 
cultured, the more inactive protein was observed. Several reasons 
night exist for the accumulation of inactive E2: a lack of an 
(unknown) cofactor, aggregation caused by the high protein con-
centration, or a wrong folding. Inactive E2 was not readily 
pelletted after centrifugation of sonicated extracts, suggesting 
that it is not present as large aggregates, that are often found 
after production of high amounts of eukaryotic [17,18] or 
prokaryotic [19] proteins expressed from recombinant Plasmids, 
and that might form separate entities, the so-called inclusion-
bodies. It is not known, why some cultures accumulate much more 
inactive £3 than others, although the same growth conditions were 
applied. 
The inactive protein was tested by limited proteolysis for 
correct folding of the domains. Limited proteolysis with trypsin 
of E2, as isolated from A.vlnelandii, yields two stable domains: 
the lipoyl domain and the catalytic domain [3]. When cell-free 
extract of an E.coli TG2(pRA282) culture that contained a large 
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Figure 4. Limited proteolysis of A.vinelandli E2 expressed in E.coli TG2(pRA282). Proteolysis 
with trypsin was carried out on cell-free extracts, prepared from cells that produced predomi-
nantly inactive Ej. Cells were grown as described in the legends of Fie. 2- Cell-free extracts 
were incubated with trypsin (0.2 ug/ml cell-free extract) at 0°C for 90 minutes, and'analysed 
by means of SDS-PAGE. Lane a-d: digests from extracts from cells after 16,20.24 and 40.5 hours 
of growth, respectively. Lane e, E2 isolated from A.vinelandii PDC, digested with trypsin, lane 
f, isolated A.vinelandii PDC. 
amount of inactive E2 was subjected to limited proteolysis with 
trypsin a usual amount of lipoyl domain was found (Fig.4), but 
hardly any catalytic domain could be observed by SDS-PAGE. This 
Indicates that the lipoyl domain is folded correctly. The 
catalytic domain, on the other hand, is degradaded into small 
fragments upon proteolysis with trypsin. Obviously, this C-
terminal part of the E2~chain is unfolded or folded in an 
incorrect way, causing that lysyl- and arginyl residues are 
available for trypsin digestion. 
Finally, a comment should be made on the late expression of E2 
protein and activity that was noticed in these experiments. One 
of the factors that might be responsible for this, could be the 
dependence of the E2 gene from the vector-encoded lacZ-promoter; 
this promotor is known to be stimulated by guanosine-5'-
diphosphate-3'diphosphate (ppGpp)[20]. The concentration of ppGpp 
is low at high growth rates and is highly raised in a process 
called "stringent respons" [21] in the stationary phase of the 
growth-cycle or when specific nutrients, like amino acids, are 
depleted. 
Activation of inactive E2 produced in E.coli 
From the experiments described in the previous part, it appeared 
that in the inactive protein the catalytic domain was incorrectly 
folded. We undertook a series of experiments aimed at restoration 
of the native folding. Therefore, Eg was first incubated in 2.5 M 
GdnHCl in order to obtain denaturation, followed by renaturation 
by removal of the GdnHCl under different conditions. Experiments 
were performed in cell-free extract because we were not able to 
purify the inactive protein. Coenzymes are known to have a 
positive influence on the rate and yield of reactivation and 
renaturation [22]. Therefore the lipoic acid cofactor and the 
substrate CoA, which both visit the active site in the catalytic 
domain, were added in the activation assay. The results of the 
activation experiments are shown in Table 1. After incubation 
with 2.5 M GdnHCl for 15 minutes at 0°C, transition of E2 to the 
unfolded state occurs, as has been observed by circular dichroism 
and kinetic measurements [4]. When a cell-free extract, 
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method/sample 
CFE 
direct 100 
diluted 60 
+L 
100 
100 
+D 
ND 
ND 
+G 
10 
20 
Table 1. A c t i v a t i o n of i n a c t i v e A . v i n e l a n d i i Eg expressed in 
E . c o l i TG2(pRA282). 
+G+A +G+L +G+A+L +G+D +G+D+A 
10 10 10 ND ND 
30 20 40 ND ND 
d i a l y s e d 100 110 100 160 170 120 140 1030 1030 
C e l l - f r e e e x t r a c t s (-CFE) of E . c o l i TG2(pRA282) c o n t a i n i n g 
p a r t i a l l y i n a c t i v e A . v i n e l a n d i i Eg were incuba ted wi th 2 . 5 M 
GdnHCl (15 minutes , 0°C;=G), fol lowed by a d d i t i o n of acetylCoA 
( 0 . 5 mg.ml;=-A), l i p o i c ac id (1 mM;=L) and /o r d i t h i o t h r e i t o l (2 
mM;=D). After i ncuba t ion with GdnHCl, a c t i v a t i o n was c a r r i e d out 
by d i f f e r e n t methods and a c t i v i t y was measured. A c t i v i t i e s a r e 
shown as pe rcen tage of the b lank , t o which no GdnHCl i s added. 
The terms d i r e c t , d i l u t e d and d i a l y s e d a re exp la ined in the t e x t . 
ND= not done. 
containing »ore than 90% inactive E2, was denatured with 2.5 M 
GdnHCl, followed by dialysis to remove GdnHCl, the Eg-activity 
increased 1.6-fold (Table 1). Only a small amount of act ivi ty was 
found when the GdnHCl-denatured extract was brought to low GdnHCl 
concentration by di lut ion. The addition of CoA or lipoic acid did 
not result in a significant higher act iv i ty . 
The addition of di thiothrei tol in the activation assay resulted 
in a significant activation: a 10-fold higher act ivi ty was found. 
Upon addition of d i th iothrei to l to cel l-free extract , which had 
not been incubated with GdnHCl, no increase in act ivi ty was 
observed. Obviously, inactive, incorrectly folded E2 resul ts from 
the formation of intermolecular or intramolecular S-S bridges. E2 
contains two (reduced) cysteine residues in the catalyt ic domain, 
that might be involved in the formation of erroneous S-S-bridges 
in the inactive protein. 
Correct folding of the activated protein was checked by limited 
proteolysis. After limited proteolysis of the E2~containing ce l l -
free extract and analysis of the digestion products by SDS-PAGE, 
the catalyt ic domain could be detected, suggesting that i t is 
correctly folded (Fig. 5). In the same sample an about 2 kDa 
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Figure 5. Limited p r o t e o l y s i s of 
A . v i n e l a n d i i E2 expressed in E . c o i i 
TG2(pRA282), a f t e r a p p l i c a t i o n of d i f -
f e r e n t a c t i v a t i o n p r o c e d u r e s . Diges t ion 
p roduc t s were sub jec t ed to SDS-PAGE. C e l l s 
were grown for 24 hou r s . P r e p a r a t i o n of 
c e l l - f r e e e x t r a c t s (CFE), the a c t i v a t i o n 
procedures and the meaning of the abb re -
v i a t i o n s a re d e s c r i b e d in the method-
s e c t i o n or in t h e legends of Table 1. 
Diges t ion with t r y p s i n was c a r r i e d out for 
90 minutes a t 0°C. Lane a, CFE+G; lane b, 
CFE+G+D; lane c , CFE+G+D+A; lane d, CFE; 
lane e , E2. i s o l a t e d from A . v i n e l a n d i i PDC 
and d i g e s t e d with t r y p s i n , lane f, molecu-
l a r weight markers . 
F igure 6. P u r i f i c a t i o n of A . v i n e l a n d i i E2 
expressed in E . c o i i TG2(pRA282). Samples 
from d i f f e r e n t s t a g e s of the i s o l a t i o n 
procedure of A . v i n e i a n d i i E2 expressed in 
E.coii TG2(pRA282) were sub j ec t ed t o 
s n s - g e l e l e c t r o p h o r e s i s . Lane a, c e l l - f r e e 
e x t r a c t ; l ane b , s u p e r n a t a n t a f t e r PEG/12 
mM M g C l 2 - p r e c i p i t a t i o n ; lane c, p e l l e t 
a f t e r PEG/12 mM M g C l 2 - p r e c i p i t a t i o n ; lane 
d, pool DEAE-Sephacel; l ane e, pool 
Sephacryl -S300; lane f, molecular weight 
markers . 
smaller protein-band was observed (F ig .5 , l ane 2) which a l so some-
times i s observed a f t e r l imi ted p r o t e o l y s i s of E2 which has been 
s tored for a long time, or a f t e r very long incubat ion with t r y p -
s in (days) . 
I s o l a t i o n of A.v ine landi i E2 expressed in E .co i i 
E .co i i TG2(pRA282) c e l l s were grown as described in the methods, 
using condi t ions r e s u l t i n g in production of E2 of which l e s s than 
10% i s i n a c t i v e . E2 was i s o l a t e d as described in the methods from 
80-100 gram c e l l s , in a t h r e e - s t e p procedure. The r e s u l t s of a 
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Table 2. Purification of A.vinelandii E2 from E.coli 
TG2(pRA282). 
sample volume protein specific total yield 
activity units 
(ml) (mg) (U/mg) (U) (*) 
crude extract 
PEG-precipi tati on 
DEAE-Sephacel 
Sephacryl-S300 
The culture of E. coli 
325 
40 
275 
81 
TG2(pRA282) 
9653 
1044 
591 
406 
, used for 
4.4 
38.9 
66.1 
79.4 
isola ti on 
42150 100 
40640 96 
39050 92 
32240 76 
. produced 
Eg that was for more than 90% active. 
purification are shown in Table 2 and Fig. 6. Eg possessed a 
specific activity of 79 U/mg. This is much higher than the 
specific activity which was found before in Eg resolved from 
isolated A.vinelandii PDC. A value of 12.6 U/mg has been reported 
[23], and in subsequent experiments a value of 30 U/mg was 
obtained (unpublished result). In the isolation described in this 
paper a more than twofold higher specific activity was found. The 
harsh conditions during resolution of the components from PDC (pH 
9.4, 3M KBr) might be responsible for the lower activity obtained 
before, although previously no difference was found between 
activity of the isolated Eg or of Eg in the complex. 
We obtained 406 mg of pure Eg from 100 gram cells (Table 2). 
During the isolation of PDC from A.vinelandii, 280 mg PDC, 
corresponding to 70 mg E 2, was obtained from 250 gram cells [24]. 
Consequently, a 15-fold higher amount of Eg can be obtained (per 
gram of cell wet-weight) from the E.coli clone compared to 
A.vinelandii. The Eg is very soluble in standard buffer and 
concentrations of 1 mM are easily obtained. This makes 
A.vinelandii Eg very suitable for NMR-experiments. 
The lipoyl groups are attached to specific sites in the lipoyl 
domain [25]. In Eg of PDC from A.vinelandii three potential 
lipoyl binding sites were indicated in the lipoyl domain [2]. In 
E2 isolated from A.vinelandii 2-2.5 lipoyl groups were determined 
per Eg-chain [26,27], but about 50* could be excised without 
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affecting the activity, as was shown for E,coli E2 by enzymatic 
removal of the lipoyl groups [28] and for mutant E.coli PDC, in 
which one or two of the lipoyl domains were deleted by genetic 
engineering [29,30], Determination of the lipoyl groups in 
A.vinelandii E2 produced in E.coli showed that only about one 
fifth of the potential lipoyl binding sites are actually occupied 
by lipoyl groups. Obviously, E.coli is able to incorporate lipoyl 
groups in A.vinelandii E2, but the efficiency is very low. It is 
not exactly known how lipoyl groups are attached to the binding 
sites, and by what factors this binding is influenced. It cannot 
be excluded that incorporation of these moieties requires a 
specific mechanism, that is not very efficient towards the 
heterologous A.vinelandii E2. Also the high synthesis rates of E2 
or the high amounts of E2 produced might influence the 
effectiveness of cofactor incorporation, if the amount of 
cofactor produced cannot cope with the amount of E2 produced. 
This latter factor might certainly be relevant: also in an E.coli 
clone that produced high amounts of E.coli lipoyl domain from a 
recombinant plasmid, both lipoylated and non-lipoylated domains 
were observed [31]. Further research will be carried out in which 
the incorporation of lipoyl groups is determined at different 
stages of the growth. 
Despite the small amount of incorparated lipoyl groups the lipoyl 
domain is correctly folded, as judged by the relative resistance 
to tryptic digestion. Obviously, this cofactor is not essential 
for correct folding. 
Separate expression of the E2 catalytic and lipoyl domains from 
Plasmids pRCl and pRLl 
Previous experiments have demonstrated that the two functional 
domains of E2 can be considered as two separate and stable 
structural domains. These two domains are relatively resistant to 
trypsin digestion and are connected by a short region that is 
sensitive to trypsin digestion, and is thought to possess the Ej-
and E3 binding sites. Here we describe experiments aimed at the 
separate expression of these domains from recombinant plasmids 
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that only contain the genetic information for either the lipoyl 
or the catalytic domain of E2- Therefore pRA282, which has a 2.8 
kbp insert, was digested with endonuclease RsrII, that has a 
unique restriction site around residue 1534 (Fig.l), in the 
middle of the region (of the gene) that is proposed to contain 
the information for the Ej- and E3 binding sites. Using the 
Hindlll-site of the multiple cloning site of the vector, plasmid 
pRCl is constructed by a deletion of the RsrII-Hindlll fragment. 
After deletion of the ±1540 residues, the resulting plasmid 
still has the genetic information for the catalytic domain and 
part of the proposed Ej- and E3 binding region, but has lost the 
information of the lipoyl domain and the start codon, GTG. 
Translation might start, however, from the in-frame AUG start 
codon for the vector-encoded-ß-galactosidase, resulting in the 
expression of the catalytic domain that is extended at the N-
terminus with the six N-terminal residues of /S-galactosidase and 
20 residues of the proposed Ej- and E 3 binding region (=E2cat+). 
Using the EcoRl-site of the multiple cloning site of the vector, 
plasmid pRLl is constructed by a deletion of the RsrII-EcoRI 
fragment. The resulting plasmid pRLl, after deletion of the 
±1260 bp, still has the genetic information for the lipoyl domain 
and part of the proposed Ej- and E3 binding region, but sequences 
for the catalytic domain and the stop codon are lost. Translation 
might terminate at an in-frame stop codon, found 30 nucleotides 
downstream of the truncated E2~gene in the vector, resulting in 
the expression of the lipoyl domain that has a 10 residues long 
C-terminal extension of vector-encoded residues and 14-30 
residues of the proposed Ej- and E3 binding region (=E2Üp+). 
E2cat+ and E2ÜP+ are produced in low amounts in E.coli TG2(pRCl) 
or E.coli TG2(pRLl), respectively. They can hardly be seen on 
SDS-gel (Fig. 7A) but after Western blotting the proteins could 
be observed after reaction with antibodies specific for the 
homologous domains of E2 (Fig. 7B,C). E2Cat+ had, as expected, an 
apparent molecular mass of 30 kDa. Also a ± 2 kDa smaller 
protein band was observed, having the same molecular mass as the 
catalytic domain obtained after digestion of E 2 with trypsin. 
Probably the region around the original claevage site is still 
easily digested. E2ÜP+ had the same apparent molecular mass (52 
kDa) as the lipoyl domain obtained after digestion of E2 with 
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FiiTure 7. Expression of A.vinelanriii l ipoyl domain and ca ta ly t ic comain (Eglip* and E2Cat+) in 
E.coli TG2(pRLl) and TG2(pRCl). A. SDS-PAGE, stained with Coomassie b r i l l i an t blue R. B. 
Western-blot, incubated with antiserum against the t rypt ic lipoyl domain. C. Western-blot, 
incub8ted with antiserum against the t ryp t ic ca ta ly t ic domain. Lane a, cel l-free extract of 
E.coli TG2(pUC9); lane b. Eg, isolated from A.vineiandii PDC, par t i a l ly degraded during 
storage); lane c. E2, isolated from A.vineiandii PDC, and digested by trypsin at 0°C for 90 
minutes; lane -d, cel l - f ree extract of E.coli TG2(pRLl); lane e. cel l - f ree extract of TG2(pRCl). 
In this experiment E2cat+ and E2 l ip* were expressed in E.coli TG2: la ter experimets showed a 
much higher level of expression in the Alon E.coli s t ra in Y1083. 
t r y p s i n , although a 2-3 kDa higher molecular mass was expected. 
Obviously, a pa r t of the p ro t e in i s cleaved off by c e l l u l a r 
p ro t ea se s , probably around the o r i g i n a l t r y p t i c cleavage s i t e . 
To diminish the p o s s i b i l i t y of c e l l u l a r c leavages , expression of 
the recombinant Plasmids was a l so s tudied in E . co l i MC1061, a 
Alon s t r a i n t ha t i s de f i c i en t in the Ion-pro tease , thereby 
reducing the degradat ion of expressed p ro te ins [10 ] . A high 
production of both E2cat+ and E2ÜP+ were observed: c l e a r l y 
v i s i b l e bands were observed when c e l l - f r e e e x t r a c t s of the clones 
were subjected to SDS-PAGE (data not shown). The E2cat+ had an 
apparent molecular mass of 30 kDa, the E21ip+ one of 52 kDA, the 
same as in E .co l i s t r a i n TG2. The much higher production suggests 
t ha t the p ro te ins are not very s t a b l e in E .co l i TG2 . Obviously, 
the domains of E2 are not as s t a b l e as the whole enzym. E2cat+ 
has been i s o l a t e d using the same method as used for i s o l a t i o n of 
E2 (data not shown). A corresponding high s p e c i f i c a c t i v i t y was 
obtained: 130 U/mg (in accordance with 55 U/mg E2), showing t ha t 
t r a n s a c e t y l a s e a c t i v i t y i s fu l ly r e t a ined in the domain. 
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CHAPTER 5 
TIME-RESOLVED FLUORESCENCE STUDIES ON THE DIHYDROLIPOYL 
TRANSACETYLASE (E_) COMPONENT OF THE PYRUVATE DEHYDROGENASE 
COMPLEX FROM AZOTOBACTER VINELANDII 
Roeland Hanemaaijer, Remco Masurel, Antonie J.W.G. Visser, 
Arie de Kok and Cees Veeger 
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SUMMARY 
The dihydrolipoyl transacetylase (E2) component of A.vinelandii PDC and its 
lipoyl domain shows similar dynamic properties as revealed with fluoresc-
nece anisotropy decay of lipoyl-bound IAANS. The lipoyl domain (32.6 kDa), 
containing three almost identical subdomains shows a mode of rotation 
characteristic for a protein of about 30 kDa. A similar rotation is found 
in E2, indicating an independent rotational mobility of the whole domain in 
the multimeric E2~core (Mr = 1.6 MDa). No independent rotation of a single 
lipoyl subdomain (Mr = 10 kDa) is observed. The Ej component, in contrast 
to the E3 component, shows interaction with the lipoyl domain. 
1. INTRODUCTION 
The pyruvate dehydrogenase complex catalyzes the oxidative decarboxylation 
of pyruvate to acetylCoA. The structural core of the A.vinelandii complex 
is composed of four dihydrolipoyl transacetylase (E2) chains, to which 
three dimers of pyruvate dehydrogenase (Ej) and one dimer of lipoamide 
dehydrogenase (E3) are bound [1]. After removal of these peripheral com-
ponents the E2~core aggregates to a cubic 24-meric structure [2,3]. The 
substrates are transferred between the different components by lipoyl-
lysine residues, which act as swinging arms between the different active 
sites [4]. In E.coli and in A.vinelandii E2 the N-terminal part of the 
E2~chain consists of three homologous repeating sequences [5,6]. Each 
repeat of about 80 amino acid residues contains a lysyl residue that is a 
potential site for lipoylation. Each repeat is separated from its neighbour 
by a region of about 20 residues, very rich in alanyl- and prolyl residues. 
After limited proteolysis of E2 with trypsin this N-terminal part, called 
lipoyl domain (32.6 kDa), is separated from a part called the catalytic 
domain, which forms the multimeric core [7]. In E. coli it is shown that 
after limited proteolysis with Staphylococcus aureus V8 proteinase the 
three repeats can be isolated separately as folded subdomains [8]. In other 
organisms such as gram-positive bacteria and eukaryotes, and also in the 
closely related 2-oxoglutarate dehydrogenase complex, only one lipoyl sub-
domain is found [9-11]. Spin label experiments with the PDC from E.coli 
have demonstrated that the dithiolane ring of the lipoyl group can rotate 
freely in the complex as is indicated by a rotational correlation time of 
0.2-1.0 ns [12]. Also a correlation time of more than 50 ns was found, 
which was attributed to the rotation of the whole complex (expected corre-
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lation time 2 M S ) . When using the triplet probe eosin-maleimide only mobi-
lity of the whole complex was found, showing that the label is folded back 
to the protein surface [13]. From a lack in energy transfer between the 
lipoyl domain and the FAD-group of E3 it is suggested that the lipoyl-
lysine residue is too short to serve all catalyic centres [14] and there-
fore at least a part of the protein chain around the lipoyl residue is 
thought to be flexible. Direct evidence for conformational flexibility in 
E2_chains was obtained from 1H-NMR spectroscopy [15] . In these experiments 
the regions, which are very rich in alanyl-and prolyl residues, are shown 
to possess conformational flexibility. Thus, from these experiments it has 
been suggested that all three subdomains in the lipoyl domain can rotate 
independently. In this paper it is shown with fluorescence anisotropy decay 
experiments that, although the alanine-proline rich region may possess 
internal flexibility, the lipoyl domain moves as a single entity within the 
large multimeric Eg-core. This movement is restricted by the binding of the 
peripheral components. 
2. MATERIALS AND METHODS 
2-(4,-iodoacetamidoanilino)-naphtalene-6-sulfonic acid (IAANS) was obtained 
from Molecular Probes. Dihydrolipoyl transacetylase (E2) was isolated from 
the pyruvate dehydrogenase complex by covalent chromatography on 
thiolsepharose 4B as described previously [16], with modifications 
according to [7]. The lipoyl domain was obtained after limited proteolysis 
with trypsin of the E2 component, which was covalently bound on 
thiolsepharose 4B and purified as described before [7]. Labelling was 
carried out as follows. E2 and the lipoyl domain were incubated for 30 
minutes at 4°C in 20 mM Tricine pH 8.5 containing 20 mM dithiotreitol, and 
anaerobically dialysed against standard buffer (50 mM potassium phosphate 
pH 7.0 containing 0.5 mM EDTA and 0.1 mM phenylmethylsulfonylfluoride). 
From a 15.9 mM IAANS stock-solution in H20/ethanol (1:1 v/v) a fifteen 
times molar excess to sulfhydryl-groups of the lipoyl-moieties was added, 
and after 30 minutes the sample was dialysed against standard buffer. From 
optical density measurements it was observed that over 80% of the lipoyl 
groups were (doubly) labelled. Since it has been shown [2] that only 2 -
2.5 of the three potential sites per E2~chain contain a lipoyl group, it is 
clear that all present lipoyl groups were (doubly) labelled. No bound label 
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was detected without prior reduction. After labelling the complex activity 
had totally disappeared, but the E2 (transacetylase) activity was fully 
retained. Fluorescence spectra were recorded on an Aminco SPF-500 fluori-
meter. Time-resolved fluorescence decay was measured with a system con-
sisting of a frequency-doubled synchronously pumped dye laser for 
excitation and time-correlated single photon counting in detection. The 
excitation wavelength was at 310 nm and the emission was monitored via a 
450 nm band-pass filter (Balzers K45). Details of the experimental set-up 
have been described in [17]. All experiments were carried out at 20°C. Data 
analysis was performed as described in [18]. The order parameter Sj is 
defined as [ (ß2+/33)/(ßl+ß2+03) 3^ [I9]- T h e parameter S2, representing the 
degree of order only connected with the very slow rotation is defined as 
[ ($3//32+03) ]%• T n e related cone angle 0C for the order parameter Sj is 
obtained from the relation (Sj)2 =%cos0c(l+cos0c) • 
3. RESULTS AND DISCUSSION 
The initial fluorescence anisotropy decay curves are shown in Figs. 1 and 
2. Fig. 1 shows the experimental and the fitted curve of the fluorescence 
anisotropy decay of E2. in Fig. 2 only the fitted curves of the lipoyl 
domain, E2, and Eg with bound Ej- and E3 components are shown. For the 
lipoyl domain the anisotropy decays as a double exponential function with a 
short (0.6 ns) and a longer (11.4 ns) characteristic time constant. 
The short component can be ascribed to the motion of the lipoylgroup 
rotating freely around the linkage with the protein chain. This time 
constant correlates well with the values found previously with spin labels 
[12]. The longer component can be ascribed to the rotation of the whole 
domain. The correlation time can be calculated on the basis of an empirical 
formula relating the correlation time $ with Mr of a hydrated, spherical 
polypeptide at 20°C: $(ns) = 3.84 x 10"4 Mr [20]. From this formula a 
correlation time of about 12.5 ns is calculated for the lipoyl domain 
having Mr = 32.6 kDa [7]. Despite the fact that the lipoyl domain is 
thought to have a swollen or extended structure, f/fo =1.7 [7], the 
agreement is rather good. For E2 the anisotropy decay curve can be 
described as a triple exponential function with a short (0.4 ns), a longer 
(10.7 ns) and a very long (600 ns) time constant. The latter is fixed in 
the fitting procedure and represents the rotation of the whole protein (1.6 
MDa). The short component is in the same order as found in the lipoyl 
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-0.1 
3.8 
TIME (NS) 
Figure 1. Fluorescence anisotropy decay of E2- Shown are two curves: the experimental (noisy 
curve) and the calculated (smooth curve) fluorescence anisotropy decay. The parameters of the 
triple exponential decay are listed in Table 1. The quality of the fit is indicated by the 
weighted residuals and the autocorrelation function, shown in the upper panels. The statistical 
parameters are x2 •= 1.06, and the Durbin-watson parameter - 2.03. 
time (ns) 
Figure 2. Fluorescence anisotropy decay of the lipoyl domain, E2. and E2 complexed with Ej or 
E3. Shown are the fitted curves of a) the lipoyl domain (•) , b) E2 (0), c) E2 * E3 (A) in a 
4:2 molar concentration, when the E3 binding site is saturated by E3, d) E2 + E3 (A) in a 4:8 
molar concentration, when both the E3- and Ej binding sites are saturated by E3, and e) E2 + Ej 
(•) in a 4:6 molar concentration, when the Ej binding sites are saturated by Ej. The parameters 
af the double (a) and the triple (b-e) exponential decays and the standard errors derived from 
the fits are listed in Table 1. 
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domain and accounts for the free rotation of the lipoyl group. The time 
constant of 10.7 ns will represent the rotation of the lipoyl domain, which 
is thought to rotate independently of the large E2-core. From the order 
parameter Sj and the related cone angle 9C that can be derived from a 
wobbling-in-cone model [19] it is shown that in E2, where the lipoyl domain 
is bound to the core, the order increases and the motion of the label is 
more restricted. This indicates that the motion of the lipoyl domain is not 
totally independent of the core, but a certain degree of interaction 
exists. Upon binding of Ej- or E3 components to the E2~core no significant 
difference in correlation times is found (table l.exps. 3-5). From /S3, Sj 
and S2 it is clear that, despite the dissociation of E 2 which takes place 
upon addition of Ej (or excess E3), a significant difference is found in 
order and in motional restriction upon binding of the Ej component (exp. 
5). Upon addition of excess E3 (exp. 4), which is thought to bind on or 
near the Ej binding site [1] no significant difference is observed. 
Obviously some interaction exists between Ej and the lipoyl domain which is 
not present between E3 and the lipoyl domain. This could be related to the 
observation of Packman et al. [8] who showed that E3 is able to use 
lipoamide as a substrate, whereas Ej needs the intact lipoyl subdomain as 
substrate; Mobility of lipoyl subdomains has been suggested from 'H-NMR 
experiments, based on observed conformational mobility of the alanine and 
proline rich regions. In these fluorescence anisotropy experiments we pre-
sent a direct indication that the lipoyl domain as a whole contains mobi-
lity more or less independent of the large E2-core. The hinge of this 
mobility should be located between the lipoyl domain and the catalytic 
domain (residue 331-381 [6]). In this region also the binding sites for the 
Ej- and the E3 components are located [7]. After binding of these com-
ponents to the E2~core no dramatic limitation of mobility is observed, 
suggesting that the hinge of the mobility of the lipoyl domain is located 
N-terminal of the Ej- and E3 binding sites. Previous fluorescence ani-
sotropy experiments of the FAD in free and in bound E3 have shown that E3, 
bound to the E2~core, still possesses a high mobility [21]. This indica-
tes a second hinge C-terminal of the E3 binding site. This region may 
correspond with a high mobile region observed in 1H-NMR experiments near 
the N-terminus of the catalytic domain [22]. 
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MOBILE SEQUENCES IN THE PYRUVATE DEHYDROGENASE COMPLEX, THE 
E_ COMPONENT, THE CATALYTIC DOMAIN AND THE 2-OXOGLUTARATE 
DEHYDROGENASE COMPLEX OF AZOTOBACTER VINELANDII, AS DETECTED 
BY 600 MHz """H-NMR SPECTROSCOPY 
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Summary 
600 MHz 'H-NMR spectroscopy demonstrates that the pyruvate 
dehydrogenase complex of Azotobacter vinelandii contains regions 
of the polypeptide chain with intramolecular mobility. This 
mobility is located in the E2 component and can probably be 
ascribed to alanine-proline rich regions that link the lipoyl 
subdomains to each other as well as to the E^ and E3 binding 
domain. In the catalytic domain of E2, which was thought to form a 
compact, rigid core, also conformational flexibility is observed. 
It is conceivable that the N-terminal region of the catalytic domain, 
containing many alanine residues, is responsible for the observed 
mobility. In the low-field region of the *H-NMR spectrum of E2 
specific resonances are found, which are not present in the 
corresponding part of the *H-NMR spectrum of the catalytic 
domain. These resonances can be ascribed to phenylalanine, histi-
dine and/or tyrosine residues. These residues are not present in 
the lipoyl domain, and therefore the resonances must arise from 
mobile residues located in the Ej and E3 binding domain that 
links the lipoyl domain to the catalytic domain. In the ^H-NMR 
spectrum of the intact complex these resonances are not clearly 
visible anymore, indicating a decreased mobility of the Ej and E3 
binding domain. 
Introduction 
The pyruvate dehydrogenase complex catalyzes the following 
reaction: 
Pyruvate + CoA + NAD+ > AcetylCoA + C0 2 + NADH + H+ 
It is composed of multiple copies of three enzymes: pyruvate 
dehydrogenase (Ej), dihydrolipoyl transacetylase (E2) and 
lipoamide dehydrogenase (E3). The E 2 component forms a structural 
core to which Ej and E3 components are bound non-covalently. 
During catalysis the substrate is carried in a thioester linkage 
by lipoyl-lysine residues that are part of the E2 component and 
act as "swinging arms" while transferring the substrates.acetyl 
groups and reduction equivalents, between the active sites of the 
different components [1]. 
The domain structure of E 2 has been examined by limited 
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proteolysis [2]. After digestion of E2 with trypsin a lipoyl 
domain and a catalytic domain are obtained. The lipoyl domain 
carries the lipoyl groups. The catalytic domain possesses the 
transacetylase active site and the E2 intersubunit binding sites, 
showing the same 24-meric structure as intact E2 [3]. The Ej and 
E3 binding sites are lost during proteolysis. They are thought to 
be located on a ±6 kDa region that links the catalytic domain to 
the lipoyl domain. 
The gene encoding E2 of the pyruvate dehydrogenase complex of 
Azotobacter vinelandii has been cloned and sequenced [4]. From 
the amino acid sequence derived from the DNA sequence it is shown 
that the lipoyl domain accounts for the N-terminal half of the 
polypeptide chain and comprises three highly homologous 
structures, each carrying a potential lipoyl binding site. In 
Escherichia coli it is shown that these repeats exist as three 
independent folded entities that retain their function as 
substrate for reductively acetylation by the Ej component [5]. 
They are linked to each other and to the E^ and E3 binding domain 
by means of long regions (±20-30 residues) that are very rich in 
alanine and proline residues [6]. 
The active sites of the different components are at least 4 nm 
apart in the complex, too far away for a single lipoyl-lysine 
group [7,8]. Therefore it has been suggested that the lipoyl 
domain might be sufficiently flexible to facilitate movement of 
the lipoyl group between the different active sites. Strong 
evidence in favor of the existence of conformationally flexible 
regions in 2-oxoacid dehydrogenase complexes from E.coli [9,10], 
Bacillus staerothermophilus [11,12] and ox heart [13] was 
obtained by using 'H-NMR spectroscopy. Unusual sharp resonances 
in the 270 and 400 MHz 'H-NMR spectra of the intact complexes are 
thought to originate from alanine-proline rich regions in the E2 
chains. In E.coli it has been suggested that the mobility of 
these regions is responsible for the independent mobility of the 
three repeats in the lipoyl domain [14,15]. Mobility of the 
lipoyl domain has also been detected by time-resolved 
fluorescence spectroscopy [16]. After labelling of the lipoyl 
groups of E2 from A.vinelandii with a fluorophore mobility is 
observed of the labelled lipoyl group, of the whole complex and 
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of the lipoyl domain. No independent mobility of the three 
repeating units has been observed. 
After cloning in E.coli a high expression of the gene, encoding 
Ë2 was obtained [17]. Both E2 and the catalytic domain, obtained 
by limited proteolysis, showed to be soluble at high protein con-
centrations and we were able to carry out 600 MHz 'H-NMR experi-
ments . 
Materials and methods 
Materials 
Tosylphenylananylchloromethane-treated trypsin was obtained from 
Worthington and phenylmethylsulphonyl fluoride was from Sigma. 
Deuterium oxide (99.8*) was purchased from Ega-chemie. 
Isolation of the proteins 
The pyruvate dehydrogenase complex was isolated from Azotobacter 
vinelandii as described by Bosma et al. [18]. The 2-oxoglutarate 
dehydrogenase complex was isolated from A.vinelandii as described 
in [19]. The E2 component of the A.vinelandii pyruvate dehydroge-
nase complex was isolated from Escherichia coli, in which the 
gene encoding A.vinelandii E2 was cloned [17]. The catalytic 
domain, obtained by limited proteolysis of A.vinelandii E2 with 
trypsin, was isolated by gelchromatography, using FPLC equipped 
with a Superose 6 K26/70 column (Pharmacia), and concentrated by 
ultrafiltration using an Amicon VM-100 membrane. 
'H-NMR spectroscopy 
Protein samples for 'H-NMR spectroscopy (in standard buffer: 50 
mM potassium phosphate, pH 7.0 containing 0.1 mM EDTA and 0.1 mM 
phenylmethylsulphonyl fluoride) were concentrated to about 0.5-
1.0 mM. 2H20 was added to a final concentration of 10%(v/v). 'H-
NMR spectra were obtained at 600 MHz with a Bruker AM-600 
spectrometer using a 16.7 kHz spectral width, 30° pulses and a 
repetition time of 1 second. 8K data points were used. Quadrature 
detection and quadrature phase cycling were used. Chemical shifts 
are relative to trimethylsilylpropionate (TSP). Wilmed 5mm 
NMR-tubes were used. The solvent resonance irridation (18 dB 
81 
attenuation from 0.2 Watt) was applied at all times, except 
during data aquisition. The transmitter frequence was placed 
exactly at the waterresonance. The sample temperature was 23°C. 
The NMR-data were transferred to a MicroVAX II and evaluated with 
(modified) software, kindly given to us by dr. R. Boelens. The 
FID's were zerofilled once before Fourier transformation (without 
any window function). The resulting frequency specrum was manipu-
lated by a fourth order polynôme for baseline correction. 
Other techniques 
Protein concentrations were measured according the method of 
Lowry [20]. A stock solution of IM phenylmethylsulphonyl fluoride 
was prepared in C^H302H and diluted 100-fold in standard buffer. 
Results 
High-field resonances 
In 'H-NMR spectra of large protein complexes (MDa) in general no 
distinct resonances can be observed; the calculated linewldth of 
a methylene proton resonance is in the range of kHz. However, in 
the 600 MHz spectrum of the pyruvate dehydrogenase complex (Fig. 
1A), superimposed on the expected broad component in the 
spectrum, many sharp resonances are observed (linewidth in the 
range of 10-100 Hz). These resonances must arise from a region or 
regions of the polypeptide chain having substantial mobility. The 
major sharp resonance occurs at 1.39 ppm which, on basis of the 
chemical shift, can be ascribed to the methyl side chains of 
alanine residues. In the intact pyruvate dehydrogenase complex of 
E.coli a similar sharp resonance has been found [10]. It was 
ascribed to the alanine-proline rich regions of the E2 component, 
located at the links between the repeating units in the lipoyl 
domain and between the lipoyl domain and the Ej and E3 binding 
domain. Indeed, in the spectrum of E2 (Fig. IB) the same sharp 
resonance is found. Also many sharp resonances are found between 
1.5 and 2.5 ppm, which partly can be ascribed to mobile proline 
residues present in the same regions. In the high-field spectrum 
of 0GDC (Fig. ID) a similar pattern of sharp resonances is 
observed, suggesting a similar mobile region. In the E2 sequence 
of A.vinelandii 0GDC also a alanine-proline rich region has been 
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found between its single lipoyl domain and the proposed Ej and E3 
binding domain (unpublished results). 
Two additional resonances of ethanol can be observed, which are 
due to a contamination. The concentration of ethanol is estimated 
to be around 5 - 10 mM 
Low-field resonances in E2 
In the aromatic region of the spectrum of Eg (Fig.IB) two 
specific sharp resonances (7.1 and 7.3 ppm) are observed which 
are not present in the spectrum of PDC (Fig.lA) or in that of the 
catalytic domain (Fig.lC). The intensity of these residues is 
about 3* of the alanine methyl resonance, which indicates that 
they can be assigned to either one or two aromatic residues, i.e. 
to phenylalanine, histidine or tyrosine. These amino acid 
residues are not present in the lipoyl domain of E2 (Fig.2) [4]. 
SEUKVPDIGGDGEVI—EUjVKTCDUEVBaaVVUSAKASMEVPSmCTV^ 
10 20 30 , 50 60 70 80 90 100 110 
SQTOVPDIGSATORVnyLVWGPgyQRBaSIJT^ 
120 130 140 150 , 160 170 180 190 200 210 220 
PQpfKVPmtöAQCARVIEVLVKAGEQVQftEQS^^ 
230 240 250 260 270 280 290 300 310 320 
GAPSRfKMWHAGTAVI^MEn^IAAINSTGPRGRIUCroVQÄYVKAM^ 
330 340 350 360 370 380 
AKEAFMGAASGAGIPPIFl^ TJFAKYGaXEVFWIRUCIGaTTUPlSVUlVPH^ 
390 400 410 420 430 440 450 460 470 480 490 
R m v m Œ T M T m m w v O T V D Q K S R j p ^ ^ 
500 510 520 530 540 550 560 570 580 590 600 610 
DJGMAARFTKM/MlADIIUUIIi 
620 630 
Figure 2. Primary structure of the E2 chain of the pyruvate dehydrogenase complex from 
A.vinelandii. The proposed lipoyl binding s i t es are indicated ( • ) . The alanine-proline rich 
regions are underlined, l i p - lipoyl domain and cat - ca ta ly t ic domain. 
Most of the aromatic amino acid residues are located in the 
catalyt ic domain but obviously not in a mobile region since in 
the spectrum of the catalyt ic domain domain no sharp resonances 
are observed which can be ascribed to these residues, although 
sharp resonances are present at low field (Fig. 1C). However, 
both a his t idine, a phenylalanine and a tyrosine residue are 
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J L 
4 3 2 1 0 ppm 
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M 
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Figure 1. 600 MHz 1H-NMR spectra of the pyruvate dehydrogenase complex, the E2 component, the 
catalytic domain and the 2-oxoglutarate dehydrogenase complex from A.vinelandii. A, pyruvate 
dehydrogenase complex, 34 mg/ml (=159 fiM E 2); B, E2 component of the pyruvate dehydrogenase 
complex, 43.6 mg/ml (=770 fiM E2); C, catalytic domain of E2, 23.7 mg/ml (=862 uM) ; D, 
2-oxoglutarate dehydrogenase complex, 66.7 mg/ml (=550 uM Eg). The sharp resonances marked E 
are from ethanol. 
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present in the region possessing the Ej and E3 binding sites that 
is located between the lipoyl and the catalytic domain. The sharp 
resonances of histidine, phenylalanine and/or tyrosine residues 
are not observed in the whole complex. In E.coli NMR-spectra 
mobility of residues in this region has never been observed since 
E2 of E.coli PDC aggregates at the high protein concentrations 
needed for NMR experiments [9]. 
Mobility in the catalytic domain 
The catalytic domain is thought to form a compact rigid core 
(0.5-0.6 kDa) [2]. However, also in the spectrum of this domain 
sharp resonances are observed (Fig. 1C). The most prominent sharp 
resonance is at 1.39 ppm; the methyl resonance of alanine 
residues. This linewidth of this peak is less than the one 
observed in the spectra of PDC, E 2 and OGDC. Its intensity, 
however, is much less than in the other spectra. A second sharp 
resonance is found very close to it at 1.50 ppm. This resonance 
cannot be observed in PDC and OGDC. Probably both resonances can 
be attributed to a region rich in alanine residues located at the 
N-terminus of the catalytic domain. A mobile region in the cata-
lytic domain has also been observed in E.coli PDC. A sharp reso-
nance at 1.52 ppm was observed which was not present in the whole 
complex. It was ascribed to a very small alanine rich region at 
the N-terminus of the catalytic domain. In the spectrum of the 
catalytic domain of OGDC Eg from Bacillus staerothermophilus [12] 
a small resonance at 1.36 ppm was observed, but was ascribed (may 
be by the lack of the amino acid sequence) to a non-protein con-
taminant. Recently a part of the amino acid sequence of this pro-
tein has been published and a small alanine rich region is shown 
at the N-terminus of the catalytic domain [21]. 
The spectrum of the catalytic domain of Eg from A.vinelandii 
shows sharper resonances than those found in the spectra of PDC 
and Eg- This can probably be explained by the smaller region that 
is mobile. Although a limited amount of sharp resonances is pre-
sent in the spectrum of the catalytic domain, these resonances 
cannot exclusively be ascribed to alanine residues. In addition 
to the 1.39 ppm and the 1.50 ppm resonances in the high-field 
region (0-4.5 ppm) some resonances can be observed which can pro-
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bably be ascribed to amino acid residues present in the 
N-terminal region of the catalytic domain (e.g. prolines, lysine 
and isoleucines). Also in the low-field region (7.5 - 8.5 ppm) a 
few resonances are observed which can probably be ascribed to 
resonances from amide protons that are protected from water, 
suggesting that part of the mobile region has a folded structure 
[22]. The resonance at 7.45 ppm can be ascribed to phenylmethyl-
sulfonyl fluoride, which is added in high amounts during isola-
tion of the catalytic domain. 
Discussion 
The experiments described above clearly show sharp resonances in 
the ^-NMR spectra of OGDC, PDC, E 2 and the catalytic domain, 
indicating conformational mobility. Like in E.coli [9,10], in 
A.vinelandil PDC sharp resonances are observed which in part can 
be ascribed to alanine-proline rich regions. In contrast to the 
experiments with the E.coli complex [9] we were able to isolate 
E2 and concentrate it up to 1 mM, without aggregation of the 
protein. The 600 MHz NMR spectrum of E 2 shows similar sharp 
resonances as the spectrum of the whole complex, which is a 
direct evidence that the mobile regions are located on the E 2 
chain. Three long alanine-proline rich regions (20-30 residues) 
are present in E 2, located between the repeats in the lipoyl 
domain and between the lipoyl domain and the Ej and E3 binding 
domain. Our results are in agreement with the proposal that the 
conformational mobility can be ascribed to these regions, which 
is confirmed by experiments with genetic engineered E.coli 
complexes, in which mutations or deletions have been introduced 
in the alanine-proline rich regions [14,15]. A further 
confirmation came from experiments using a synthetic alanine-
proline rich polypeptide, representing one of these regions in 
E.coli E 2 [23]. 
From the NMR experiments on the E.coli complex it has been 
suggested that the presence of the highly mobile alanine-proline 
sequences gives an independent conformational mobility to the 
three repeating subdomains in the lipoyl domain [14,15]. However, 
no sharp resonances of the subdomains (±8 kDa) are observed in 
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the spectra of the whole complex. Similar results have been 
obtained from NMR spectra of OGDC of Bacillus staerothermophilus 
[12]. This complex contains only one llpoyl domain per E2 chain. 
This lipoyl domain contains one tryptophan, one tyrosine and four 
phenylalanine residues. Since no aromatic proton resonances of 
the lipoyl domain were visible in the spectrum of the intact 
complex, it has been suggested that the lipoyl domain is not free 
to move rapidly, but must spend a major part of the time bound to 
one of the other components of the complex. Thus, a mobile 
alanine-proline region can be observed without the corresponding 
mobility of the lipoyl domain. In the spectra of A.vinelandii 
PDC, OGDC or E2 no indications for a small, mobile lipoyl-
subdomain are found. This is in agreement with results obtained 
from fluorescence anisotropy experiments in which mobility of the 
single lipoyl-label group, the whole complex and the whole lipoyl 
domain (32 kDa) was found, but no mobility of a lipoyl-subdomain 
(9 kDa) could be observed. Obviously, using 'H-NMR spectroscopy, 
no conclusions can be drawn about mobility of the lipoyl-
subdomains, when only mobility of the alanine-proline rich region 
is observed. 
In the low-field part of the spectrum of E2 two specific sharp 
resonances are observed, which are ascribed to phenylalanine, 
histidine and/or tyrosine residues. Since no similar resonances 
are observed in the spectrum of the catalytic domain and no such 
residues are present in the lipoyl domain. Thus these resonances 
must be ascribed to the phenylalanine, histidine and/or tyrosine 
residues that are present in the region between the lipoyl and 
the catalytic domain. In this region the binding sites for the Ej 
and E3 components are located [2]. Recently, evidence has been 
obtained for a Ej and E3 binding domain in this region of the E2 
chain of PDC from Bacillus staerothermophilus [21]. Obviously, 
this region possesses conformational mobility. This is in 
agreement with previous results from fluorescence anisotropy 
experiments on FAD in free and bound E3. After binding of E3 to 
the E2 core almost no change in rotational correlation 
coefficient was observed, from which was suggested that the 
binding region should possess mobility [24]. 
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No sharp resonances of residues from this region have been 
observed in the spectrum of the whole complex. Obviously after 
binding of the large Ej dimer (200 kDa) or E3 dimer (100 kDa) the 
mobility of this region in E2 diminishes to an extent which 
cannot be observed as a sharp resonance by 'H-NMR spectroscopy. 
The spectrum of the catalytic domain of E2 from A.vinelandii 
(M=0.5-0.6 kDa), in contrast to the spectrum of the same domain 
from E.coli [9], shows a certain degree of conformational 
mobility. Probably the sharp resonances in the spectrum can 
partly be ascribed to an alanine-proline rich region located at 
the N-terminus of the catalytic domain. Besides the sharp 
resonance at 1.39 ppm a smaller resonance at 1.50 ppm is 
observed. In the spectrum of the whole complex this resonance is 
not observed; in the spectrum of E2 it is present, partly masked 
by the large resonance at 1.39 ppm. Probably the alanine 
residues, located at the N-terminus of the catalytic domain 
become more mobile when the N-terminal half of the E2 chain is 
excised after proteolysis, and partly change to a somewhat 
different environment. In E2 the environment can differ from the 
one in the whole complex, since no large components are bound and 
the binding domain of Ej and E3 possesses mobility. 
It has been shown that 'H-NMR spectroscopy can be used to obtain 
information about conformational mobility in proteins, but clear 
results can only be obtained when residues, showing specific 
resonances in the 'H-NMR spectrum, are present on well-defined 
sites in the protein. Therefore, the use of genetic engineered 
complexes in which mutations have been introduced, together with 
'H-NMR spectroscopy is a useful combination to study 
conformational mobility in specific regions of the polypeptide 
chain. With the use of both the intact complex, isolated E2 and 
domains of E2 new possibilities are created in studying the 
structure and mechanism of 2-oxoacid dehydrogenase complexes. 
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CHAPTER 7 
THE QUATERNARY STRUCTURE OF THE DIHYDROLIPOYL TRANSACETYLASE 
COMPONENT OF THE PYRUVATE DEHYDROGENASE COMPLEX FROM AZOTOBACTER 
VINELANDII: A RECONSIDERATION 
Roeland Hanemaaijer, Adrie H. Westphal, Tini van der Heiden, 
Arie de Kok and Cees Veeger 
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Summary 
After limited proteolysis of the dihydrolipoyl transacetylase 
component (Eg) of A.vinelandii pyruvate dehydrogenase complex 
(PDC) a C-terminal domain was obtained which retained the tran-
sacetylase active site and the quaternary structure of Eg but had 
lost the lipoyl containing N-terminal part of the chain and the 
binding sites for the peripheral components pyruvate dehydroge-
nase and lipoamide dehydrogenase. 
The C-terminus of this domain was determined by treatment with 
carboxypeptidase Y and shown to be identical with the C-terminus 
of Eg. Together with the previously determined N-terminus and the 
known amino acid sequence of Eg, as determined from the DNA 
sequence, a molecular mass of 27.5 kDa was calculated. 
Ultracentrifugation in 6 M guanidine hydrochloride of the 
tryptic catalytic domain resulted in large systematic deviations. 
Similar deviations were obtained with a fragment of 30.7 kDa, 
obtained by genetic engineering. These deviations are probably 
due to incomplete unfolding. From the molecular mass of the 
native catalytic domain, 530 kDa, and the symmetry of the cubic 
structures observed on electron micrographs a 24-meric structure 
is concluded instead of the 32-meric structure proposed pre-
viously. 
From the effect of guanidine hydrochloride on the lightscat-
tering of intact Eg it was concluded that dissociation occurs in 
a two-step reaction resulting in particles with an average mass 
1/6 of the original mass before the N -» D transition takes place. 
The first step is correlated with the transition of one or both 
tryptophan residues from a buried environment to an intermediate 
exposed one. 
Crosslinking experiments with the catalytic domain indicated 
that the multimeric Eg is built from tetramers and that the 
tetramers are arranged as a dimer of dimers. 
A model for the quaternary structure of Eg is given, in which 
it is assumed that the tetrameric Eg core of PDC is formed from 
each of the six morphological subunits, located at the lateral 
faces of the cube. Binding of peripheral components to a site that 
interferes with the cubic assembly causes dissociation resulting 
in the unique small PDC of A.vinelandii. 
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Introduction 
The pyruvate dehydrogenase complex (PDC) catalyzes the 
following reaction: 
Pyruvate + NAD+ + CoA > AcetylCoA + CO2 + NADH +H+. 
It is composed of multiple copies of three enzymes: pyruvate 
dehydrogenase (Ej), dihydrolipoyl transacetylase (E2) and 
lipoamide dehydrogenase (E3HI]. The Ej- and E3 components are 
non-covalently bound as dimers to a core of E2-chains [2]. PDC 
from gram-positive bacteria [3] or from mammalian sources [4] is 
based on a core of 60 Eg-chains with an icosahedral symmetry, 
whereas the E2~core of PDC from Escherichia coli is composed of 
24 subunits, arranged in a cubic structure with 432 symmetry 
[1,5]. The PDC from Azotobacter vinelandli is the smallest 
complex known [6]. It is based on a tetrameric E2~core [7,8]. The 
sedimentation coefficient of this complex is 17-19S [7]; the 
complex from E.coli is 53-60S [3,9,10]. However, a 17-20S form of 
E.coli PDC has also been observed [5,9]. This small form is 
enzymatically active and is present in small amounts in E.coli 
PDC preparations. It is indicated as having a trimeric core, 
being the morphological subunit of both the cubic and the 
icosahedral complexes [11,12]. On the other hand, upon removal of 
the peripheral components of the A.vinelandii tetrameric core, E2 
associates to a multimer. In electron micrographs a similar cubic 
appearance as the E.coli E2 core is observed [1,13]. On basis of 
its molecular mass of about 2 MDa [7,13] and its association-
dissociation behaviour [13] it was thought to be composed of 
tetrameric instead of trimeric morphological subunits, arranged 
at the vertices of the E2-cube. This would result in an E2~core 
composed of 32 subunits [7]. 
The E2 components of PDC's from different organisms are 
exquisitely sensitive to proteolytic cleavage under non-
denaturing conditions [14-17]. After proteolysis usually a domain 
comprising the lipoyl moieties and a structural domain are 
obtained. In the latter the quaternary structure of intact E2 and 
the transacetylase active site are retained. The binding sites 
for the Ej- and E 3 components are retained [14,15] or lost [16-
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20] after proteolysis, depending on the source and on the 
conditions of proteolysis [19]. After limited proteolysis with 
trypsin of the Eg component of A.vlnelandii PDC a stable 
multimeric fragment was found which had lost the Ej- and E3 
binding sites but still possessed the transacetylase active site 
and the Eg intersubunit binding sites [16]. Electron micrographs 
of this domain showed the same cubic appearance as intact E2- The 
N-terminal amino acid sequence has been determined by automated 
Edman degradation and is located at residue 381 of the amino acid 
sequence derived from DNA sequence analysis of the gene encoding 
A.vinelandii Eg [16,21]. The molecular mass determination by 
sedimentation equilibrium experiments in the presence of 6M 
GdnHCl and 2 mM dithiotreitol gave a value of 15.8 kDa [16]. The 
molecular mass of the native catalytic domain core was found to 
be 530 kDa [16], which supported the model of a core of 32 
subunits. However, no definite data on the chain mass of the 
catalytic domain, such as obtained from the amino acid sequence, 
were available. In this paper we report the determination of the 
C-terminal sequence of the catalytic domain, obtained by reaction 
with carboxypeptidase Y. It showed to be identical to the C-
terminal sequence of the intact Eg-chain. This means that the 
catalytic domain has a molecular mass of 27 kDa. Together with 
results obtained from light-scattering experiments and 
crosslinking experiments a model for the quaternary structure of 
Eg is proposed, showing an Eg-core with a cubic structure, being 
comprised of 24 subunits, with tetrameric morphological subunits 
forming the lateral faces of the cube. 
Materials and methods 
Materials 
Carboxypeptidase Y was obtained from Boehringer. Dimethyl-
suberimidate was from Sigma, all other crosslinkers were synthe-
sized as described in [22]. Guanidine hydrochloride was purchased 
from Merck and re-crystallized in ethanol, resulting in less than 
0.1 absorption unit at. 240 nm for a 1 M solution. All other che-
micals were analytical grade. 
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Protein purifications 
The E2 component was isolated from the pyruvate dehydrogenase 
complex by covalent chromatography on thiolsepharose 4B as 
described before [23], with modifications according to [16]. The 
catalytic domain was obtained after limited proteolysis with 
trypsin of the E2 component, which was covalently bound on 
thiolsepharose 4B, as described previously [16]. When used in 
sedimentation equilibrium experiments the catalytic domain was 
purified by FPLC, equipped with a Superose 12 column, in standard 
buffer (50 mM potassium phosphate pH 7.0, 0.5 mM EDTA and 0.05 mM 
phenylmethylsulfonylfluoride) containing 6M GdnHCl. An extended 
catalytic domain was isolated as a fusion protein from a produc-
tion clone which was obtained by transformation of the C-terminal 
part of the gene encoding E2 (residue 1522-2365 [21]) cloned into 
the Hindi!I/BawHI sites of the multiple cloning site of the pUC9 
vector (details to be published). Its N-terminus contains the 6 
N-terminal residues of the vector encoded ß-galactosidase. 
C-terminus determination 
The catalytic domain of the E2 component (2.2 mg) was 
dialyzed against 25 mM ammoniumhydrogencarbonate, freeze-dried 
and dissolved in 50* acetic acid. The sample was eluted on a 
Sephadex G25 column to remove small material which could result 
from the digestion with trypsin. After elution the void fraction 
was again freeze-dried and citraconylated according the method 
described by Perham [24]. The sample was eluted on a Sephadex G25 
column in 100 mM sodiumacetate pH 6.0. 40 nmol protein was incu-
bated with 15 fig carboxypeptidase Y (dissolved in the same buf-
fer) and samples of 10 nmol protein were withdrawn after 0, 1, 10 
and 90 minutes, respectively. The reaction was stopped by addi-
tion of 2 mg sulfosalicylic acid, followed by incubation at 0°C 
for at least 30 minutes. The precipitated protein was removed by 
centrifugation and the supernatant, containing the free amino 
acid residues, was directly used for amino acid analysis. 
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Crosslinking 
Crosslinking experiments were essentially performed as 
described in [22]. Dimethylsuberimidate or other crosslinking 
reagents were dissolved in 100 mM triethanolamine-HCl pH 8.5 and 
immediately mixed with the protein solution (1 mg/ml) to final 
concentrations of 10-100 mM. After incubation for 3.5 h at room 
temperature the reaction was stopped by addition of glycine at a 
100-500 mM concentration. Samples were analysed by 
SDS-gelelectrophoresis. 
Light-scattering 
Light-scattering measurements were performed at 436 nm with a 
Fica 50 photometer. Measurements were carried out at 25°C in 
Danliker cuvettes. Samples were filtered before use to remove 
dust particles. Variable GdnHCl concentrations were obtained by 
addition from a 7.5 M stock solution to the protein sample. After 
mixing the solution it was incubated for 15 minutes at 25°C and 
measured at different angles between 30° and 135°. Results were 
corrected for the signal obtained from a blank without protein. 
Light scattering data were analysed according [25]. The ratio of 
molecular mass in the presence of GdnHCl (M^) to that in the 
absence of GdnHCl (M0) was determined from Eqn. 1 
Mj_ < • / (dn/dco); (c0)(I1|X) ( i ) 
Mo (n.)2 (dn/dc.)2 (c.)(Io x) 
where n represents the refractive index, (dn/dc)n the refractive 
index increment at constant chemical potential, c the enzym 
concentration, I the scattered light intensity at x degrees, and 
the subscripts i and o refer to the quantities in the presence 
and absence of GdnHCl, respectively. Eqn. 1 was derived assuming 
that the second virial coefficient is negligibly small. The 
refractive indices of the solutions with different concentrations 
GdnHCl were obtained from [26], the refractive index increments 
were taken from data obtained for bovine serum albumine [27], 
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assuming that for all globular proteins under the same conditions 
the refractive index increments are similar. In the analysis of 
M^/MQ the mean intensity of the signals obtained at 45°,75° and 
90° was used, because at these angles the lowest background 
signal from the buffer was observed. 
Other methods 
E2 transacetylase activity was assayed spectrophotometri-
cally at 240 nm and 25°C, measuring the formation of S-
acetyldihydrolipoamide as described previously [6]. Amino acid 
analysis was performed on a Biotronik LC 6000E analyser, equipped 
with a Durrum DC6A ion-exchanger (physiological run) . 
Sedimentation equilibrium experiments were performed in a MSE 
Centriscan 75, equipped with an ultraviolet/visible monochroma-
tor. Solutions contained 50 mM potassium phosphate pH 7.0, 0.5 mM 
EDTA, 0.05 mM phenylmethylsulfonylfluoride, 6M GdnHCl and 2 mM 
dithiotreitol. Corrections for the solvent density were made 
according to standard procedures [28]. Circular dichroic spectra 
were measured as described previously [16]. Fluorescence spectra 
were measured on an Aminco SPF-500 spectrofluorimeter, ther-
mostatted at 25°C. 
Results and discussion 
C-terminus determination 
Protein samples of the catalytic domain fragment, obtained 
by trypsinolysis as described in methods, were incubated with 
carboxypeptidase Y. Already after a reaction time of one minute a 
release of amino acids is observed (see table 1). Hardly any 
arginyl- or lysyl residues were released which was expected if 
the C-terminus of the catalytic domain was formed by an internal 
cleavage of trypsin in the E2~chain. Instead, from the start 
leucyl- and isoleucyl residues were found in a 2:1 ratio. After 
longer incubation times (10 minutes) also alanyl-, arginyl- and 
aspartyl residues are observed. This finding excludes the pos-
sibility of an internal cleavage. It is exactly to be expected 
from the sequence -DIRAILL at the C-terminus of intact E2 [21]. 
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No similar region is found elsewhere in the E2~sequence. As 
expected, with intact E2 the same pattern is observed. Because 
the N-terminus has been determined previously at residue 381 
[16,21] this result indicates that the catalytic domain repre-
sents peptide fragment 381-637. 
Table 1. Number of amino acid residues (nmo!) released from the 
Eg C-terminus after Incubation with carboxypeptidase Y during 0. 
1, 10 and 90 minutes, respectively. Residues which are not shown 
were present at less than 2.5 nmol after 90 minutes incubation. 
Resi 
Leu 
He 
Ala 
Arg 
Asp 
due 
t»0 
0.0 
0.0 
0.8 
0.0 
0.0 
Time 
(minutes' 
t = l 
2.8 
1.1 
1.1 
0.9 
0.4 
t = 10 
10.5 
5.8 
3.3 
2.3 
1 .0 
t-90 
16.3 
8.3 
8.0 
4.3 
4.8 
Previously, we have also shown that neither the catalytic domain 
nor the lipoyl domain (fragment 1-about 330) binds Ej or E3. 
Therefore these results also indicate that the region 330-380 has 
an important role in the binding of Ej and E3, although we cannot 
exclude the involvement of either domain in the binding. 
Especially the observation that E^-binding (or E3 in excess) 
leads to dissociation of the E2-multimer [8] indicates an inter-
ference with E2-E2 interaction sites, which are located at the 
catalytic domain. Such interference does not necessarily require 
binding on the catalytic domain but may be due to steric factors. 
In ultracentrifugation experiments no effect of E^ or E3 has 
been observed on the aggregation state of the catalytic domain. 
Sedimentation equilibrium experiments 
Previously, the molecular mass of the catalytic domain was 
estimated at 15.8 ±0.5 kDa [16] by sedimentation equilibrium 
experiments of the protein in 6M GdnHCl in the presence of 2 mM 
dithiotreitol or after reduction and carboxymethylation. In 
contrast on SDS-gels a mass of 27 kDa was observed. It is known 
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however for the intact protein that large deviations on SDS-gels 
are observed: 82 kDa instead of 65 kDa. Ultracentrifugation of 
the intact E2 in 6M GdnHCl gave a value of 61-63 kDa [13,16]. 
Therefore the value of 15.8 kDa for the catalytic domain was con-
sidered a good estimate. The large deviation from the true mole-
cular mass of 27 kDa as obtained from sequence information must 
therefore arise from a systematic error such as the presence of 
considerable amounts of small material, incomplete unfolding or 
an internal cleavage by trypsin. To avoid small material, which 
could have arisen from the proteolytic cleavage, the catalytic 
domain was purified extensively under denaturing conditions, as 
desribed in the methods. From the carboxypeptidase treatment and 
the determination of the N-terminus it was clear that neither 
small proteolysed material was present nor internal cleavage had 
taken place in the samples. To check whether the prolonged incu-
bation during ultracentrifugation did not result in further 
fragmentation the protein was dialysed after ultracentrifugation 
and resubjected to gelelectrophoresis. Again a value of 27 kDa 
was found. 
Incomplete unfolding seems unlikely because the N -> D tran-
sition takes place at about 2.5 M GdnHCl (see below). However, it 
is known that even in 6M GdnHCl not all secondary structure is 
lost [29]. When the ultracentrifugation experiment was carried 
out at pH 5.0 (or pH 1.0) a somewhat higher molecular mass was 
observed, 19.6 kDa instead of 15.8 kDa. By genetic engineering we 
obtained a protein fragment corresponding to residue 353-637 of 
E2, which contains 6 N-terminal amino acid residues of the E.coli 
/5-galactosidase. It shows normal catalytic activity and proper-
ties comparable to the tryptic catalytic domain (to be 
published), having a calculated molecular mass of 30.7 kDa. When 
the molecular mass of this protein was analysed by sedimentation 
equilibrium experiments in 6M GdnHCl and 2 mM dithiotreitol at pH 
5.0, a value of 23.4 kDa is obtained, showing the same absolute 
deviation as the tryptic catalytic domain. 
In conclusion, we cannot exclude that this relatively large 
deviation is due to incomplete unfolding, but also other unknown 
effects may contribute to this anomaly. 
The subunit mass of the E2 component is of importance in the 
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determination of the quaternary structure of the E2~core. 
Hydrodynamic data of the intact, native E2~core indicated a mass 
of 1.8-2.0 MDa [13], significantly larger than that of the E.coli 
E2 f3°]• Combined with the monomer weight, the chain 
stoichiometry of the components of PDC, and the cubic structure 
of Ë2, which in E.coli is thought to be composed of eight 
morphological subunits [11], a model was proposed based on 32 
subunits [8], in which the tetrameric E2~core of PDC constitutes 
the corners of the isolated E2-cube. With structures of this size 
with a known tendency to either dissociate or associate to dimers 
[13], large absolute deviations could result from 
heterodispersity of the system. The catalytic domain structure on 
the other hand is more stable (e.g. no crosslinking was required 
in preparations for electronmicroscopy) and no dimerization was 
observed in sedimentation velocity experiments. Sedimentation 
equilibrium experiments gave a molecular mass of 530 kDa [16] 
resulting in a multimer of 19-20 subunits. This indicates that 
probably the A.vinelandil cubic structure, in analogy with E.coli 
[11] and with the related 2-oxoglutarate dehydrogenase complex 
[31] is composed of 24 subunits. 
Dissociation and unfolding 
Further support for a 24-meric structure was obtained by 
light-scattering experiments of E2 in GdnHCl. The ratio of the 
molecular mass (Mj) of E2 in different concentrations GdnHCl to 
the molecular mass (M0) of the enzyme in standard buffer (see 
methods) is shown in fig. 1. Since the subunits of E2 are iden-
tical, the molecular mass ratio is a direct measure of the extent 
of dissociation of the multimer. 
From fig. 1 it is clear that two transitions in the disso-
ciation are observed, at 1.0 M and 1.8 M, respectively. At 1.0 M 
GdnHCl the multimer dissociated to one third of its original 
mass, and at 1.8 M GdnHCl a particle of about one sixth of the 
original mass resulted. At still higher concentrations a further 
small decrease in light-scattering is observed. Up to 2.0 M 
GdnHCl E2~activity is still retained (fig. 2) and hardly any 
secondary structure is lost (fig. 3). At slightly higher con-
centrations GdnHCl a very clear transition is shown and both 
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0.5 1.0 1.5 2.0 2.5 3.0 
GdnHCL (M) 
0.5 1.0 1.5 2.0 2.5 3.0 
GdnHCL (M) 
Figure 1. Var iat ion of the molecular mass 
ra t io of E2 with varying GdnHCl-concen-
t r a t i o n s . The mean l i g h t s c a t t e r i n g 
i n t e n s i t y at 45° , 75" and 90» of a s o l u -
t ion of E2 (1 .8 mg/ml) in 50 mM potassium 
phosphate, 0 .05 i«M EDTA and 0.05 mM phe-
ny lmethy l su l fony l f luor ide was measured at 
20°C. Concentrated GdnHCl was then added 
to y i e l d the molarity indicated , and the 
r e s u l t i n g s c a t t e r i n g was neasured. The 
molecular mass r a t i o was ca lcu lated 
according Eqn. 1. 
Figure 2. Variat ion of the percentatage 
a c t i v i t y of E2 and of c a t a l y t i c domain 
with varying GdnHCl-concentrations. The 
t ransace ty lase a c t i v i t y of E2 (o) and of 
the c a t a l y t i c domain (x) was measured at 
25«C. 
a c t i v i t y and secondary s t r u c t u r e are l o s t ( f i g s . 2 , 3 ) . The c a t a l y -
t i c domain shows a comparable behaviour with respec t t o c a t a l y t i c 
a c t i v i t y and molar e l l i p t i c i t y . These r e s u l t s show tha t one s i x th 
of the multimeric E2~core forms an enzymatical ly a c t i v e morpholo-
g i ca l subuni t . 
The two tryptophan res idues of the E2 component (Trp429 and 
Trp591) are located in the c a t a l y t i c domain. Fluorescence i s a 
powerful technique to i nd i ca t e the environment and changes in the 
environment of tryptophan r e s idues . Fluorescence emission spec t ra 
(not shown) i nd i ca t e t h a t both tryptophan res idues a re bur ied , 
belonging to type I (no ta t ion by Burnstein , ref . 32) . Upon 
add i t ion of GdnHCl up to 1 M a decrease in the emission a t 331 nm 
i s observed ( f i g . 4) and a small red s h i f t occurs to give a 
spectrum of the in termedia te type I I . Above 1.8 M GdnHCl a 
fur ther decrease a t 331 nm i s observed which i s due to a s h i f t of 
the emission to 359 nm , c h a r a c t e r i s t i c of a completely exposed 
tryptophan r e s idue . This coincides with the N-->D t r a n s i t i o n 
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Figure 3. Variation of the percentage of 
the mean residue ellipticity at 220 nm of 
E2 and the catalytic domain with varying 
GdnHCl-concentrât!ons. Circular dichroic 
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domain (x) were measured at 25°C at pro-
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Figure 4 , V a r i a t i o n of the f l uo re scence 
emission of Eg wi th v a r y i n g GdnHCl-
c o n c e n t r a t i o n s . F luorescence measurements 
a t Aem=330 nm (o) and Aem=359 nm (•) were 
c a r r i e d out a t 25°C a t 0.15 mg/ml and 
Xexc=295 nm. C o r r e c t i o n s for the 
i n f l u e n c e of GdnHCl on f l uo re scence 
emiss ion were made wi th samples con-
t a i n i n g t r y p t o p h a n i n s t e a d of p r o t e i n . 
discussed above. In comparison with f i g . 1 i t i s concluded t h a t 
the changes t h a t occur up to 1.0 M GdnHCl r e f l e c t the d i s s o -
c i a t i o n in to octamers. This causes a change in the environment of 
one or both tryptophan res idues from a completely buried type to 
an in termedia te exposed one. From 1.0 - 1.8 M GdnHCl, when the 
octamers d i s s o c i a t e to t e t r amers , almost no d i f fe rence in t r y p -
tophan f luorescence i s observed. Obviously the i n t e r a c t i o n s b e t -
ween the te t ramers a re d i f f e r e n t from those between the octamers. 
At s t i l l higher GdnHCl concent ra t ions the p ro te in unfolds and 
both tryptophan res idues become exposed. 
Cross l inking 
The c a t a l y t i c domain forms the same multimeric s t r u c t u r e as 
i n t a c t E2 but has a much lower molecular mass. This makes i t very 
s u i t a b l e for c r o s s - l i n k i n g experiments, followed by an a ly s i s with 
SDS-gele lec t rophores is . The c a t a l y t i c domain was incubated with 
the b i funct ional c ro s s l i nk ing reagent dimethylsuberimidate (DMS, 
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Figure 5. SDS-ge le lectrophores i s of the c a t a l y t i c domain of E2 cross l inked with various 
cross l inking , reagents . Cross l inking was carried out m 100 mM trietnanolamine-HCl pH B . 5 , for 
3 .5 h a t room temperature. Lane 1-3 , wi th 0 mM, 25 mM and 75 mM dimethylsuberimidate, r e s p e c -
t i v e l y , lane 4 , marker p r o t e i n s , lane 5, with 1.6 mM dimethyldodecylimidate, lane 6, with 14 mM 
dimethyladipyl imidate . Molecular masses are indicated in kDa. 
1.1 nm) a t pH 8.5 and 20°C for 3.5 h. The p ro te in concent ra t ion 
was kept low to avoid in termolecular c ro s s l i nk ing [33] . Analysis 
by SDS-gelelectrophoresis ( f i g . 5) showed t ha t c ro s s l i nk ing took 
place up to a t e t ramer . When a shor te r c ro s s l i nke r was used l i k e 
dimetyladipimidate (DMA, 0.9 nm) only monomer and dimer were 
found ( f i g . 5, lane 6) and us ing dimethyldodecylimidate (DMD, 
1.5 nm) only la rge mater ia l was found, not able to en te r the gel 
( f i g . 5 , lane 5 ) . These r e s u l t s confirm the proposed model of 
te t ramers being the morphological subuni ts of the l a rge , 24-meric 
core . Within the te t ramer the arrangement of subuni ts i s such 
t ha t a preference for d imer iza t ion e x i s t s . 
A model for the quaternary s t r u c t u r e of E2 
From the data presented above we conclude t ha t the i s o l a t e d E2 
from A.v ine land l i i s a 24-meric s t r u c t u r e , analogous to t h a t of 
E . c o l i . Unlike the E2~core of E . c o l i , upon add i t ion of the 
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peripheral components the A.vinelandii E2-core dissociates into 
tetramers. This gives a clue to the structure of the morphological 
subunits from which the E2~cube is bu i l t . A model for th is 
structure should explain 1) the stoichiometry and symmetry of 
component binding and 2) the dissociation and vice versa the 
assembly of the E2~cube. From the crystal structure (Schierbeek, 
personal communication) i t i s clear that the subunits in E3 are 
oriented around a twofold symmetry axis, as is the case with glu-
tathion reductase [35]. Binding of a single E3 dimer to E2 does 
i 
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Figure 6, A schematic model of the tetrameric A.vinelandii PDC. The tetrameric E2, which upon 
removal of the peripheral components aggregates to a 24-meric cubic s t ructure , represents the 
la tera l face of a cube. The Ej and E3 dimers possess a two-fold symmetry axis ( • ) . The E2-chain 
is indicated by L~C, in which L represents the lipoyl domain, C the ca ta ly t ic domain and the 
connecting region 330-380 is represented by a wavy l ine . 
The mobile lipoyl domain is not necessarily present at the indicated location. The dashed box 
represents the additional Ej binding s i t e at the rear face of the tetramer. 
not lead to dissociation [8] . Therefore a unique E3 binding s i t e 
is indicated in the centre of the tetramer, analogous to the 
structure proposed for the E.coli PDC [11]. The arrangement of E2 
subunits should obey this symmetry and therefore an arrangement 
is proposed as indicated in fig. 6. In this arrangement a dimer 
of dimers is assumed as indicated by the crosslinking experi-
ments. The binding s i tes of Ej and E3 are located in the con-
necting region (indicated in f ig. 6 by a wavy line) between the 
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lipoyl and catalytic domains. 
In the optimum catalytic stoichiometry three Ej dimers and 
one E3 dimer are bound to the E2 tetramer. Because competition 
between binding of E3 and Ej is observed [8] it is assumed that 
the subunit orientation in the Ej dimer is identical to the E3 
dimer. Compared to other 2-oxoacid dehydrogenase complexes the 
A.vinelandii PDC contains one additional binding site for Ej per 
E2 tetramer. We assume that this extra binding site becomes 
available during dissociation. This assumption is based on the 
observation that the dissociation is driven by component binding 
[8,13]. The additional binding site, indicated in fig. 6 by a 
dashed line, is located at the interface of the E2 tetramer that 
is involved in cubic assembly. The three potential Ej binding 
sites must have a comparable affinity for E^ because the extent 
of dissociation is proportional to the extent of binding. 
The model could also apply to the substructure of the E.coli 
PDC. Dissociation to an active 17S species of E.coli, in 
equilibrium with the usual 53-60S species, is observed [5,9]. The 
difference with the A.vinelandii E2 is probably due to the 
absence of the additional binding site for Ej, as no evidence is 
presented that the association-dissociation equilibrium of E.coli 
PDC is shifted by binding of components. 
The model does not explain the 2-step dissociation observed 
in the light-scattering experiments. According to the model the 
tetramers are considered to have equivalent positions in the 
cube. The fluorescence experiments indicate that the environmen-
tal changes which occur upon dissociation, as reported by tryp-
tophan fluorescence, are completed at the dimer stage. Apparently 
the tetramers associate in a different way to octamers than do 
the octamers to form the cube. Whether this 2-step process is due 
to the presence of Gdn-HCl or indicates the jji vivo pathway of 
assembly remains an open question. 
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Summary 
The studies described in this thesis deal with the structure of 
the Azotobacter vinelandii dihydrolipoyl transacetylase, the core 
component (E2) of the pyruvate dehydrogenase complex. 
In all organisms the pyruvate dehydrogenase complex is closely 
related to the 2-oxoglutarate dehydrogenase complex and, if 
present, the branched-chain 2-oxoacid dehydrogenase complex. 
These enzyme complexes are large multimeric structures. The 
smallest known is the pyruvate dehydrogenase complex from 
A.vinelandii. Upon resolution of the other components, the 
tetrameric core component of this complex aggregates to a well-
defined multimeric structure, resembling the structure from the 
large complexes from other organisms.. Therefore, it seems likely 
that the A.vinelandj i complex could represent the model for the 
building unit of the large complexes from other organisms. Since 
the core component (E2) carries all the information concerning the 
quaternary structure of the complex, we focussed our attention on 
this intriguing enzyme. 
The domain structure of E2 has been examined by limited proteoly-
sis of E2, as described in chapter 2. After limited proteolysis 
with trypsin two stable domains were obtained. The lipoyl domain 
carries the lipoyl groups which are concerned with the transport 
of the substrates between the active sites of the different com-
ponents. The catalytic domain possesses the transacetylase active 
site and the E2"intersubunit binding sites, responsible for the 
quaternary structure of E2. The binding sites for the Ej and E3 
components are lost during proteolysis. 
The cloning and sequencing of the gene encoding dihydrolipoyl 
transacetylase have been described in chapter 3. The gene, located 
downstream of the gene encoding the PDC Ej component, does not 
possess an own promoter, but is probably regulated by the 
Ej-promoter. The gene possesses a strong terminating sequence. 
Downstream the gene encoding E2 no open reading frame, that codes 
for the E3 component, has been identified, as has been found in 
E.coli. The primary structure of E2, derived from the DNA 
sequence, is homologous to that of E2 from E.coli. The lipoyl 
domain, located at the N-terminus, is built from three repeating 
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sequences, separated by regions which are very rich in alanine 
and proline residues. The catalytic domain, located at the C-
terminus, comprises the transacetylase active site and the Eg 
intersubunit binding sites. The region, located between the 
lipoyl and the catalytic domain contains many charged amino acid 
residues and is thought to possess the Ej and E3 binding sites. 
The expression of the gene encoding E2, located on plasmid pRA282 
and cloned in E.coli, has been described in chapter 4. A high 
production of Eg was obtained. The production raised dramatically 
when the cells were in the stationery phase of the growth-cycle. 
The percentage active Eg varied strongly per culture. The inac-
tivation was found to be caused by formation of intramolecular or 
intermolecular S-S-bridges, resulting in incorrect folding of the 
catalytic domain. An activation and an isolation procedure have 
been described. 
Mobility of the repeating units within the lipoyl domain has been 
studied using time-resolved fluorescence, as described in chapter 
5. It has been shown that the repeats show no independent 
rotational mobility, but rotate as one unit, serving the active 
sites of the different components. 
Internal mobility within the lipoyl domain has been observed by 
'H-NMR experiments, as described in chapter 6. Probably this 
internal mobility, that is ascribed to the alanine-proline rich 
region, does not result into an independent mobility of the three 
repeats. The catalytic domain, despite its compact structure, 
still possesses a certain amount of internal mobility. This can 
partly be ascribed to alanine and proline residues, probably the 
N-terminal region of the domain, which is rich in these residues. 
In the spectrum of Eg sharp resonances have been observed that can 
be ascribed to mobility of the Ej and E3 binding domain. Such 
mobility has not been found after binding of Ej and E3 components, 
in the whole complex. 
The molecular mass of the native catalytic domain and of the 
single polypeptide chain have been determined, and from this and 
light-scattering and crosslinking experiments it has been con-
cluded that the large multimeric structure of the isolated cataly-
tic domain (and of Eg) is built from 24 subunits in contrast to a 
32-meric structure as proposed previously. A model has been pre-
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sented for the quaternary structure of E2, in which it is assumed 
that the multimeric E2-core is built from six tetrameric morpholo-
gical subunits, forming the lateral faces of the cubic 24-mer. 
These tetrameric subunits represent the E2~core of the intact 
complex. Compared to other 2-oxoacid dehydrogenase complexes, the 
A.vinelandii PDC contains one additional binding site for Ej per 
E2 tetramer. It is assumed that this extra binding site becomes 
available during dissociation, resulting in the unique small PDC 
of A.vinelandii. 
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Samenvatting 
Suikers, die we door onze voeding opnemen, worden in het lichaam 
afgebroken tot energierijke verbindingen. Een belangrijke stap in 
dit proces is de omzetting van pyruvaat in acetylCoA dat 
vervolgens in de citroenzuurcyclus verder wordt omgezet tot 
energierijke verbindingen, zoals ATP, nodig om cellen en organen 
optimaal te doen funktioneren. De omzetting van pyruvaat in 
acetylCoA vindt plaats o.i.v. het pyruvaat dehydrogenase complex 
(PDC), een complex van drie verschillende enzymen. Door als 
complex aanwezig te zijn kunnen deze enzymen efficiënter funk-
tioneren dan in het geval dat ze elk apart zouden voorkomen. Het 
produkt van het eerste enzym (Ej) is direct op de goede plaats om 
te reageren met enzym twee (E2), dat vervolgens zijn produkt weer 
direkt kan afgeven aan enzym drie (E3). 
Het complex is opgebouwd uit een vast aantal E2 componenten, waar 
de Ei en E3 componenten aan kunnen binden. Het complex is een van 
de grootste enzymcomplexen die in de cel voorkomen, van ongeveer 
dezelfde grootte als ribosomen. De grootte van het PDC verschilt 
per organisme en wordt gedikteerd door de quaternaire structuur 
van de E2 component. In zoogdieren bestaat het bv. uit 60 E2 
ketens, terwijl het in gram-positieve bacteriën en in de gram-
negatieve darmbacterie E.coli uit 24 E2 ketens is opgebouwd. 
Het onderzoek, dat in dit proefschrift beschreven is, handelt 
over PDC uit de gram-negatieve bacterie Azotobacter vinelandii• 
Het unieke van dit PDC is dat het is opgebouwd uit slechts vier E2 
ketens. De vraag die we ons dan ook stellen is of de grootte ook 
een funktionele betekenis heeft. Ook is het van belang te weten 
hoe de reakties binnen zo'n complex verlopen. Om dit te bestuderen 
is onderzoek naar de structuur van het eiwit noodzakelijk. Omdat 
veel van de karakteristieke eigenschappen van het complex op E2 
gelegen zijn, is de aandacht op dit enzym gericht. 
In de inleiding (hoofdstuk 1) is een overzicht gegeven wat er 
over PDC (en twee verwante enzymcomplexen, OGDC en BCOADC) bekend 
is. De vraag wordt gesteld of het kleine PDC uit A.vinelandii de 
bouwsteen kan zijn van de grotere enzymcomplexen. Omdat ook in het 
onderzoek geldt: "hoe kleiner, hoe eenvoudiger", neemt PDC uit 
A.vinelandii een centrale plaats in in het totale onderzoek aan 
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deze enzymcomplexen. 
De domeinstructuur van E2, de opbouw van de eiwitketen, is 
onderzocht m.b.v. beperkte Proteolyse, hetgeen beschreven is in 
hoofdstuk 2. Na digestie van natief E2 met trypsine worden twee 
stabiele domeinen verkregen: het lipoyl domein, dat de 
lipoylgroepen bezit die het transport van de substraten tussen de 
verschillende componenten verzorgen, en het katalytisch domein, 
dat de actieve plaats bezit en de bindingsplaatsen voor de E2 
subeenheden, die de quaternaire structuur van het complex 
bepalen. De bindingsplaatsen voor de Ej- en E3 component zijn 
door Proteolyse verloren gegaan. 
In hoofdstuk 3 zijn de clonering en sequentiebepaling van het gen 
dat codeert voor E2 beschreven. Het gen dat codeert voor E2 ligt 
op de DNA keten stroomafwaarts van het gen dat codeert voor Ej. 
Het bezit geen eigen promoter, maar wel een sterke terminatie 
sequentie. De aminozuurvolgorde van E2, is uit de DNA sequentie 
afgeleid en komt sterk overeen met de aminozuurvolgorde van E2 uit 
E.coli. Het lipoyl domein, dat N-terminaal gelegen is, bestaat uit 
drie repeterende sequenties, met daartussen gebieden van 20-30 
aminozuren die zeer veel alanine- en proline residuen bevatten. 
Het katalytisch domein ligt C-terminaal. Het gebied tussen het 
lipoyl en katalytisch domein, waarvan gedacht wordt dat het de 
bindingsplaatsen voor de Ej- en E3 component bezit, bevat veel 
geladen aminozuren. 
Het gen, dat codeert voor A.vinelandii E2, is in een plasmide 
gezet en gedoneerd in E.coli, zoals beschreven is in hoofdstuk 4. 
In E.coli werd een hoge produktie aan A.vinelandii E2 gevonden, 
ongeveer 15 maal zo hoog als in A.vinelandii zelf. De produktie 
van E2 nam sterk toe als de cellen in de stationaire fase van de 
groeicyclus waren. Een deel van het E2 (variërend per celkweek) 
bleek inaktief te zijn. De oorzaak hiervan bleek te liggen in de 
vorming van (normaal niet voorkomende) intermoleculaire- of intra-
moleculaire S-S-bruggen. Een methode om het enzym weer aktief te 
krijgen en een methode om het uit E.coli te isoleren zijn in 
hoofdstuk 4 beschreven. 
De mobiliteit van het lipoyl domein is bestudeerd zoals beschreven 
in hoofdstuk 5. Door het lipoyl domein specifiek te labelen kon 
m.b.v. tijdsafhankelijk fluorescentie anisotropic verval aange-
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toond worden dat het lipoyl domein als geheel erg beweeglijk is, 
maar dat geen onafhankelijke beweeglijkheid van de drie repe-
terende structuren in het lipoyl domein aanwezig is. Ook is de 
mobiliteit onderzocht m.b.v. proton NMR, zoals beschreven in 
hoofdstuk 6. De drie alanine-proline rijke gebieden, die tussen de 
drie repeterende strukturen in het lipoyl domein liggen, bleken 
wel mobiel te zijn, maar blijkbaar resulteert deze mobiliteit niet 
in een afzonderlijke beweeglijkheid van de repeterende strukturen. 
In E2 bleek het Ej- en E3 bindings domein ook zeer mobiel, terwijl 
na binding van de componenten (in PDC) geen mobiliteit meer werd 
gevonden. Omdat in PDC het lipoyldomein nog steeds beweeglijk is, 
moet zich tussen het lipoyl domein en het Ej- en E3 bindingsdomein 
een scharnierpunt bevinden. Het katalytisch domein bleek ook een 
mobiel gedeelte te bezitten, waarschijnlijk een deel van de N-
terminus van dit domein. Hier zou een tweede scharnierpunt kunnen 
liggen, dat verantwoordelijk is voor de beweeglijkheid van het 
Ej-en E3 bindingsdomein. 
Het E2 aggregeert, na verwijdering van de gebonden E^-en E3 com-
ponenten tot een grote E.coli-achtige structuur. Het katalytisch 
domein heeft eenzelfde struktuur. Uit vroegere metingen werd een 
struktuur verondersteld, bestaande uit 32 ketens. In hoofdstuk 7 
is beschreven, dat uit bepalingen van het molecuulgewicht van het 
natieve katalytisch domein en dat van de enkele keten, alsmede uit 
lichtverstrooiiings- en cross]inking experimenten kan worden 
gekonkludeerd dat het katalytisch domein (en E2) bestaat uit 24 
ketens. Dit betekent dat A.vinelandii PDC meer op E.coli lijkt dan 
altijd gedacht werd. Een model is voorgesteld, waarin zes 
A.vinelandii PDC's kunnen aggregeren tot een E.coli-achtig PDC. 
Het verschil tussen de twee complexen kan een extra bindingsplaats 
voor de Ej component op A.vinelandii E2 zijn. Na dissociatie van 
de grote structuur komt deze bindingsplaats vrij, wat resulteert 
in de unieke structuur van A.vinelandii PDC. 
Het (relatief) kleine A.vinelandii pyruvaat dehydrogenase complex 
lijkt dus model te staan voor de grotere pyruvaat dehydrogenase 
(en verwante) complexen uit andere organismen. 
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